the journal of pharmacy practice and research · ahmed d see sonallah h 2014 159 ... journal of...

JOURNAL OF

Pharmacy Practice and Research

Cumulative Author Index 1994-2014

Volumes 24-44

Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 2

Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014

Author Title or 1st Author Year Page

Abarno AC Comprehensive approaches to improving minds and lives [letter] 2009 331

Abarno AC See Cheh RM 2010 184

Abarno AC See Winter SJ 2013 11

Abbott F Certification in geriatric pharmacy exam in Hobart 2002 95

Abd Wahab MS Liberalisation of pharmacist training: the need to reflect on pharmaceutical education in Malaysia

[letter]

2013 162

Abdelmessiah D Ensuring appropriate use of high cost drugs: octreotide [letter] 1997 250

Abdolkarim P Survival following severe aluminium phosphide poisoning 2002 297

Abdollahi M See Abdolkarim P 2002 297

Abdollahi M Review of drug-induced skin reactions 2003 12

Abdulwahab A Do Saudi community pharmacists know how to use MDIs? [letter] 2012 77

Abu Hassan F See Leow FH 2006 194

Accordino A A short-term stability study of an oral solution of dexamethasone 1994 312

Accordino A The stability of a topical solution of cocaine hydrochloride 1996 629

Acharya LD See Ghosh S 2006 246

Acharya R See Thunga G 2013 163

Acharya RV See Singh A 2014 60

Adams J Pharmacists and complementary medicine in Australia [letter] 2004 73

Adams RC See Seaton SM 2010 199

Addison RS See Roberts JA 2009 198

Adepu R See Nagavi BG 2005 332

Adhikari O See Bedi TR 2006 164

Adu A Ciprofloxacin usage in a community hospital 1994 318

Adu A Drug utilisation review of filgrastim in three teaching hospitals 1995 336

Adu A Survey of pharmacy resources needed to implement hospital antibiotic policies 1999 92

Agar M See Currow DC 2012 91

Agarwal J Need for an acute poisoning registry data base in India [letter] 2014 162

Ahlgren KL See Leversha A 2001 130

Ahmad FJ See Khan ZI 2005 328

Ahmad KM See Hasan SS 2010 294

Ahmadi K See Hasan SS 2010 294

Ahmadi-Abhari SA Lithium erythrocyte concentration and neurological toxicity in bipolar disorder 2005 103

Ahmed D See Sonallah H 2014 159

Ahuja A See Khan ZI 2005 328

Aikman KL Adherence to guidelines for treating community-acquired pneumonia at a New Zealand hospital 2013 272

Ailakis JG See Stafford L 1998 246

Al Hadithy AF Thiopurines for inflammatory bowel disease: role of pharmacogenetics 2005 213

Al Harbi G See Roberts GW 2012 200

Alabid AH Malaysian community pharmacists' professional practices and services [letter] 2010 164

Alabid AH Dispensing practices of general practitioners and community pharmacists in Malaysia - a pilot study 2013 187

Alam K See Bedi TR 2006 164

Alam K See Izham MI 2008 331

Aldama PC Prescribing patterns and consumption of medication in a rural community in Mexico [letter] 2003 330

Alderman CP Hospital pharmacists — believe in yourselves 1994 45

Alderman CP Atypical presentation of the neuroleptic malignant syndrome 1994 245

Alderman CP Nephroprotective effects of the angiotensin converting enzyme inhibitors in diabetic renal disease 1995 410

Alderman CP The role of angiotensin converting enzyme inhibitors after myocardial infarction 1995 511

Alderman CP Cogito ergo sum [ed] 1996 210

Alderman CP See Ng D 1996 358

Alderman CP See Cosh D 1996 673

Alderman CP See Lim JW 1997 33

Alderman CP A preliminary study of the effects of venlafaxine on 24-hour urinary catecholamine excretion profile 1997 232

Alderman CP Clinical pharmacy input into a respiratory rehabilitation program [practice report] 1998 181

Alderman CP Perhexiline-paroxetine drug interaction [clinical communication] 1998 254

Alderman CP Medication alert cards to minimise antidepressant drug interactions [practice report] 1998 259

Alderman CP See Ryan MJ 1998 304

Alderman CP See Cosh DG 1998 334

Alderman CP See Wiese MD 1999

Alderman CP Creating the future of clinical pharmacy in Australia 1999 29

Alderman CP Pindolol augmentation of antidepressant therapy 1999 146

Alderman CP E-Pharmacy - the future is here [ed] 2000 44

Alderman CP Geriatric pharmacy practice - an emerging specialty in Australia [ed] 2000 91




Alderman CP Nitrous oxide abuse in a community setting: case report [clinical communication] 2000 109

Alderman CP Syndrome of inappropriate antidiuretic hormone secretion secondary to venlafaxine 2002 35

Alderman CP An international perspective on psychiatric pharmacy 2002 303

Alderman CP See Ng KH 2004 183

Alderman CP See Kethini T 2004 308

Alderman CP Caring in a time of disaster war and tragedy [ed] 2005 7

Alderman CP Caring after traumatic times [ed] 2010 7

Alderman CP See Cheh RM 2010 184

Alderman CP See Winter SJ 2013 11

Alderman CP What should a Journal really be about? Where the JPPR came from and where it is going next? [ed] 2013 93

Alderman CP The health of politics and the politics of health [ed] 2013 176

Alderman CP Our duty of care towards older people [ed] 2013 260

Alderman CP See Chan TW 2013 269

Alderman CP See Tran W 2013 283

Alderman CP The true impact of changes to professional services program in Australian pharmacy [ed] 2014 4

Alderman CP See Westaway KP 2014 44

Alderman CP Some thoughts about a good death [ed] 2014 73

Alderman CP The challenges of HIV [ed] 2014 175

Aldous D Drugs and medical conditions affecting the periodontum 1994 80

Alexander M Does outpatient status really confer lower thrombotic risk? [letter] 2014 163

Alexander M See Thakerar A 2014 231

Alexander S Fred J Boyd Award 2007 2007 315

Alexander SM Expanding roles for technicians 1994 84

Alexander SM Technicians' program — beyond the imprest cupboard. Management's expectations 1996 62

Al-Harbi Y See Abdulwahab A 2012 77

Ali AA See Abd Wahab MS 2013 162

Allen A Adequate training: enough to get by or could there be more to it? [letter] 2010 246

Allen B See Mottram MC 1997 290

Allen K PBS in public hospitals [letter] 2004 244

Allen K See Roberts JA 2007 200

Allen KM See Ryan M J 1998 304

Allen KM Hospital pharmacy- making a difference 2001 9

Allen P Handbook of nonprescription drugs: an interactive approach to self-care [book review] 2005 81

Allinson Y Fred J Boyd Award 2013 2013 304

Allinson YA See O'Leary KM 2012 259

Allinson YM See O'Leary KM 2002 72




Allinson YM See Stowasser DA 2004 293




Alraman H See Barras M 2011 183

Al-Sallami HS MDI with spacer versus nebuliser for acute exacerbation of asthma-a literature review 2001 189

Alshakka M See Maarup N 2011 49

Al-Sulaiti FK See Ibrahim MIM 2013 79

Alurkar VM See Mishra P 2006 81

Alvarez SJ See Harding AM 1999

Alvarez SJ Education outreach to the community: does hospital pharmacy have a role? 2001 13

Al-Worafi YM Do community pharmacists need a workshop about MDI use? [letter] 2013 165

Al-Worafi YM Towards supporting clinical pharmacy research in Arabic countries [letter] 2013 247

Al-Worafi YMA See Manan MM 2014 83

Amadio M Formulation of nitrazepam oral solution [letter] 1996 371

Ambados F Compatibility of morphine and ketamine for subcutaneous infusion [letter] 1995 352

Ambados F Incompatibility between aminophylline and elemental zinc injection [letter] 1996 370

Ambados F Incompatibilities with trace elements during TPN solution admixture 1998 112

Ambados F Precipitation of potassium sulphate in TPN admixture [letter] 1998 444

Ambados F Destabilisation of fat emulsion in total nutrient admixtures by concentrated albumin 20% infusion 1999 210

Ambados F Incompatibility between concentrated albumin 20% infusion and trace element injections [letter] 2000 71

Ambados F Topical haemostatic agents: avoid multi-use containers [letter] 2000 229

Ambados F Incompatibility between calcium and sulfate ions in solutions for injection 2002 307




Ambados F Phenytoin stability [letter] 2005 80

Ambados F Surface contamination from cytotoxic chemotherapy [letter] 2008 80

Ambados F See Lee SG 2009 181

Ambados F Eliminating cytotoxic background [letter] 2009 247

Ambados F Preparation method and stability of a temozolide suspension: a pilot study 2012 111

Ambados G See Lee SG 2007 271

Amerena J See Weeks GR 2012 17

Amir M Successful trial of pharmaceutical care services in a community pharmacy in Karachi [letter] 2011 78

Amornsak W See Thawornchaisit P 2012 189

Anderson BA See Toy AC 2006 35

Anderson BA See Yu K 2007 22

Anderson BA See Nguyen A 2007 111

Anderson EA See Cheong EA 2008 267

Anderson EA See Davis SR 2010 31

Anderson PO See Knoben JE 1994 176

Anderson PO Dosage of drugs in breast milk [letter] 1996 288

Anderson S ISOPP/HOPA conference 2008 [letter] 2008 327

Andrews C See McFarlane AE 1996 635

Andrews HP Fall-related hospital admissions in elderly patients: contribution of medication use 2001 183

Ang P See Ng SP 1998 177

Ang T-S Extravasation of high-dose methotrexate: a case about nothing [clinical communication] 1998 430

Ang WC See Manan MM 2014 83

Angalakuditi M Impact of an educational program on antibiotic use in paediatric appendectomy procedures 2005 21

Angalakuditi M Paediatric severe community-acquired pneumonia in India 2005 183

Angley M See Lovgren S 2009 269

Angley M Feasibility and timeliness of alternatives to post-discharge HMRs for high-risk patients 2011 27

Angley M See Padhye V 2012 273

Angley M See Ellis D 2013 190

Angley M Advocating for patients and the pharmacist’s role in primary care [ed] 2014 6

Angley MT See Grzeskowiak LE 2008 9

Angley MT See Bollella G 2008 107

Anh AV Modelling drug loss during IV infusion to premature neonates 2006 262

Anticevich-Bosnic SZ See Nguyen YB 2010 211

Antoni R See Elliott RA 2014 95

Anwar M See Hasan SS 2010 294

Aprea S See Zolezzi M 2007 11

Aqil M See Jindal D 2005 331

Armenores P Survey of clopidogrel use in a teaching hospital 2006 40

Armour CL See Adu A 1994 318

Armour CL See Adu A 1995 336

Armour CL See Katsogiannis W 1996 529

Armour CL Penicillin allergy in two Sydney teaching hospitals 1998 410

Armour CL See Adu A 1999

Armour CL See To NN 1999

Arnold M See Murnane JM 2013 109

Arumugam K European palliative care conference [letter] 2003 329

Asamoah P See Zolezzi M 2007 225

Asghar MN See Young J 2006 275

Askew D See McDonald PK 2003 114

Askew D See McDonald PK 2003 114

Aslani P See Koo MMM 2005 94

Aslani P See Gu P 2011 196

Assef IL See Aldama PC 2003 330

Atif M See Saleem F 2011 333

Atkin PA See Kristoffersen SS 1997 367

Atkin PA See Armour CL 1998 410

Attia MF Warfarin/complementary medicine interaction [letter] 2000 23

Atwa H See Ibrahim MIM 2014 62

Austin NC See Kunac DL 2010 290

Avent M Controversies in infectious diseases [letter] 2006 245

Avent M See Coombes I 2010 111

Avent M See Chu KP 2010 119




Avent ML See Poh EW 2009 176

Avent ML Drug use evaluation services in Australia and New Zealand: a neglected area of research? 2010 15

Avent ML See Shah SS 2013 129

Awaisu A See Ibrahim MIM 2014 62

Awasthi S Corticosteroid an ambiguity in ARDS [letter] 2013 248

Badarudin NZ See Hasan SS 2010 294

Badov D See Lam A 2013 297

Bahri S See Leng CB 2011 250

Bailey M Controversies in vaccination with measles mumps rubella (MMR) vaccine [letter] 1998 443

Bailey M Public health pharmacy practice and pharmaceutical service development 1999 118

Bailey M Pharmaceuticals as new technology: the driving forces 1999 335

Bailey M See George J 2006 99

Bailey MC See Attia MF 2000 23

Bajorek B See Buchan DS 2008 200

Bajorek B See Kong MS 2008 205

Bajorek B See Nasser S 2012 129

Bajorek BV A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation 2001 93

Bajorek BV See Hanes CA 2005 178

Bajorek BV See Valiya SN 2005 279

Bajorek BV See Khoo A 2006 190

Bajorek BV See Kay OC 2006 199

Bajorek BV See Nguyen NA 2008 35

Bajorek BV See Vracar D 2008 96

Bajorek BV See Page MA 2008 286

Bajorek BV See Su EY 2008 292

Bajorek BV See Glover S 2008 300

Bajorek BV Management of - over-anticoagulation in warfarinised hospital patients 2009 13

Bajorek BV See Yip A 2010 285

Bajorek BV Conducting your pharmacy practice research project. A step-by-step guide [book review] 2011 82

Bajorek BV See Cao BY 2011 102

Bajorek BV See Kumar N 2011 108

Bajorek BV See Lee YF 2011 283

Bajracharya O See Shankar PR 2009 245

Bajramovic J See Burrows J 2002 315

Baker JL Mandatory electronic sources of approved product information-are they up-to-date? 2005 295

Baker S Tribute to I Brand [letter] 2000 73

Baker S Community pharmacy: symptoms diagnosis and treatment [book review] 2008 82

Baker SJ Getting published 1994 410

Baker SJ Blurred vision and psychotropics [inform] 1995 47

Baker SJ The light's better over here: new antidepressants on the horizon 1996 98

Baker SJ A history and philosophy of pharmaceutical research I. Some thoughts on Popper Kuhn and other

philosophers

1996 331

Baker SJ History and philosophy of pharmaceutical research II. Is pharmaceutical research scientific? 1996 337

Baker SJ Who can read consumer product information? 1997 126

Baker SJ In Reply to 'Who can read consumer product information?' [letter] 1997 253

Baker SJ Hospital pharmacists a place in mainstream clinical research? 1998 348

Baker SJ Olanzapine for schizophrenia: in reply 1999 54

Ball P Is clinical pharmacy in vein? [ed] 2003 256

Ball P Clinical pharmacy formulation for a better future? [ed] 2006 172

Ball P See Flavel D 2012 121

Ball PA See Monk PM 1997 323

Ball PA See Kunac DL 1999

Ball PA What is a pharmacist? [ed] 2000 44

Ball PA See Scott-Walker TM 2000 157

Ball PA Clinical pharmacy: what stage of evolution have we reached? 2000 250

Ball PA See Al-Sallami HS 2001 189

Ball PA See Mirkov SR 2003 199

Ball PA Anticholinergic burden assessed using general practice electronic records 2013 202

Ball PA See Bushell MA 2013 292

Ballantine DL Use of acid suppression medications in postoperative cardiac surgical intensive care unit patients 2014 108

Bandiera E See Tucci J 2009 223

Banks SL See Lim CB 2003 59




Barazanchi N See Tordoff JM 2006 12

Barker BJ See Hambridge JA 2001 121

Barlow MJ Pharmacological management of erectile dysfunction in the older male 1995 168

Barnes M See Zolezzi M 2007 11

Barnett LM See van Beurden E 2003 51

Barras M Abnormal laboratory results 2002 159

Barras M Effective conference presentations [letter] 2004 157

Barras M See Sim L 2005 276

Barras M See Roberts JA 2007 200

Barras M See Gujral GR 2009 202

Barras M Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis 2011 183

Barras M Abnormal laboratory results 3rd edition [book review] 2011 330

Barras MA See Rofail S 2006 29

Barras MA Individualised vs conventional enoxaparin dosing [letter] 2008 77

Barratt JD See Bell JS 2011 316

Barratt JD See Kalisch LM 2013 182

Barry AR Making hospital pharmacists indispensable on the healthcare team: revolution in waiting [ed] 2009 256

Barton-Smith KY Developing a medication reconciliation form [letter] 2008 162

Basavanagowdappa H See Joseph J 2010 279

Basheti IA See Nguyen YB 2010 211

Basurto I See Traverso ML 2004 246

Batagol RP Drugs and breastfeeding [letter] 1996 454

Bates I See Coombes I 2010 111



Batty KT Manual of travel medicine: a guide for practitioners at pre-travel clinics 1999 181

Batty KT See Clifford RM 2003 260

Batty KT See Nita Y 2005 9

Baume P New realities 1994 12

Bayles M Cytotoxic manufacturing: what a load of rubbish 1999 213

Bayles M See Siderov J 2002 178



Baysari MT Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch' [ed] 2012 178

Baysari MT Error prone abbreviations in hospitals: is technology the answer [letter] 2012 246

Baysari MT See Teo CK 2013 32

Baysari MT See Brett J 2013 97

Baysari MT Electronic medication information sources: understanding the needs and preferences of health

professionals

2013 288

Beaton M Cardiotoxicity from non-sedating antihistamines [inform] 1995 193

Becket G See Fawcett JP 1996 552

Bedi TR Corticosteroid-induced avascular necrosis [letter] 2006 164

Begg EJ See Pearce MJ 1995 13

Begg EJ See Mottram MC 1997 290

Behan KP Not seeing the light? 2010 222

Behayaa M See Garg S 2008 28

Behjati M Elevated INR despite warfarin discontinuation [letter] 2012 77

Bekur R See Singh A 2014 60

Belfrage MK See Elliott RA 2009 216

Bell JS See Moles RJ 2007 265

Bell JS Prescriber feedback to improve quality use of medicines among older people: the Veterans' MATES

program

2011 316

Bell JS See Grzeskowiak LE 2012 5

Bell JS See Chan TW 2013 269

Bell K Federal Government support for the quality use of medicines 1996 55

Bell SC See Burrows J 2002 315

Bellette PK See Clark LM 2001 134

Bellomo R See Klemz K 2008 296

Belz MM See Crosara SLR 2013 221

Belz SA Afatinib after disease progression with gefitinib in advanced adenocarcinoma of the lung 2013 137

Bennett A Perceived barriers by hospital pharmacists to become accredited to perform med reviews in the home 2003 183

Bennett A Pharmacist's role in chronic disease management [letter] 2007 81




Bennett AA See Hargraves TL 2008 103

Bennett S Australian Clinical Pharmacy Award 2013 2013 309

Bennett S See Angley M 2014 6

Benoussan Al See Drew A 2000 71

Benporath CH See Jackson JK 2001 262

Benrimoj SI A review of drug distribution systems: part 1—current practice 1995 119

Benrimoj SI A review of drug distribution systems: part 2—automated dispensing for unit dose systems 1995 230

Benrimoj SI See Smith MA 2002 227

Benrimoj SI See Moles RJ 2007 119

Benson HA Optimisation of drug delivery I. Principles of oral absorption and limitations of conventional oral

dosage forms

1997 222

Benson HA Optimisation of drug delivery 2. Principles of drug delivery and limitations of conventional non-oral

dosage forms

1997 313

Benson HA Optimisation of drug delivery 3. Sustained/controlled-release oral drug delivery 1997 381

Benson HA Optimisation of drug delivery 4. Transdermal drug delivery 1997 441

Benson HA Optimisation of drug delivery 5. Pulmonary drug delivery 1998 19

Benson HA Optimisation of drug delivery 6. Modified-release parenteral 1998 99

Benson HA See Prankerd RJ 1998 165

Benson HA Optimisation of drug delivery 8. Mucosal drug delivery via the nose and mouth 1998 236

Benson HA Optimisation of drug delivery 9. Mucosal drug delivery via the eye vagina uterus and rectum 1998 318

Benson HA Optimisation of drug delivery 10. Site-specific drug delivery of small-molecules 1998 417

Benson HA See Prankerd RJ 1999

Benzie JL Experience with clinical indicators 6.2 and 6.3 [letter] 1994 174

Benzie JL Support staff in hospital pharmacy practice - a decade of change 1997 430

Berbatis CG Response to `TDM: clinical pharmacy activity with a shortening half-life?' [letter] 1996 671

Berbatis CG Methadone programs in Australia [letter] 1996 674

Berbatis CG University training in clinical testing for pharmacists in 1997 [letter] 1997 470

Berbatis CG Methadone programs harm reduction chronic diseases and hospital pharmacists 1998 41

Berbatis CG National evaluation of pharmacy services in methadone maintenance treatment 2001 309

Berbatis CG National study of pharmacy practice in Australian community settings in 2002 2002 16

Berbatis CG National survey of Australia's community pharmacies in 2002: rationale and methodology 2002 143

Berbatis CG National Community Pharmacy Database Project 2002 177

Berbatis CG See Wibowo Y 2012 26

Bereznicki L Closing the gap between evidence and practice [ed] 2005 173

Bereznicki LR Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation [letter] 2006 162

Bereznicki LR Improving clinical outcomes for hospital patients initiated on warfarin 2007 300

Bereznicki LR See Luinstra MM 2009 265

Bergin PJ See Korajkic A 2011 126

Berry PR See Scott-Walker TM 2000 157

Bessell TL See Marriott JL 2008 114

Bessell TL See Marriott JL 2008 117

Betke T See FitzGerald KH 2000 21

Bettenay K See Coombes I 2010 111

Betteridge F Evaluation of a weight-based heparin drug chart [letter] 2007 78

Beulke SH First-aid treatment of dermal exposure to hydrofluoric acid [letter] 1998 445

Beulke SH Casarett and Doull's toxicology: the basic science of poisons 5th edition 1999 74

Beulke SH European Association of Poisons Centres and Clinical Toxicologists international congress 2001 62

Bhagvandas NS Need for a poisons database in developing countries [letter] 2013 247

Bhandakar AA See Agarwal J 2014 162

Bhindi AK Optimisation of digoxin maintenance dose in toxicity 2010 50

Bhojraj S See Kaleemuddin M 2001 26

Bhosle MJ See Sansgiry SS 2004 262

Bialy LH Trans-Tasman comparison of non-prescription medicine purchasing behaviour 2007 277

Bian JE See Easton-Carter KL 2002 235

Bicknell ME Off-label drug use in an outpatient setting — a pilot study 1995 527

Biddle RA Survey of women's attitudes to complementary medicines 2003 55

Billy R See Tordoff JM 2006 12

Bingham JM Taxus brevifolia: clinical gem or endangered species 1994 72

Bingham JM Australian register of imported drugs (ARID) [letter] 1994 440

Bingham JM See Vernon GM 1995 32

Bingham JM Neoplastic fever: is there any effective therapy? [inform] 1995 293

Bingham JM Cancer pain and the enigma of analgesia 1996 113




Bingham JM Safe handling of early phase investigational agents [letter] 1996 287

Bingham JM See Howitt KM 1996 315

Bingham JM EXTRA a database to record analyse and disseminate information on the extravasation of cytotoxic

drugs [letter]

1996 372

Bingham JM EXTRA a database to record and review cytotoxic drug extravasation events 1998 89

Bird MR Gonadal hormone replacement therapy in the elderly 1996 564

Bird MR Urinary incontinence in the elderly 2004 319

Birdsey G Australian Clinical Pharmacy Award 2010 2010 315

Birdsey GH Pharmacist-initiated electronic discharge prescribing for cardiology patients 2005 287

Bista D See Mishra P 2005 165

Black AJR See Birdsey GH 2005 287

Blackah J Written consent and SAS drugs [letter] 1994 281

Blennerhassett J Lithium concentration in liquid preparations made from lithium carbonate tablets [letter] 1994 439

Blennerhassett J Medication safety and patient participation: pharmacist emergency department and beyond 2005 244

Blennerhassett J A novel medicines management pathway 2006 175

Blennerhassett J Medicine management in older people from non-English speaking backgrounds 2011 33

Blewitt P See deClifford JM 2012 134

Blogg LC Prescribing benzodiazepines in residential aged-care facilities 2012 287

Blumgart AF See Loe EA 2008 209

Boddy M See Smith BA 1996 560

Boeker EB Development and implementation of a ward-based pharmacy intervention for Dutch surgical patients 2013 41

Boermeester MA See Boeker EB 2013 41

Bogovic A Development of a home infusion program for the treatment of children with primary pulmonary

hypertension

2000 222

Boland C See Aldous D 1997 341

Boland C See Bereznicki LR 2007 300

Bollella G Optimal level of liaison pharmacist intervention to facilitate a post-discharge home medicines review 2008 107

Bollenhagen S Technicians over the border [letter] 2004 73

Bolton PG Impact of medication review by general practitioners and patient peer education 2004 8

Bong XJ See Angley M 2011 27

Bong XJ See Padhye V 2012 273

Bonollo M See Stell R 2008 132

Bonwick RJ The role of antidepressants in the elderly [geriatric therapeutics] 1998 187

Boon Ou DK See To TP 2005 33

Booth D See Chieng R 2014 105

Booth J Operating suite pharmacy practice in the UK [letter] 2011 332

Booth J See To T-P 2013 177

Booth JC Establishing clinical pharmacy services in the operating suite 2012 296

Booth JC See To TP 2014 89

Booth JC See Elliott RA 2014 258

Booth JL The ACHS' changing approach to quality in health care 1996 86

Borgstedt J Pre-admission and post-hospital management of heart failure in patients not enrolled in specialist

programs

2009 186

Bortoletto DA Patients' attitudes to discharge medications supplied under the PBS 2004 288

Bortoletto DA See Birdsey GH 2005 287

Bortoletto DA See Muir PR 2007 187

Boston A Epidural infusions 1999 346

Boulton DW The stability of an enalapril maleate oral solution prepared from tablets 1994 151

Boulton DW See Fawcett JP 1995 19

Bounda G-A See Hui HZ 2012 166

Bowen L Stability of frusemide tablets repackaged in dose administration aids 2007 178

Bowman SL See Simpson MD 2004 26

Boxall A-m See Lehnbom EC 2009 207

Boyce LE Audit of general practitioner medication lists for older patients at a regional hospital 2013 105

Boyce M See Yu K 2007 22

Boyce M See Nguyen A 2007 111

Boyd IW Co-dispensing of contraindicated drugs with cisapride 2008 23

Boyd RGD See Jackson JK 2005 28

Boyle Clare M Missed doses: an evaluation in two drug distribution systems 1998 413

Bradshaw-Leung H See Zolezzi M 2007 11

Braitberg G See McD Taylor D 2006 96

Braitberg G Therapeutic guidelines: toxicology & wilderness [book review] 2008 334




Braitberg G See Marmor GO 2011 113

Braitberg G Toxicology handbook 2nd edition [book review] 2011 164

Bramley-Moore SR Patterns of analgesic prescribing for patients with chronic non-malignant pain in NSW 1998 83

Brand IAG Fred J Boyd award [conference presentation] 2000 16

Branford D See Wheeler AJ 2007 33

Branley P See Pellizzer AM 1998 432

Braun L Herbal medicinal products [book review] 2004 160

Braun L Herbal remedies. 5th edition, [book review] 2004 160

Braun LA Australian hospital pharmacists' attitudes perceptions knowledge and practices of CAMs 2007 220

Brealey J See Ambados F 1998 112

Brealey J See Ambados F 1998 444

Brett J See Baysari MT 2012 178

Brett J Pneumonia severity scores and prescribing antibiotics for community-acquired pneumonia at an

Australian hospital

2013 97

Brien J Clinical pharmacy services in 2020 [editorial] 2013 9

Brien JE See Campbell B 1995 327

Brien JE See Simioni D 1996 221

Brien JE Career opportunities for pharmacists [career opportunities] 1998 267

Brien JE See McConachy KA 1999

Brien JE See McLennan DN 1999

Brien JE A new course in clinical pharmacy in Victoria 1999 95

Brien JE Pharmacokinetics made easy 1999 236

Brien JE Challenges to the profession [ed] 2000 46

Brien JE Pharmacy practice research [ed] 2000 192

Brien JE See Tan EL 2003 65

Brien JE See Easton-Carter KL 2003 106

Brien JE See Slader CA 2003 157

Brien JE Pharmacy leadership and multidisciplinary partnerships [letter] 2003 158

Brien JE Pharmacogenomics-clinical and social implications 2003 224

Brien JE See Sabet P 2004 36

Brien JE See Gallego G 2004 100

Brien JE See Cocks HJ 2004 109

Brien JE See Lawler C 2004 174

Brien JE See Tan EL 2004 178

Brien JE See Kay O 2004 259

Brien JE See Kay OC 2004 300

Brien JE See Slader SA 2005 15

Brien JE See Gallego G 2005 18

Brien JE Planning the future [ed] 2006 10

Brien JE Evidence-based practice [ed] 2006 94

Brien JE Clinical governance [ed] 2006 174

Brien JE See Kay OC 2006 199

Brien JE Pharmaceutical review-a view from academia [ed] 2006 256

Brien JE Access and quality use of medicines [ed] 2007 10

Brien JE Plus ça change [ed] 2007 93

Brien JE See Moles RJ 2007 119

Brien JE Clinical training - the inconvenient truths [ed] 2007 172

Brien JE Integration - putting it all together [ed] 2007 257

Brien JE Pharmacogenetics and the future of clinical pharmacy practice [ed] 2008 7

Brien JE Keeping up with the evidence trials and journals [ed] 2008 91

Brien JE See Hargraves TL 2008 103

Brien JE What is ethical research? [ed] 2008 178

Brien JE See Page MA 2008 286

Brien JE Is it advertising or evidence? [ed] 2009 10

Brien JE See Lehnbom EC 2009 45

Brien JE Drug interaction alerts in dispensing and prescribing software [letter] 2009 81

Brien JE Lifelong learning [ed] 2009 94

Brien JE Healthcare reform 2009 [ed] 2009 175

Brien JE See Lehnbom EC 2009 207

Brien JE Leadership and succession planning [ed] 2010 12

Brien JE Medication errors - research and practice partnerships [ed] 2010 91

Brien JE Patient safety beyond the hospital [ed] 2010 179




Brien JE The Journal of Pharmacy Practice and Research what do we want to be? [ed] 2010 264

Brien JE Understanding non-inferiority trials [ed] 2011 16

Brien JE Principles of quality prescribing [ed] 2011 97

Brien JE Health services evidence the message and the audiences [ed] 2011 263

Brien JE Don't be admitted to hospital on a weekend [ed] 2012 7

Brien JE Have your say! [ed] 2012 93

Brien JE Phase four trials and drug safety evidence [ed] 2012 179

Briggs D See Edwards CT 1997 133

Bright JM The clinical services documentation system for documenting clinical pharmacists' services 2000 10

Britton ME Drugs delirium and older people 2011 233

Brizzi J See Roller L 2008 79

Broad JM See Rofail S 1999

Broad N See Siderov J 2005 165

Broadbent RS See Kunac DL 1999

Brodaty H See Peisah C 1997 49

Brodaty H See Peisah C 1997 159

Brooks C See Lauchlan R 1995 342

Brooks C See Howitt KM 1997 302

Brouwers JR See Al Hadithy AF 2005 213

Brown AN Validated competency framework for delivery of pharmacy services in Pacific-Island countries 2012 268

Brown GJE Factors determining prescribing decisions in a teaching hospital setting 1999 311

Brown JA Complementary medicines: hospital pharmacists’ attitude knowledge and information seeking

behaviour

2009 281

Brown KE Pain severity cut-points and analgesic use by community-dwelling people for chronic pain 2012 196

Brown S See Day R 1996 622

Brown S-E See Welch SA 2000 262

Bruno AF See Brown AN 2012 268

Brushett D See Thawornchaisit P 2012 189

Bryant W See Lehnbom EC 2009 45

Buchan D See Masood N 2006 111

Buchan DS Incidence of venous thromboembolism and thromboprophylaxis after total hip or knee arthroplasty 2008 200

Buckley J See Dunning TL 2010 203

Buddhirakkul P See Thawornchaisit P 2012 189

Bui D See Ng C 2013 25

Bui T UK and US perioperative pharmacists’ experience [letter] 2012 334

Buick M See Alvarez SJ 2001 13

Bula N Financial analysis in pharmacy practice [book review] 2011 331

Bull RM See Simpson MD 2006 119

Bulsara C Seniors prefer pharmacists for advice on medications [ed] 2013 7

Burbury K See Alexander M 2014 163

Burford OJ See Parkinson AM 1998 436

Burgess CL Audit of nausea and vomiting management in palliative care hospital patients 2007 306

Burgess N GlaxoSmithKline Medal of Merit 2009 2009 310

Burgess NG See Martin ED 2000 94

Burgess NG See Martin ED 2000 141

Burgess NG See Dooley MiJ 2000 150

Burgess NG See Howitt KM 2001 181

Burgess NG See La Forgia SP 2002 65

Burgess NG See O'Leary KM 2002 72

Burgess NG See Sharley NA 2003 279

Burke R E-prescribing and the future of hospital pharmacy [letter] 2006 76

Burke R GlaxoSmithKline Award 2007 2007 318

Burke R Entering the electronic medication management age - implications for pharmacists [ed] 2008 258

Burke R See O'Connor K 2009 135

Burke R See Lo C 2010 106

Burke RA See McCrudden EA 1995 261

Burke RA Medication incident prevention: the medication chart competition as an educational strategy 2000 69

Burke RA Current medication safety practices within the United States 2002 97

Burnett D Cell-based therapies- a role for pharmacy technicians 2003 296

Burridge N See O'Leary KM 2013 88

Burrows J Association between self-reported adherence to HIV therapy and disease markers 2002 315

Burrows J See Luetsch K 2012 249




Burrows S See Joyce AW 2007 42

Burton DL See Simpson MD 2004 26

Burton MA See Simpson MD 2004 26

Bushell MA Case for pharmacist administered vaccinations in Australia 2013 292

Butler R See Sheridan J 2007 19

Bye L See Zolezzi M 2014 188

Byrne A Prescribing for Drug Withdrawal [book review] 2003 161

Byrne GJ Treatment of cognitive impairment in Alzheimer's Disease 1998 261

Byrnes D Access to pharmacy medication review services [letter] 2013 248

Byth K See Cheong EA 2008 267

Cabalag M See McD Taylor D 2009 24

Cabrera A See Silva MA 2013 37

Cadart CR From Melbourne to Martindale [career opportunities] 2000 25

Cain MJ Report on oncology pharmacist activities at Sir Charles Gairdner Hospital WA [letter] 1995 53

Caird CJ See Bollella G 2008 107

Cairns C Where should we be going in pharmacy education? - part 2 [ed] 2008 259

Cairns C What should we be doing in pharmacy education? - part 3 [ed] 2011 89

Calabretto JP So that was IT: the Hawaii International Conference on System Sciences 2002 219

Calabretto JP Initial assessment of an internet-based medication record 2005 99

Calabretto J-P See Gordon J 2011 271

Calcino LJ See Boyd IW 2008 23

Camac KJ Medication errors — a comparative study of drug storage sites 1996 234

Campbell B Pharmacokinetics in spinal cord injured patients 1995 327

Campbell DG Renal effects of high-dose tobramycin and vancomycin impregnated bone cement 2008 140

Campbell S Pharmacological treatment of frailty in the elderly 2009 147

Candiloro JA See Welch SA 2014 161

Cao BY Implementing a pharmacist charting service in the pre-admission clinic 2011 102

Capes DF A review of the restrictive flow infusion devices available for parenteral drug therapy 1997 115

Caplygin FM See deClifford JM 2007 284

Carberry J See Bogovic A 2000 222

Cardiff L See Coombes I 2010 111

Cardiff LM See Radford JM 1998 400

Cardiff LM See Radford JM 1999

Cardiff LM See Matthews JJ 2001 279

Carlos L See Betteridge F 2007 78

Carpenter J The top 100 drug interactions. A guide to patient management [book review] 2002 294

Carpenter J Good things come in small packages-learning to teach evidence-based practice [letter] 2004 73

Carrington C See Gilbar P 2004 159

Carrington C Cancer pharmacists group [letter] 2007 81

Carrington C Doctor of Clinical Pharmacy - evidence-based protocol [letter] 2008 165

Carrington C Pharmacists pharmacovigilance, unapproved indications and the TGA [letter] 2010 249

Carrington CV See Gilbar PJ 2005 195

Carroll JA Stability of flucloxacillin in elastomeric infusion devices 2005 90

Carroll M The American pharmaceutical association drug treatment protocols 1999 349

Carroll M Case studies in practice: medication review-a process guide for pharmacists [book review] 2003 162

Carroll ME Potential support roles for pharmacy technicians in provision of clinical pharmacy services 2003 186

Carroll ME See McLachlan GB 2008 47

Carroll PR See Johnston CF 2011 275

Carter FA See O'Shea TJ 2009 114

Carter L See Harvey PA 2012 246

Casanova JM See Eaton VS 2000 58

Cecchele R See Nasser S 2012 129

Cesnik B See Pappas A 1998 312

Cesnik B See Pappas A 1999

Chaar B Professional code of ethics [ed] 2006 7

Chaar BB See Penm J 2009 192

Chaar BB See Gu P 2011 196

Chaboyer W See Latimer SL 2011 188

Chae J See Khan M 2011 265

Chahadi F See To T-P 2012 118

Challen J International Clinical Trials Symposium 2002 264

Challen J International Clinical Trials Symposium [letter] 2007 333




Chambers RA See Accordino A 1994 312

Chambers RA See Amadio M 1996 371

Chambers RA See Accordino A 1996 629

Chambers RA Trissel's stability of compounded formulations 2nd edition 2000 231

Chan E Broaden knowledge and improved networking [letter] 2007 166

Chan EW Artemether-lumefantrine and primaquine for mixed P. falciparum and ovale malaria 2006 134

Chan EW Role for aspirin after total hip replacement 2006 214

Chan EW ASHP Midyear Clinical Meeting [letter] 2009 333

Chan EW International pharmacy preceptorship in emergency medicine [letter] 2010 76

Chan EW Intravenous olanzapine for acute agitation in the emergency department 2011 135

Chan EW Cost-minimisation analysis of midazolam versus droperidol for acute agitation in the ED 2012 11

Chan JG Board of Pharmaceutical Specialties Certification Examination in Nuclear Pharmacy 2002 301

Chan RK See Shah K 2006 301

Chan TW Non-medical use of prescription drugs among clients admitted to an acute psychiatric unit 2013 269

Chandler K See Harding AM 2010 332

Chang DWH See Lam A 2013 297

Chao G See Fawcett JP 1996 552

Chapman AB See Osborne RH 2002 276

Chapman CB See Corallo C 1995 123

Chapman CB See Easton-Carter KL 2002 235

Chapman CB See Easton-Carter KL 2003 106

Chapman CB See Lee CY 2011 98

Chapman R See Wein S 2002 212

Charles B Handbook of basic pharmacokinetics including clinical applications. 6th ed. [book review] 2004 333

Charles BG Fundamentals of population modelling: opportunities for hospital pharmacy practice 1999 88

Charles BG See Anh AVQ 2006 262

Charles PG See McD Taylor D 2009 24

Charlton KE See El-mani SF 2014 113

Chase D Management of cardiac rhythm disturbances in the ageing heart 2008 312

Chau A See Brett J 2013 97

Cheh RM Outcomes of pharmacological management of violent behavioural disturbances in older hospital

patients

2010 184

Chen AWJ Snapshot of antimicrobial stewardship in Australian hospitals 2010 19

Chen AWJ Snapshot of barriers to and indicators for antimicrobial stewardship in Australian hospitals 2011 37

Cheng AC See Fernando S 2012 80

Cheng G See Zolezzi M 2007 225

Cheong EA Home pharmacy service: three years experience 2003 212

Cheong EA Adverse drug reactions associated with home parental therapy 2008 267

Cherukuri H See Devabhaktuni R 2013 333

Chesney K See Tordoff JM 2006 12

Chiang C See Dooley MJ 2008 188

Chieng R ISOPP/HOPA 2008 [letter] 2008 250

Chieng R Implementation of a clinical pharmacy service to an allogeneic stem cell transplant ambulatory clinic 2014 105

Chin DY See Mahler SM 2003 7

Chin KL Behavioural component of patient care [letter] 2011 332

Chin M See Ambados F 2012 111

Ching MS See To TP 2008 219



Chiu F See To NN 1999

Chong DW See Hasan SS 2010 294

Choo C Drug facts and comparisons 1999 edition 1999 301

Choo C World Congress on Pain 2005 291

Choo CS D2 D3-what's the difference? [letter] 2006 246

Choo S See Bingham J 1996 287

Choo S See Dooley MJ 2011 208

Choo S See Tong EY 2012 140

Chow C See Cao BY 2011 102

Chu K-P Evaluation of antifungal treatment guidelines for immunosuppressed patients 2010 119

Chu KPJ Hypothermia associated with olanzapine 2005 216

Chu MTY See Taylor SE 2007 214

Chui SY Incidence of vancomycin-induced red man syndrome in a women's and children's hospital 2007 124




Chuong M See Silva MA 2013 37

Ciccia M See Betteridge F 2007 78

Claes MT See Mackenzie FD 2002 31

Clark FC Antiretroviral therapy in 2014 and beyond: simplicity and complexity? [ed] 2014 181

Clark LM Communication of adverse drug reactions between the hospital health care team and general

practitioners: how effective is it?

2001 134

Clark RA See Borgstedt J 2009 186

Clark RA See Lovgren S 2009 269

Clark RP Safety cabinet containment testing [letter] 2002 259

Clifford RM Pharmaceutical care of diabetes patients - let's take up the challenge [letter] 2003 17

Clifford RM Developing key competencies for a clinical pharmacy education and peer review program 2003 208

Clifford RM Prevalence and predictors of complementary medicine usage in diabetes 2003 260

Clifford RM Patient-centred care: are we meeting patients' needs? [letter] 2006 165

Clifford RM See Taylor KL 2007 287

Clifford RM See Burgess CL 2007 306

Clifford RM Post-registration learning trends of community pharmacists 2011 203

Clifford RM See Kiani M 2011 217

Clifford RM See Lie K 2011 278

Clifford RM See Blogg LC 2012 287

Clifford RM See Gudka S 2013 15

Clunie L See Zolezzi M 2007 11

Cocks HJ Evaluation of therapeutic drug monitoring services and comparison of two models of service provision 2004 109

Cocohoba J HIV in the United States: a pharmacy perspective [ed] 2014 177

Cohen B See Renwick J 1998 439

Cohen MM See Braun LA 2007 220

Colarco T See Alderman CP 1999

Cole M We all make mistakes - but what can we do about it? 2002 261

Cole-Sinclair M See Lubliner M 2005 266

Colgan JE A cup of tea my pharmacist and me: can extended communication make the difference? 1997 398

Colley D See Borgstedt J 2009 186

Colley D See Lovgren S 2009 269

Colley D See Angley M 2011 27

Collins DM See Stowasser DA 1997 362

Collins DM See McGuire TM 1997 403




Collins M Continuing professional development as a prerequisite for registration: a worldwide trend 2001 57

Collins MA See Pascuet E 2010 92

Collison C SPA 1997 remuneration survey published [letter] 1997 335

Collyer FM Privatisation on the agenda: policy direction in health care [conference presentation] 1998 108

Colman PG See Rando L 2004 95

Colvin J See Schwantzer M 1994 439

Colvin J Drugs in breast milk — timing of mother's dose and baby's feed [letter] 1995 486

Condon LA Drug utilisation review of cephalothin 1995 238

Connellan P See Thawornchaisit P 2012 189

Connolly J See Robinson MK 1999

Connolly MJ See Wilson RK 2013 51

Cook DA See Mackenzie FD 2006 185

Cook GK Extemporaneous compounding in Queensland hospitals 2007 204

Coombes I Pharmaceutical review-Queensland health's experience [ed] 2006 256

Coombes I See Lum E 2007 7

Coombes I See Hale A 2009 163

Coombes I GlaxoSmithKline Medal of Merit 2010 2009 318

Coombes I Improvement in pharmacist's performance facilitated by an adapted competency-based general level

framework

2010 111

Coombes I Developing and recognising advanced practitioners in Australia: an opportunity for a maturing

profession? [ed]

2011 17

Coombes I See O'Leary KM 2012 259

Coombes I Advancing pharmacy practice in Australia: the importance of national and global partnerships [ed] 2012 261

Coombes I See Hale A 2013 256

Coombes I See Angley M 2014 6




Coombes ID Quality of medication ordering at a large teaching hospital 2001 102

Coombes ID The PBS-Its future involvement in the debate? 2002 15

Coombes ID Extended role of the clinical pharmacist in the management of heart failure and acute coronary

syndromes

2002 17

Coombes ID Australian Clinical Pharmacy Award 2003 2003 305

Coombes ID Identification of medication errors by nurses during a simulated ward medication safety orientation

program

2005 190

Coombes ID See Shah SS 2013 129

Coombes J See Coombes I 2010 111

Coombes JA See Radford JM 1997 140

Coombes JA See Stowasser DA 2000 47

Coombes JA See Matthews JJ 2001 279

Coombes JA Piloting an objective structured clinical examination to evaluate the clinical competency of pre-

registration pharmacists

2003 194

Cooper G Developing the skills and attributes of a clinical pharmacist within a master of pharmacy curriculum

[ed]

2006 172

Cooper GM See Brown AN 2012 268

Cooper JM Providing medicines information and education to hospital in-patients: patients’ experiences and

preferences

2014 213

Copeland TS See Wilmott V 2004 210

Corallo CE Determination of insulin concentrations in plastic infusion systems 1995 129

Corallo CE Anaphylactic shock following intravenous vitamin K1 1997 146

Corallo CE See Jenney A 1999 36

Corallo CE See Coutsouvelis J 2011 225

Corallo CE See Fernando S 2012 80

Cosh DG Collaborative approach to TDM [letter] 1996 673

Cosh DG Clinical pharmacy - being there 1997 15

Cosh DG The 23rd federal conference [ed] 1997 357

Cosh DG Australian perspectives on the BPS examinations 1998 334

Cosh DG See Ng D 1999

Cosh DG See Wiese MD 1999

Cosh DG Australian Clinical Pharmacy Award 1999 2000 283

COSP Aged Care Medication management in residential care facilities by hospital pharmacists 1995 541

COSP Cancer

Services

SHPA standards of practice for the provision of oral chemotherapy for the treatment of cancer 2007 149

COSP Drug Dist Evaluating the effectiveness of drug distribution systems 1994 93

COSP Drug Info Drug information: management clinical trials and clinical pharmacy perspectives 1994 89

COSP Drug Info SHPA standards of practice for drug information services 1999 171

COSP DUE SHPA standards of practice for drug usage evaluation in Australian hospitals 1996 240

COSP DUE SHPA position statement on the provision of drug utilisation data 1996 247

COSP DUE SHPA standards of practice for drug use evaluation in Australian hospitals 2004 220

COSP Home Health

Care

A survey of parenteral therapy services provided to home patients by Australian hospital pharmacies 1997 373

COSP Investigation

Drugs

SHPA standards of practice for pharmacy investigational drugs services 1999 227

COSP Med Safety SHPA standards of practice for medication safety 2012 300

COSP Oncology SHPA standards of practice for the oncology pharmacist 1995 455

COSP Oncology SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments 1999 108

COSP Oncology SHPA standards of practice for the transportation of cytotoxic drugs from pharmacy departments 2000 116

COSP Oncology Guidelines for counselling patients receiving drugs used in the treatment of neoplastic disease: a

pharmacist's guide to advisory labels and patient information

2001 51

COSP Oncology SHPA standards of practice for the provision of clinical oncology pharmacy services 2002 115

COSP Oncology SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments 2005 44

COSP Outpatient

Services

SHPA practice guidelines for outpatient services 1994 421

COSP Pharm Manage How to win in the right sizing game [workshop] 1994 88

COSP Pharm Manage Format for practice standards 1995 156

COSP Poisons Info SHPA standards of practice for Australian poisons information centres 1995 161

COSP Poisons Info Guidelines for information sources for poisons information centres 1995 163

COSP Poisons Info Guidelines on minimum staffing levels of professional staff for poisons info centres 1995 460

COSP Poisons Info SHPA policy guidelines on quality assurance for poisons information centres 1996 442

COSP Psych Pharm SHPA guidelines for the practice of psychiatric pharmacy 1995 347

COSP Psych Pharm SHPA standards for the practice of psychiatric pharmacy 2000 292




COSP QA Survive and thrive with quality assurance 1994 92

COSP Rehab Bridging the gap: community liaison pharmacy 1994 91

COSP Rehab SHPA self-medication guidelines 1994 416

COSP Rehab SHPA standards of practice for the community liaison pharmacist 1996 570

COSP Rehab SHPA guidelines for self-administration of medication in hospitals and residential care facilities 2002 324

COSP-Clin Pharm Making the most of medication chart review 1994 90

Costello N Adherence to antiretroviral therapy in hospitalised patients [letter] 2013 79

Costello N See Heath EK 2014 201

Cottrell N See Sim L 2005 276

Cottrell N Australian Clinical Pharmacy Award 2007 2007 319

Cottrell N See Freeman C 2014 240

Cottrell WN See Whitty JA 2001 300

Cottrell WN See Coombes ID 2002 15

Cottrell WN See Coombes ID 2002 17

Cottrell WN See Overland V 2002 232

Cottrell WN See Gujral GR 2009 202

Cottrell WN See LaCaze A 2012 6

Cottrell WN See Freeman C 2012 184

Couch G Continuity of medication supply and provision of patient information on discharge: development of a

survey tool

2007 210

Coulthard K Update on cystic fibrosis 2004 125

Coulthard K See Chui SY 2007 124

Coulthard K Fred J Boyd Award 2009 2009 307

Coulthard KP Clinical pharmacy award [conference presentation] 2000 19

Coulthard KP Australian Society for Antimicrobials [letter] 2000 290

Coulthard KP See Stacey SR 2013 45

Coulthard MG See Roberts JA 2009 198

Coutsouvelis J Systemic absorption from oral vancomycin: check the dose! 2011 225

Coutsouvelis J See Chieng R 2014 105

Cox IR Pharmacokinetics in patients with burns 2005 53

CPI Working Party Standards of practice for the provision of consumer product info by pharmacists in hospitals 1996 434

Crameri QM See Adu A 1995 336

Crane J See Cao BY 2011 102

Crank M Pharmaceutical and medicines information management: principles and practice 2002 160

Crank MY Drug information services: hospital pharmacists' utilisation and opinion 2005 284

Crankshaw DP Stability of methoxyflurane loaded penthrox inhaler 2009 274

Cranswick M See Shah K 2006 301

Cranswick N See Juliana GS 2005 187

Crea J See Ambados F 2012 111

Creasey H Tacrine — for and against. The case against 1995 569

Creber ES See Larmour I 1995 220

Creber ES See Larmour I 1998 226

Cree ML Fifth Congress of the European Association of Hospital Pharmacists 2000 288

Cree ML International Paediatric Pain Symposium 2010 [letter] 2010 81

Criddle D Research — reviving the lost art of questioning 1996 52

Criddle D See Angley M 2014 6

Crookes PA See Mullan JR 2003 284

Crosara SLR Mitomycin-C induced thrombotic thrombocytopenic purpura 2013 221

Crowe DM See Dartnell JG 1994 333

Crowe S See Duncan AJ 2005 291

Crowley PMP Epilepsy: diagnostic and management dilemmas in the elderly 1994 270

Cuell S See McConachy KA 1999

Currow DC Evidence-based practice - where does the buck stop? [ed] 2012 91

Cusack BM See Blennerhassett JD 2006 175

Cutts C Review of information resources on the use of medication in breastfeeding women 2001 207

Cutts C Teaching the teacher - the missing link in Australian clinical pharmacy training? 2003 45

Cutts C Audit of selective and non-selective NSAID use in rural general practice 2003 70

Czajkowski F See Feeney GF 1997 42

D S (Sahiti D.) See Singh A 2014 60

Daftary MN Patients' willingness to pay for cognitive pharmacy services in ambulatory care settings in the USA 2003 265

Dahms K See Behan KP 2010 222

Dakin C See Barras M 2011 183




Daly G Australian and New Zealand Children's Haematology and Oncology meeting [letter] 2008 328

Daly GE 21st annual scientific meeting of the Clinical Oncological Society of Australia 1995 466

Daly GE Alteplase for veno-occlusive disease in bone marrow transplant patients [inform] 1995 547

Daly GE Amgen Australia clinical pharmacy practice grant [letter] 1996 373

Daly GE See To NN 1999

Daly GE International bone marrow transplant registry/autologous blood and marrow transplant registry

meeting Keystone USA

1999 287

Daly GE Report from the International Society of Paediatric Oncology Meeting 2001 66

Danby RW See Jackson JK 2001 262

Dartnell JG Learning as a pharmacy educator in Belize Central America 1994 254

Dartnell JG Review of the use of adverse drug reaction labels on medical records 1994 333

Dartnell JG Audit of cefotaxime prescribing at a major teaching hospital 1994 392

Dartnell JG See Brown GJ 1999

Dartnell JG Thinking about prescribing. A handbook for quality use of medicines [book review] 2000 76

Dartnell JG DUE-an essential tool to achieve QUM 2000 251

Darwiche R See Tucci J 2009 223

Darzins P Ethical and practical dimensions of prescribing for older people as quality of life decreases 2008 64

Das R Mirtazapine-induced lower limb oedema 2005 310

Das R Allopurinol-associated angitis [letter] 2006 77

Das RN See Mishra P 2005 165

Das RN Peripheral oedema associated with imatinib [letter] 2007 80

Das RN Skin discoloration and melanonychia associated with hydroxyurea [letter] 2007 82

Dashti-Khavidaki S See Ahmadi-Abhari SA 2005 103

Davey AK See Al-Sallami HS 2001 189

Davey AK Clinical relevance of cytokine-induced changes in drug metabolism 2002 147

Davies D Guidelines for safe handling of contact sensitisers [practice report] 2000 216

Davies G Medicines patients and the care process - tackling the non-adherence agenda [ed] 2008 256

Davies G See Coombes I 2010 111

Davies GE See Lau D 2008 179

Davies J See Alvarez SJ 2001 13

Davies JG See Coombes JA 2003 194

Davis A Self-administration of medication [letter] 1995 52

Davis ID See Siderov J 2002 108

Davis J Intrathecal drug administration [letter] 1995 174

Davis J See Graham B 2002 177

Davis J See Weekes L 2006 91

Davis J See Gilbar P 2007 115

Davis MR See Xu QA 1998 156

Davis S The TAGNet Network 1999 179

Davis SR Ketamine in chronic pain: a review 1998 94

Davis SR See Kelly M 2004 32

Davis SR Creation of a temperature stability database for refrigerated medicines 2010 31

Davis SR Medication reviews for people with developmental disability – a call to action! [letter] 2014 160

Davis TM See Clifford RM 2003 260

Davis W See Clifford RM 2003 260

Davison JG See Ware GJ 1994 329

Dawson AH See Drew A 2000 71

Day R Pharmaceutical Benefits Scheme: rapid change and impetus towards achieving QUM [ed] 2007 4

Day R India: emerging centre of drug development [editorial] 2009 262

Day R Death of the 'blockbuster' and 'pivotal' clinical trial: rethinking the drug development process [ed] 2011 94

Day R See Inam S 2014 195

Day RO Drug committees — the key to quality use of medicines? [ed] 1996 622

Day RO See Bramley-Moore SR 1998 83

Day RO COX-2 specific inhibitors and the hospital pharmacist [ed] 2000 41

Day RO COX-2 specific inhibitors in cancer: in reply [letter] 2000 120

Day RO See Welch SA 2000 262

Day RO See Tan EL 2003 65

Day RO Pharmaceutical health and rational use of medicines committee [ed] 2003 87

Day RO See Tan EL 2004 178

Day RO See Baysari MT 2012 178

Day RO See Teo CK 2013 32

de Boer M See Boeker EB 2013 41




de la Roca J See Aldama PC 2003 330

De Luise MA Thyroid disease in the elderly 2003 228

De Rosa NF Stability of venlafaxine hydrochloride liquid formulations suitable for administration via enteral

feeding tubes

2008 212

De Villiers Smit P See Mann T 2007 281

De Zylva JB Adherence to prophylaxis guidelines for symptomatic VTE at a Darwin hospital 2012 37

Deans K To manager and company director 1999 46

deClifford JM Impact of an emergency department pharmacist on prescribing errors in an Australian hospital 2007 284

deClifford JM Evaluation of a pharmacist-initiated e-script transcription service for discharged patients 2009 39

deClifford JM Implementation and acceptance of a pharmacist-initiated e-script transcription service for discharge

prescriptions

2009 286

deClifford JM See Pang RK 2011 192

deClifford JM How do clinical pharmacists spend their working days a time-and-motion study 2012 134

Dehpour AR See Ahmadi-Abhari SA 2005 103

Deidun DM Participating in an International Pharmacist Exchange Program 2001 44

DeLuise MA See Bird MR 1996 564

Denaro C See Coombes ID 2002 17

DeSantis GN See Stuchbery P 2007 102

DeSantis GN See Stuchbery P 2008 126

Dettwiller P See De Zylva JB 2012 37

Devabhaktuni R Mixed organophosphate and rodenticide poisoning accelerates fulminant hepatic failure [letter] 2013 333

Dhungana K See Das R 2005 310

Diamandis S See Moles RJ 2007 265

Dib JG Ginger for nausea and vomiting in pregnancy 2004 305

Dines A See Avent ML 2010 15

Dinh NT See Tan ISP 2013 279

Dionysopoulos D Pharmacist service in a surgical preadmission clinic [letter] 2011 75

DiPiro JT Biotechnology: are you ready to meet the challenge? 1996 74

Dirnbauer NJ See Hodgkinson MR 2009 19

Ditty A Are proton pump inhibitors over-prescribed in infants? 2014 220

Dixon AE See Mackenzie FD 2006 185

Dixon B See Dooley MJ 2008 188

Dobson PM A nurse’s perspective of HIV: past, present and future [ed] 2014 179

Doecke C Equity of access to pharmaceuticals in Australia [editorial] 2005 4

Doecke CJ Clinical pharmacy in Australia: a personal perspective 1998 105

Doecke CJ Joint appointments in education [career opportunities] 1998 369

Doecke CJ See Martin ED 2000 94

Doecke CJ See Martin ED 2000 141

Doecke CJ Patient safety is paramount 2001 220

Doecke CJ See La Forgia SP 2002 65

Doecke CJ See Sorich MJ 2004 22

Doecke CJ See Kethini T 2004 308

Doecke CJ See Yu K 2007 22

Doecke CJ See Nguyen A 2007 111

Doecke CJ See Poh EW 2009 176

Doecke CJ PBAC recommendation versus PBS approval [editorial] 2011 88

Doggrell SA Medicines management by the older-aged living independently in different types of retirement villages 2012 208

Doherty DA See Lim SC 2008 191

Doherty P Medication safety [letter] 2011 75

Dollman WB Comparison of the bioavailability of vigabatrin tablets and sachets in healthy male subjects 1996 229

Dolton MJ Prevalence of potentially harmful drug interactions in older people in Australian aged-care facilities 2012 33

Donnan GA See Srikanth VK 2000 60

Donnan GA See Srikanth VK 2000 176

Donnelly RJ See Benzie JL 1997 430

Donovan B See Adu A 1994 318

Doogue MP See Polasek TM 2011 77

Doolan G See Hassan FA 2006 266

Doolan SM Clinical oncology in the west 1995 473

Dooley M See Angley M 2014 6

Dooley MJ See Corallo C 1995 129

Dooley MJ See Bingham JM 1998 89

Dooley MJ See McLennan DN 1999




Dooley MJ See Poole SG 1999

Dooley MJ See McLennan DN 2000 6

Dooley MJ Multicentre pilot study of a standard approach to document clinical pharmacy activity 2000 150

Dooley MJ See Lau P 2000 175

Dooley MJ Strategy for identification of 'near miss' events and improving dispensing accuracy 2001 125

Dooley MJ Hospital pharmacists fail to record their research in the QUM mapping project 2002 141

Dooley MJ Prescribing of warfarin and brand selection 2002 259

Dooley MJ Publication rate of abstracts presented at the SHPA 24th Federal Conference 2003 111

Dooley MJ See Carroll ME 2003 186

Dooley MJ See Burnett D 2003 296

Dooley MJ GlaxoSmithKline Medal of Merit 2003 2003 302

Dooley MJ See Larizza MA 2006 115

Dooley MJ See Rice CA 2007 303

Dooley MJ See Van De Vreede M 2008 19

Dooley MJ See Tsui M 2008 40

Dooley MJ See Stell R 2008 132

Dooley MJ Phenotyping for thiopurine therapy in clinical practice 2008 188

Dooley MJ Patient-completed medication histories vs those obtained by a pharmacist in a pre-admission clinic 2008 216

Dooley MJ See Van De Vreede M 2008 263

Dooley MJ See Larizza MA 2009 277

Dooley MJ See Korajkic A 2011 126

Dooley MJ Successful implementation of a pharmacist anticoagulant dosing service in ambulatory care 2011 208

Dooley MJ See Fernando S 2012 80

Dooley MJ See Graudins LV 2012 95

Dooley MJ See Tong EY 2012 140

Dooley MJ See Chieng R 2014 105

Dorevitch MI See Moran JA 2001 35

Dotta L Country technician visits the city technician [letter] 2004 331

Dowden JS Quality use of medicines - a Canberra Contribution [editorial] 1998 78

Dowden JS Entangling experts [editorial] 2011 179

Dowling H CPI workshop report 1994 264

Dowling H Consumer product information — where to from here? 1996 293

Dowling H See O'Leary KM 2003 93

Dowling H Corollaries of the vision-challenges as goal setter, net worker, navigator and cheerleader 2005 302

Dowling H The Garling report: thorns in a bed of roses? [editorial] 2010 8

Dowling HV See O'Leary KM 2012 259

Dowling HV See Coombes I 2012 261

Dowling HV See O'Leary KM 2013 88

Dowling HV See Angley M 2014 6

Drew AK A survey of drug information centres in Australia 1995 433

Drew AK Chinese herbal medicine [letter] 2000 71

Driscoll SE See Angley M 2014 6

Drummond MF The rise of pharmacoeconomics: implications for pharmacists 1994 38

Drummond SH Hospital admissions due to drug overdose 1994 231

Druskeit T See Roberts GW 2013 276

D'Souza DC Reporting review and application of near-miss prescribing medication incident data 2004 190

Dubrava S Identification of potential and actual breaches in the cold-chain within a tertiary hospital 2007 16

Duffull SB See Pearce MJ 1995 13

Duffull SB Concepts for critical appraisal of an original research paper 2001 200

Duffull SB See Shaw JP 2013 122

Duffy TM See Riley RH 1999

Dugdale P Toward lucid health care [editorial] 2012 256

Duggan C See Coombes I 2011 17

Duggan C See Coombes I 2012 261

Duguid M Fred J Boyd Award 2005 2005 300

Duguid M See MacPherson RD 2008 88

Duguid M Evaluating new medicines for use in Australian hospitals: lessons from North America 2010 124

Duguid M Pharmacists and antimicrobial stewardship [editorial] 2011 92

Duguid MJ CPI — education or information? [editorial] 1994 229

Duguid MJ Consultant pharmacy — clarifying the issues [editorial] 1995 217

Duguid MJ Labelling of imported products — beware [letter] 1996 673

Duguid MJ See Bajorek BV 2001 93




Duguid MJ See Wilcox C 2001 268

Duguid MJ Review of discharge prescriptions by pharmacists integral to continuity of care 2002 94

Duguid MJ SHPA grants program-does it meet members' needs? 2005 201

Duke JM See Adams J 2004 73

Duncan A International AIDS Conference 2010 [letter] 2010 247

Duncan AJ Providing HIV education for health professionals in India 2005 291

Duncan G Pharmacy practice 3rd edition [book review] 2003 42

Duncan GJ See Jackson JK 2004 290

Duncan GJ See Vernon GM 2007 80

Dunkley K Oh you are a chemist! 1999 47

Dunne PF See Peterson GM 1996 545

Dunning TL Do high-risk medicines alerts influence practice? 2010 203

Dutta AP See Daftary MN 2003 265

Dutton J Career opportunities in government: a personal view [career opportunities] 1998 441

Dwari B See Das RN 2007 82

Dwari BC See Paudel R 2006 218

Eakin EG See van Beurden E 2003 51

Easton KL See Maxwell DJ 2004 212

Easton-Carter KL Issues in the interpretation and design of studies investigating drug-related morbidity and mortality 2002 235

Easton-Carter KL Adverse drug reactions in paediatrics: are we getting the full picture? 2003 106

Eaton V Superwarfarin poisoning 2005 56

Eaton V See Chen AW 2010 19

Eaton V See Chen AW 2011 37

Eaton VS Azathioprine hepatotoxicity confirmed by rechallenge [clinical communication] 2000 58

Eaton VS See Hutchinson KA 2001 98

Eaton VS See To TH 2007 30

Ebeling PR Pharmacological management of osteoporosis in 2000 2000 111

Ede J See Robertson K 2012 193

Edmonds E See Kelly AM 1995 487

Edwards CT Gentamicin usage and monitoring in a Sydney teaching hospital 1997 133

Edwards S See Alderman CP 1995 511

Edwards SM See Gailer JL 1996 587

Eikelboom JW See Peng YG 2004 14

Ekert H Current and preferred treatment of haemophilia A 1995 382

El-den S Over-the-counter drugs for pre-menstrual syndrome: is the pharmacist still part of the picture? 2014 224

Elkalmi RM See Hassali MA 2009 245

Elkalmi RM Community pharmacists involvement in the pharmacovigilance program in Malaysia [letter] 2010 245

Elkerton JR The documentation of adverse drug reactions 1995 502

Ellershaw J See Tasker J 1997 251

Elliott P See Snowdon GM 1998 232

Elliott P See Cao BY 2011 102

Elliott PA See Hudson BJ 1995 257

Elliott RA Nasogastric administration of omeprazole [inform] 1998 174

Elliott RA Assessment of a nursing home medication review service provided by hospital-based clinical

pharmacists

1999 255

Elliott RA Indicators of prescribing quality for elderly hospital inpatients 2001 19

Elliott RA Clinical pharmacy: an evolving area of pharmacy practice in India 2001 147

Elliott RA Quality of prescribing for elderly inpatients at nine hospitals in Victoria, Australia 2003 101

Elliott RA Problems with medication use in the elderly: an Australian perspective 2006 58

Elliott RA Complementary medicines in Australian veterans [letter] 2006 80

Elliott RA Is QUM an efficient use of healthcare resources? [editorial] 2008 172

Elliott RA Assessment of risk associated with medication-related problems in elderly outpatients 2009 109

Elliott RA Unplanned medication-related hospital readmission following transfer to a residential care facility 2009 216

Elliott RA Review of instruments used in clinical practice to assess patients' ability to manage medications 2010 36

Elliott RA Impact of hospitalisation on the complexity of older patients' medication regimens and potential for

regimen simplification

2011 21

Elliott RA See Lee CY 2011 98

Elliott RA See Tran T 2012 100

Elliott RA National survey of clinical pharmacy services and pharmacy technician roles for subacute aged-care

inpatients

2012 125

Elliott RA See Harvey PA 2012 246

Elliott RA GlaxoSmithKline Medal of Merit 2012 2012 305




Elliott RA Identifying inappropriate prescribing for older people 2013 312

Elliott RA Impact of an expanded ward pharmacy technician role on service-delivery and workforce outcomes in

a subacute aged care service

2014 95

Elliott RA Problems with medicine use in older Australians: a review of recent literature 2014 258

Ellis AG See To TP 2008 219



Ellis D What can happen when suspensions are not shaken? [letter] 2011 79

Ellis D See Mihaila B 2012 103

Ellis D Prescribing antipsychotics for young people and monitoring physical health and adverse effects 2013 190

Ellis DP Child and adolescent psychiatry - an update from Hawaii 2002 216

Ellis DP Practical child and adolescent psychopharmacology [book review] 2002 293

Ellis DP See Grzeskowiak LE 2008 9

Ellyard P Creating a healthy future 1996 11

El-mani SF Folic acid and iodine supplementation during pregnancy: how much do pharmacists know and which

products are readily available?

2014 113

El-Saddik RA See Dib JG 2004 305

Elshami SS See Ibrahim MIM 2013 79

Emmerton LM See Mitchinson GH 1996 215

Emmerton LM See Bialy LH 2007 277

Emmerton LM See Tan ACW 2012 48

Emmerton LM See Habak JE 2013 101

Emmerton M See George LJ 2011 212

Emmott N See McKnight DL 1997 390

Enggist S L See Armour CL 1998 410

Eu P Radiopharmacy – it shows the way! [career opportunities] 2000 74

Eu P Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed. [book review] 2006 82

Evans AM See McKinnon RA 2000 102

Evans AM See McKinnon RA 2000 146

Evans AM See Ward MB 2009 55

Ezzy J See Tett S 1997 435

Ezzy J See Stewart P 2000 72

Ezzy J See Stewart P 2001 56

Fahimi F See Ahmadi-Abhari SA 2005 103

Fairley CK See Yin C 2002 320

Fallah H See Su EY 2008 292

Fardell B Drug delivery in palliative care 1994 74

Fardy HJ See Gaetani L 2009 164

Farhoodian A See Ahmadi-Abhari SA 2005 103

Farouque O See Chase D 2008 312

Farouque O See To T-P 2012 118

Farouque O See Grewal J 2012 228

Fawcett JP See Boulton DW 1994 151

Fawcett JP Stability of amiloride hydrochloride oral liquids prepared from tablets and powder 1995 19

Fawcett JP Binding of parabens to sodium carboxymethylcellulose in oral liquid formulations 1996 552

Feeney GFX Alcohol and medication go ahead ask your doctor or pharmacist 1997 42

Fellows L A survey of drug audit practices and promotion of quality prescribing in Australian hospitals with a

focus on psychotropic drugs

2000 196

Feng SR See Hasan SS 2010 294

Feng Y See Hui HZ 2012 166

Fergusson JA Wound management in older people. 1997 461

Fernando S Early-onset vancomycin-associated neutropenia [letter] 2012 80

Ferrari RL See Capes DF 1997 115

Ferrier N See Berbatis CG 1996 674

Ferry DG See Fawcett JP 1995 19

Fiddes K See Stell R 2008 132

Fielding DI See Radford JM 1999

Finch JE Counselling discharged patients in their homes [on a different note] 1998 117

Finckh A See Slader SA 2005 15

Finckh AS See Welch SA 2014 161

Fisher MJ See Camac KJ 1996 234

Fisquet P IV phenoxybenzamine for acute hypertension of phaeochromocytoma a case report 1998 332




Fisquet SJ See Ballantine DL 2014 108

FitzGerald KH Progesterone to prevent postnatal depression [clinical communication] 2000 21

Fiumara AM Treatment of nocardiosis: three case reports 1995 532

Flavel D Two examples of student placement tasks: drug use evaluations 2012 121

Fleming AM See Mackenzie FD 2002 31

Fleming G See Coombes JA 2003 194

Flicker L See Guthridge JM 1999

Flood VM See El-mani SF 2014 113

Fong CM Management of osteoporosis in older people 1995 372

Foo J See Milne DJ 2004 272

Foot C See Roberts JA 2009 198

Foran SM See Vernon GM 1995 32

Foran SM See Luu C 1995 548

Foran SM Utilisation of drug information resources by community healthcare practitioners 1996 429

Forbes A See Zolezzi M 2007 11

Forbes A See Zolezzi M 2007 225

Ford D Topical salicylates and warfarin — an unforeseen interaction [letter] 1996 671

Ford D See Power DA 2008 137

Ford DA Pharmacy costs of aged care rehabilitation 1996 325

Ford DA A hospital-based opportunistic immunisation program 1996 539

Ford DA See Brien JE 1999

Ford GA See Le Couteur DG 2010 148

Ford P Medication prescribing - not a task for non-medical health practitioners [editorial] 2008 256

Ford V See Lie K 2011 278

Forrester K See Hattingh HL 2007 174

Foster M Fresenius Kabi Australia Cancer Services Pharmacist Grant 2013: Oncology pharmacy team shining

with potential for pharmacist-led clinic [grant report]

2014 295

Fowler PR Medprofs — individualised medication profiles produced on a word processor 1995 26

Fowler PR Vancomycin-resistant enterococci [inform] 1997 149

Fowler PR See Cosh DG 1998 334

Fowler PR 25th Federal Conference 2001 91

Fowler PR eTG complete the complete Therapeutics Guidelines in electronic format 2002 159

Fowler S From the outback to the city in the world of critical care [letter] 2004 71

Fox C Casemix funding in Victoria — a CEO's perspective 1996 134

Frajman C No encouragement of mature-age pharmacy students [letter] 2003 159

Francis JM See Awasthi S 2013 248

Frank OR See Westaway KP 2014 44

Frank OR See Westaway K 2014 138

Fraser JF See Ballantine DL 2014 108

Freeman C Pharmacists', General practitioners' and consumers' views on integrating pharmacists into general

practice

2012 184

Freeman C The Australian practice pharmacist 2014 240

Freeman JK See Adu A 1995 336

Freeman M See To T-P 2012 118

Friedel H See Tasker J 1997 251

Frost E National registration and accreditation [editorial] 2007 172

Fucile DV See Pearce MJ 1995 13

Fullinfaw R See Lau D 2008 179

Fusha B See Zolezzi M 2007 11

Fyfe R See Weeks GR 2012 17

Gabardi S Drug dosing in acute kidney injury versus chronic renal insufficiency [editorial] 2008 175

Gabardi S See Martin S 2009 257

Gabardi S Risk evaluation and mitigation strategies: implications for US pharmacists [editorial] 2011 5

Gabardi S The evolving role of the transplant pharmacist [ed] 2013 174

Gaboury I See Pascuet E 2010 92

Gaetani L Medication omission rates after inclusion of patients' names on medication drawers 1998 185

Gaetani L See Thomas B 2005 245

Gaetani L Interdisciplinary teaching of pharmacotherapeutics to pharmacy graduates and medical students [letter] 2009 164

Gailer JL SSRIs and anticonvulsants [inform] 1996 587

Gailer JL See Abdelmessiah D 1997 250

Gailer JL Beyond BCPS 2001 227

Galbraith K Australian Clinical Pharmacy Award 2006 2006 313




Galbraith K Future of hospital pharmacy: global consensus? [letter] 2008 332

Galbraith K See Coombes I 2012 261

Galbraith K Ancora imparo [ed] 2013 175

Galbraith K SHPA Medal of Merit 2014 2014 300

Galbraith KJ See Cosh DG 1998 334

Galbraith KJ See Dooley MJ 2000 150

Galbraith KJ See Carroll ME 2003 186

Galbraith KJ See Simpson MD 2006 119

Galbraith KJ See Coombes I 2011 17

Gallego G Impact of high-cost drugs for individual patient use 2004 100

Gallego G Access to high-cost drugs: decision makers' perspectives 2005 18

Galloway JG See Peterson GM 1996 545

Ganachari MS See Mohite SS 2006 245

Garas G See Smith BA 1996 560

Garci CS See Welch SA 2003 16

Garg A Sulfur allergies can be misleading [letter] 2013 332

Garg A See Ditty A 2014 220

Garg S Properties of a formulated paediatric phenobarbitone oral liquid 2008 28

Garrett K See To TP 1998 289

Garrett K Pharmaceutical review-hospital pharmacy manager's perspective [editorial] 2006 261


Garrett K See Tran T 2012 100


Garrett K See Elliott RA 2014 95

Garrett MK See To TP 2010 101

Garrett MK See Booth JC 2012 296

Garrett T See Masood N 2006 111

Garrett T Pharmacy workforce recruitment and retention: an Australian area health service perspective 2008 183

Garrett T Beliefs and attitudes that influence reporting of clinical interventions by pharmacists 2009 99

Garrett T Engaging pharmacists in adverse medication incident reporting: pilot of a streamlined reporting

application

2010 269

Garrett T Once-daily IV antibiotics 'best' for home-based cellulitis management [letter] 2012 81

Garrett T Insights into hospital pharmacy safety culture 'Down Under' [letter] 2012 332

Garrett T Does an electronic discharge referral system improve the quality of medication prescribing? 2014 29

Garrett T See Cooper JM 2014 213

Gascard DJ See Toh CT 2010 27

Gayathridevi S See Lakshmi PK 2002 24

GazarI M See Graudins LV 2002 104

Gazarian M See Graudins LV 2006 297

Gebauer M Vitamin D deficiency in aged-care facilities: prescribing support through residential medication

management reviews

2007 194

George J Opportunity to broaden clinical and research knowledge [letter] 2004 244

George J Medication regimen complexity and adherence in patients at risk of medication misadventure 2006 99

George J Smoking cessation: COPD patients' perspective 2006 107

George J Adherence to disease management interventions for COPD patients: patients' perspectives 2006 278

George J See Weeks GR 2010 187

George J See Lee CY 2011 98

George J See Weeks GR 2012 17

George LJ Hospital pharmacy — science or anti-science? [editorial] 1996 307

George LJ Impact of a surgical preadmission clinic pharmacist on the quality of medication management from

preadmission to discharge: a randomised controlled study

2011 212

Ghaeli P See Ahmadi-Abhari SA 2005 103

Ghelani D See Somasundaram R 2011 45

Ghiculescu RA Australian reports of bleeding complications associated with antithrombotic drug combinations 2008 32

Ghiculescu RA Rapidly progressive severe amiodarone-induced hypothyroidism in an elderly female 2009 140

Ghosh S Adverse drug reaction pattern in hospitalised children of South Indian teaching hospital 2006 246

Gibb SM Non-approved consensus indications for drugs [letter] 1994 280

Gibson M See Duguid M 2002 94

Gibson M See Wood PJ 2004 285

Gilbar P Inadvertent intrathecal administration of vincristine [letter] 2004 159

Gilbar P 10th international symposium on oncology pharmacy practice 2006 122

Gilbar P The end is not nigh [letter] 2006 166




Gilbar P Retention and recruitment of oncology pharmacists 2007 115

Gilbar PJ Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix) with selected drugs

during simulated Y-site injection

1994 167

Gilbar PJ Intermittent transdermal GTN therapy: survey of prescribing and patient compliance 1995 197

Gilbar PJ Report on the fourth international symposium on oncology pharmacy practice 1995 476

Gilbar PJ Guidelines for drug administration during enteral feeding 1997 214

Gilbar PJ Ticarcillin-potassium clavulanate and vancomycin incompatibility [letter] 1997 470

Gilbar PJ Cancer chemotherapy: potential errors with external referrals 1999 100

Gilbar PJ Seventh International Symposium on Oncology Pharmacy Practice [on a different note] 2000 170

Gilbar PJ See Andrews HP 2001 183

Gilbar PJ Palmar-plantar erythrodysaesthesia associated with an initial course of bolus fluorouracil 2002 178

Gilbar PJ Oral antineoplastic chemotherapy 2005 195

Gilbar PJ External contamination of cytotoxic drug vials [editorial] 2005 264

Gilbar PJ Should the pharmaceutical industry be doing more to reduce the cost of cancer drugs? [editorial] 2011 4

Gilbert A Making medicines safer [editorial] 2006 92

Gilbert A HMRs: is the damage out of control [editorial] 2013 4

Gilbert AL See Roughead EE 1998 7

Gilbert AL See Vial RJ 2002 57

Gilbert AL See Toy AC 2006 35

Gilbert AL See Kalisch LM 2007 292

Gilbert AL See Roughead EE 2008 14

Gilbert AL What will it take for pharmacy practice to change? [editorial] 2009 4

Gilbert AL See Grzeskowiak LE 2010 46

Gilbert AL See Morris S 2010 261

Gilbert AL See Grzeskowiak LE 2010 265

Gilbert AL See Bell JS 2011 316

Gilbert AL See Kalisch LM 2013 182

Gilbert AL Time to rethink the funding model for home medicines review [ed] 2014 9

Gilbert BJ See Brown AN 2012 268

Giles ML The older traveller 1999 222

Gillett M See Corallo CE 1997 146

Gissing PM See Simpson MD 2004 26

Glass B See Haywood A 2005 181



Glass B See Bowen L 2007 178

Glass B See Mylrea M 2012 204

Glass B See Kockler J 2013 218

Glasson E See Ng C 2013 25

Glover S Exploring point-of-care testing of capillary blood in warfarin management 2008 300

Goh LH See Tan CH 2014 17

Goh SF See Ng K 1997 307

Goldsworthy SJ See Bollella G 2008 107

Golledge CL See Irawati L 2006 286

Gombert-Handoko

KB

See Boeker EB 2013 41

Goodman M Career opportunities in management in a professional society [career opportunities] 1998 440

Gordon J Unanswered health-related questions in community pharmacy: frequency nature and consequences 2011 271

Gore R Provision of pharmacy services by private practitioners [letter] 1994 281

Gore S See Rao PGM 2005 40

Gore SB See Lakshmi PK 2002 240

Gourlay SG Nicotine replacement therapy for smoking cessation — a review. Part 2 — clinical aspects 1994 200

Gowan J Handbook of nonprescription drugs 12 edition [book review] 2000 291

Gowan S Documenting passage of stools in overdose situations [letter] 1996 372

Goy R See Lim SC 2008 191

Grafanakis H See Welch SA 2003 16

Graham BM Cytotoxic drug safety cabinets 1999 291

Graham BM HEPA filter testing 2001 154

Graham BM What price safety? Changes to test methods and certification for cytotoxic cabinets. 2002 177

Graham KJ Experience of the Master of Clinical Pharmacy degree [letter] 2005 248

Graham R See Cocks HJ 2004 109

Grainger D See Day R 2007 4




Grant G See Haywood A 2005 181

Graudins L See Blennerhassett J 2005 244

Graudins L See Maxwell DJ 2006 124

Graudins LV See McCrudden EA 1995 261

Graudins LV Cisapride review-local use after overseas withdrawal 2001 154

Graudins LV Celecoxib use and overuse-too much 'celebration'? 2002 104

Graudins LV COX-2 inhibitors: continuing use and overuse [letter] 2003 157

Graudins LV Pharmacists are an integral component of quality use of medicines 2004 201

Graudins LV Promoting safe use of paracetamol in children 2006 297

Graudins LV See Welch SA 2007 27

Graudins LV Pharmacoepidemiology-QUM vadis? 2007 127

Graudins LV Stability of omeprazole mixtures: implications for paediatric prescribing 2008 276

Graudins LV Variation in paediatric omeprazole dosing 2008 283

Graudins LV Paedpharm: paediatric pharmacy network 2009 290

Graudins LV Adverse drug reactions during hospital stay: evaluation of a model for informing patients 2012 95

Graudins LV ISQua - advancing quality and safety now and into the future [letter] 2013 80

Graudins LV WHO High 5s Project: medication reconciliation international meeting 2013 133

Graudins LV Centre Hospitalier Universitaire Grenoble [letter] 2013 164

Gray MJ See Leversha A 2001 130

Green B See Whitty JA 2001 300

Green B See Barras MA 2008 77

Green L See Blennerhassett JD 2006 175

Greene L See Alvarez SJ 2001 13

Gregory D See Linsley RF 1998 256

Gregory F Danazol effects on platelets [inform] 1995 292

Gregory LA See Clifford RM 2011 203

Grewal J Anticoagulation for non-valvular atrial fibrillation in older people 2012 228

Grey L See Flavel D 2012 121

Grice P Harle's Herbal Baby's Friend [letter] 1995 352

Grima GJ See Belz SA 2013 137

Groves CF See Gilbar PJ 1994 167

Groves CF See Andrews HP 2001 183

Grzeskowiak LE Monitoring physical health and adverse effects in children and adolescents prescribed antipsychotics 2008 9

Grzeskowiak LE Conception and beyond: using population-based record linkage to monitor long-term effects of

medications used during pregnancy

2010 46

Grzeskowiak LE Hospital pharmacy dispensing records for pharmacoepidemiology research into late gestation exposure

to antidepressants

2010 265

Grzeskowiak LE Role of the practitioner-researcher in pharmacy practice [editorial] 2012 5

Grzeskowiak LE See Whennan LD 2012 22

Grzeskowiak LE Paediatric and perinatal health abstracts at SHPA national conferences: trends in presentation and

subsequent publication

2014 22

Gu P Direct-to-consumer advertising of prescription medicines on the Internet: an Australian consumer

perspective

2011 196

Gudka S See Clifford RM 2011 203

Gudka S Future pharmacy-based chlamydia screening: consumer preference 2013 15

Guidone DM Fixed-dose statins with no lipid targets: a new paradigm of dosing? [letter] 2014 64

Guille GP See Aldama PC 2003 330

Guirguis K Prescribing by non-medical practitioners [letter] 2009 82

Gujral G See LaCaze A 2012 6

Gujral GR Myalgia in patients on high-dose and low-to-moderate dose statin therapy 2009 202

Gupta AN See Singh A 2014 60

Gupta S See Seleem M 2011 132

Gurung K See Das RN 2007 80

Guthridge JM Health promoting medications in older people 1999 273

Guymer RH See Lim L 2004 53

Haack LA See Taylor SE 2007 214

Haas SJ European Society of Cardiology Congress 2003 2004 39

Habak JE Prophylactic antibiotic use in breast cancer surgery patients 2013 101

Hachem AH See Saab YB 2004 18

Haines W A technician's role in a TPN service 1996 67

Hale A Pharmacist prescribing - taking steps towards the future [letter] 2009 163

Hale A Hospital pharmacists’ views on collaborative pharmacist prescribing [ed] 2013 256




Hall J Introduction to health economics 1994 34

Hall T Are pharmacists allied health professionals? [letter] 2009 330

Hall T See Karaksha AA 2010 208

Hall T See Latimer SL 2011 188

Hall TD See Walker MP 2012 291

Hamblin VA See Maddocks I 1994 400

Hambridge JA Novel use of placebo tablets in the treatment of choking phobia 2001 121

Han P See Nasser S 2012 129

Hancy T Re-engineered healthcare systems — internationally and nationally 1996 18

Hanes CA Pharmacist prescribing: views of Australian hospital pharmacists 2005 178

Hardidge A See To T-P 2013 177

Harding A See O'Leary KM 2006 32

Harding AM A snapshot of admissions to an acute medical unit for the aged [practice report] 1998 359

Harding AM Adverse drug reactions as an educational tool 1999 220

Harding AM The role of an emergency department pharmacist 2001 303

Harding AM Pharmacy practice in the Marshall Islands 2003 216

Harding AM Patch identification poster and education to reduce transdermal medication errors [letter] 2010 332

Harding AM See Khan M 2011 265

Hardy JE Deprescribing in the last year of life 2011 146

Hargraves T-L Developing an outpatient heart failure pharmacy service 2008 103

Harlow MA See Winter SJ 2013 11

Harrhy KL See Coombes JA 2003 194

Harris J See Ng D 1999

Harris M See Barras M 2011 183

Harris R Further education - ever thought of a business degree? 2002 180

Harris RG See Ware GJ 1994 329

Harrison J See Zolezzi M 2014 188

Harrup RA See Wilson RK 2013 51

Harugeri A See Joseph J 2010 279

Harvey PA Management of hypertension in older people 2001 212

Harvey PA See Elliott RA 2009 216

Harvey PA Audit of medication management after discharge from hospital to residential care [letter] 2012 246

Hasan SS Factors influencing concomitant use of complementary and alternative medicines with warfarin 2010 294

Hashemi M See Behjati M 2012 77

Hassali MA Quality use of generic medicines in Malaysia [letter] 2007 334

Hassali MA Introducing the concept of disease mongering to social pharmacy students in Malaysia [letter] 2009 79

Hassali MA Medicine safety seminar for Malaysian community pharmacists [letter] 2009 245

Hassali MA Status of generic medicine use in Malaysia [letter] 2009 329

Hassali MA See Alabid AH 2010 164

Hassali MA See Elkalmi RM 2010 245

Hassali MA See Malik M 2011 73

Hassali MA Lack of medicine safety communication channels: the case of HPV vaccine in Malaysia [letter] 2011 80

Hassali MA See Shafie AA 2011 163

Hassali MA See Chin KL 2011 332

Hassali MA See Saleem F 2011 333

Hassali MA Pharmacy practice in Malaysia 2014 125

Hassali MAA See Alabid AH 2013 187

Hassan FA Potential interactions between drugs taken by ED patients of an Australian hospital 2006 266

Hattingh HL Regulation of the pharmacy profession throughout Australia 2007 174

Hattingh HL See Karaksha AA 2010 208

Hattingh HL See Tan ACW 2012 48

Hattingh LH See Walker MP 2012 291

Havill C Meeting the challenge [letter] 2005 332

Haywood A Extemporaneous isoniazid mixture: stability implications 2005 181

Haywood A Stability implications of repackaging paracetamol tablets into dose administration aids 2006 25

Haywood A Managing extemporaneous oral liquids in practice 2007 131

Haywood A See Bowen L 2007 178

Haywood A See Nissen LM 2009 129

Haywood A See Mylrea M 2012 204

Haywood A See Kockler J 2013 218

Haywood CC Management of obesity in older people 2013 145

Heath EK On-call pharmacist enquiries and outcomes: an on-call database review, 2003-2012 2014 201




Hebbard GS Management of oesophageal disease in the elderly 2001 285

Hecker JR Pharmacological management of Alzheimer's disease 2003 24

Heddle R See Hebbard GS 2001 285

Heel AC See Coombes ID 2005 190

Heland M See To T-P 2013 177

Helboe T See Roberts GW 2013 276

Hellyar AG See Dartnell JG 1994 392

Hemmens VJ See Joseph PD 2012 213

Hemming M From hospital pharmacy to publishing [career opportunities] 1998 368

Hemming M Fred J Boyd Award 2003 2003 299

Hemming M Evidence in context [editorial] 2006 94

Hender EA See Magarey J 1996 454

Hender EA Victoria Poisons Information Centre- 25 years in the RCH’s Pharmacy Department 2001 151

Hender L Moclobemide in overdose [inform] 1996 272

Henderson A See Coombes ID 2005 190

Henschke PJ See Scott SD 1994 325

Hetherington N Studying in the US—there's more available than you think! 1999 344

Hewitt J Drug-related unplanned readmissions to hospital 1995 400

Heywood M See Baysari MT 2012 246

Heywood M See Baysari MT 2013 288

Hidalgo FJ See Aldama PC 2003 330

Hijazi R See McD Taylor D 2009 24

Hilbers J See Blennerhassett J 2011 33

Hilet AJ Pharmacy involvement with HITH programs [letter] 1998 142

Hill R Treatment of Wilson's disease in patients unresponsive or intolerant to conventional agents 1995 295

Hill SJ See Ryan RE 2011 295

Hilmer SN See Mitchell SJ 2009 122

Hilmer SN See Hardy JE 2011 146

Hilmer SN See Johnston CF 2011 275

Hilmi SC See Smith BA 1996 560

Hilmi SC See Santoro VA 2013 194

Hines L See Alvarez SJ 2001 13

Hiremath SS See Shankar PR 2009 162

Hirth KE See Dartnell JG 1994 392

Hirth KE Treatment of primary pulmonary hypertension 2002 185

Ho J See McD Taylor D 2009 24

Ho L Renal failure and acute interstitial nephritis associated with NSAIDs 2005 219

Ho L Australian and New Zealand annual scientific meeting on intensive care 2006 44

Ho L Serial point-prevalence studies to investigate hospital antimicrobial prescribing 2007 190

Ho L Preceptorship at the University of Pittsburgh Medical Center [letter] 2008 164

Ho L Liposomal amphotericin and caspofungin: salvage therapy for invasive aspergillosis in hepatic failure 2008 223

Ho L See Klemz K 2008 296

Ho L Insulin e-learning module an effective means of education delivery to hospital health professionals? 2009 34

Ho MC Influenza vaccination and the elderly 1995 36

Ho PC See Wong VK 1996 641

Ho WK Treatment of venous thromboemboliosm in older people 2010 309

Hobbs MR See Aikman KL 2013 272

Hobson LT See Sullivan JA 1994 397

Hodgkinson MR Identification of adverse drug reactions using the ICD-10 Australian modification clinical coding

surveillance

2009 19

Hodgkinson MR See George LJ 2011 212

Hoenemann D Stability of thalidomide suspension - approved use and safety considerations [letter] 2012 248

Hoffman J APEC/APRA project to develop a national competency assessment tool [letter] 1997 158

Hogue VW Community education program on oral antidiabetes medicines 2005 112

Hohaia L Exceptional patient loyalty under the new pharmacy services agreement in New Zealand [ed] 2013 259

Holford NHG See Ware GJ 1994 329

Holmes NJ See Wheeler AJ 2007 33

Hong GW See Hui HZ 2012 166

Hope D See Kockler J 2013 218

Hope ME See Stafford L 1998 246

Hopkins AM Stability study of a thalidomide suspension 2012 115

Hopper I See Graudins LV 2012 95




Hopwood MJ Drug treatment in Alzheimer's disease 1994 190

Hopwood MJ See To TP 2000 202

Hopwood MJ Psychotropic medication use in older people 2007 153

Hort AL See Santoro VA 2013 194

Hotham NJ A visit to the Motherisk Program in Canada 2001 230

Hotham NJ Review of: drug therapy and breastfeeding. From theory to clinical practice. 2002 293

Hoti K Pharmacist prescribing in Australia [editorial] 2010 175

Hoti K See Hughes J 2012 172

Howard R Impact of a pharmaceutical care program at a mental health clinic 1996 250

Howarth H See Nicklason F 2000 175

Howarth HD See Simpson MD 2006 119

Howat C See Parke J 2003 268

Howat P See Joyce AW 2007 42

Howden BP See McD Taylor D 2009 24

Howes LG See Edwards CT 1997 133

Howitt KM Casemix funding and pharmacy [letter] 1994 282

Howitt KM Implementation of patient costing software — a pharmacy perspective 1996 315

Howitt KM Refinement of an Australian pharmacy casemix classification for the acute healthcare setting 1997 302

Howitt KM Coding of clinical pharmacy services [editorial] 1997 425

Howitt KM Management tool that allows comparison of pharmacy services 2001 181

Hsieh M Abnormal renal function and electrolyte disturbances in older people 2009 230

Hsu M See Roberts JA 2007 200

Hudson BJ A study of adverse effects following vancomycin administration 1995 257

Hughes J Hospital pharmacy-training ground of consultant pharmacists for the future [editorial] 2005 175

Hughes J See Hoti K 2010 175

Hughes J It all begins with one case [editorial] 2010 258

Hughes J Research: quantity vs quality vs impact (bronze vs silver vs gold) [editorial] 2012 172

Hughes JD See Tenni PC 1996 416

Hughes JD Clinical pharmacy - a career of opportunities [career opportunities] 1998 269

Hughes JD The worth of clinical pharmacy 1998 325

Hughes JD See Fellows L 2000 196

Hughes JD Training consultant pharmacists: the future of clinical pharmacy in hospitals 2002 7

Hughes JD Medicines in the elderly 2002 208

Hughes JD See Irawati L 2006 286

Hughes JD See Wee JS 2007 108

Hughes JD See Ramadaniati HU 2014 205

Hui HZ Evaluation of enoxaparin treatment at a Chinese tertiary referral teaching hospital [letter] 2012 166

Humagain B See Shankar PR 2009 162

Humphris MA See Dubrava S 2007 16

Hung CW A study of aminoglycoside usage in a Hong Kong hospital 1997 235

Huppatz C Testing the Surefuser: a disposable subcutaneous infusion pump [short communication] 1998 241

Hurley E Do ACE inhibitors cause gynaecomastia? [inform] 1995 292

Husband AJ See Westaway KP 2014 44

Husband AJ See Westaway K 2014 138

Hussain A See Malik M 2011 73

Hutchinson J See Patel RP 2013 112

Hutchinson KA Are E-codes the answer to identifying adverse drug reactions? 2001 98

Hynes KI See Bingham JM 1994 440

Hynes KI See Vernon GM 1995 32

Hynes KI Glaxo Medal of Merit 1995 1996 106

Hynes KI See Bingham JM 1996 287

Hynes KI Provision of hospital pharmacy services for clinical drug trials 2010 300

Iansek R Pharmacological management of Parkinson's disease 2004 229

Ibrahim MI See Palian S 2009 329

Ibrahim MI Effective pharmaceutical management and policy in developing countries [editorial] 2010 89

Ibrahim MI See Alabid AH 2010 164

Ibrahim MI See Elkalmi RM 2010 245

Ibrahim MI See Maarup N 2011 49

Ibrahim MI Clinical pharmacy education in the Middle East and Asia: are we doing it right? [editorial] 2011 176

Ibrahim MI See Leng CB 2011 250

Ibrahim MI See Abdulwahab A 2012 77

Ibrahim MIM Do community pharmacists in Qatar practice rationally for a minor ailment? [letter] 2013 79




Ibrahim MIM See Alabid AH 2013 187

Ibrahim MIM How do community pharmacists in Qatar respond to patients presenting with symptoms of acute

respiratory tract infections? [letter]

2014 62

Ibrahim MIM See Sonallah H 2014 159

Ibrahim R Knowledge and perceptions of community patients about generic medicines 2012 283

Ibrahim T See Sonallah H 2014 159

Ientile CS Complimentary medicines use by Australian veterans 2005 110

Ilomäki J See Chan TW 2013 269

Inam S A review of strategies to improve rational prescribing in asthma 2014 195

Inderjeeth CA Management of osteoporosis in older people 2010 229

Inglis D Renal study tour [letter] 2005 79

Ioannides-Demos L See Rayner CR 1998 394

Ioannides-Demos L Survey of pharmacy services and drug usage in Victorian public hospital HITH programs 1999 16

Ioannides-Demos L See George J 2006 107

Ioannides-Demos L See George J 2006 278

Irawati L Influence of penicillin allergy on antibiotic prescribing patterns and costs 2006 286

Irving LB See Ho MC 1995 36

Izham MI ADR reporting by community pharmacists in Nepal [letter] 2008 331

Jabbour H See Armour CL 1998 410

Jackson B See Toh CT 2010 27

Jackson J Hospital use of the Pharmaceutical Benefits Scheme [letter] 2004 157

Jackson J See Dunning TL 2010 203

Jackson JK The Society of Hospital Pharmacists of Australia 22nd Federal Conference [editorial] 1995 310

Jackson JK What do hospital pharmacists want from conferences? 1995 464

Jackson JK Use of the Pharmaceutical Benefits Scheme in private hospitals: 1. Associated problems 2001 194

Jackson JK Use of the Pharmaceutical Benefits Scheme in private hospitals: 2. An alternative model 2001 262

Jackson JK Analysis of the impact of public hospital pharmaceutical reforms on discharge medication supply 2001 295

Jackson JK See O'Leary KM 2002 72

Jackson JK Public health-recognising the role of Australian pharmacists 2004 290

Jackson JK Evaluation of drug use indicators in private hospitals 2005 28

Jackson S See Bereznicki L 2005 173

Jackson SL See Bereznicki LR 2006 162

Jackson SL See Bereznicki LR 2007 300

Jalali N See Abdolkarim P 2002 297

James A See Tibballs J 1995 516

James CR Patient's own drugs and one-stop dispensing: improving continuity of care and reducing drug

expenditure

2008 44

James R Privatisation of a repatriation hospital pharmacy 1996 47

James R The Pharmaceutical benefits scheme and public hospitals 2002 175

Janczak MB Team effort produces results 2001 305

Janczak MB Practice developments for hospital technicians in the UK 2005 207

Jankewicz G See Lee S-G 2007 271

Jankewicz G See Ambados F 2008 80

Jankewicz G See Lee S-G 2009 181

Jankewicz GJ See Lee SG 2009 95

Janney EP See Stafford L 1998 246

Jansen LJ See Loe EA 2008 209

Jao K See Khan M 2011 265

Jarvis DA See Sorich MJ 2004 22

Jarvis VI See Tan ACW 2012 48

Jayasinghe C See Mellor JD 2011 42

Jayasuria PH See Angley M 2014 6

Jayasuriya P See Brien JE 2009 81

Jeffery DM See Jackson JK 2001 262

Jeffreys AJ Anaesthesia for the elderly 1994 430

Jenkins B Managing conflicts of interest [editorial] 2013 8

Jenkins BG See Santoro VA 2013 194

Jenney A Interventions of an antibiotic management team 1999 36

Jennings R See Harvey PA 2012 246

Jensen M See Kairuz T 2009 162

Jepsen DM Australian hospital pharmacists reflect on career success 2013 29

Jerums G See MacIsaac RJ 2002 188




Jess K See Barras M 2011 183

Jestrimski KW See Leow CC 1994 250

Jestrimski KW Management challenges in large rural hospital pharmacy departments 1999 202

Jha N See Shankar PR 2009 162

Jha N See Shankar PR 2009 245

Jindal D Public perception of community pharmacists in Delhi [letter] 2005 331

Johansen C See Roberts GW 2013 276

Johns C See Patel RP 2013 112

Johns RA See Rai PGM 2005 166

Johnson DW See Ng CS 2008 280

Johnston CF 'You look like a 240 mg': gentamicin dosing at a Sydney hospital 2011 275

Johnstone JM Writing a case report [letter] 1998 68

Johnstone JM Some reflections on writing and publishing [conference presentation] 2000 66

Jones A See Lim CM 2004 11

Jones AL See Lau ET 2013 19

Jones EF Drug therapy of heart failure in the elderly 2000 274

Jones TE See Vial RJ 2002 57

Jordan M See To NN 1999

Jørgensen LE See Roberts GW 2013 276

Jose J Career satisfaction among Indian pharmacists [letter] 2005 333

Joseph J Frequency and nature of medication-related problems in elderly Indian inpatients 2010 279

Joseph PD Stability of oral cholecalciferol (vitamin D3) liquid formulations in olive oil 2012 213

Joyce A See Wibowo Y 2012 26

Joyce AW See Irawati L 2006 286

Joyce AW Community pharmacy's role in promoting healthy behaviours 2007 42

Joyce AW See Wee JS 2007 108

Jukka C See Rothwell M 2011 290

Juliana GS Emergence of adverse reactions to tramadol in children and adolescents at a paediatric hospital 2005 187

Jupe DM See Bereznicki LR 2007 300

Kaesler Sb See Eaton V 2005 56

Kaesler SB Certified Geriatric Pharmacist credential by computer-based testing [letter] 2007 81

Kainey S Hospital-based pharmacy pre-registration training and the hospital pharmacy workforce 2004 70

Kainey SH See Hender EA 2001 151

Kainey SH Pharmacist shortage 2002 175

Kairuz T See Sheridan J 2007 19

Kairuz T See Garg S 2008 28

Kairuz T Prescription interventions in community pharmacy in New Zealand [letter] 2009 162

Kairuz T See Doggrell SA 2012 208

Kairuz T See Lau ET 2013 19

Kairuz TE History of extemporaneous compounding in Australia: changes and developments in the APF 2013 117

Kaleemuddin M Role of the clinical pharmacist in poison-related admissions in a secondary care hospital 2001 26

Kalisch LM Do pharmacists adhere to brand substitution guidelines? The example of simvastatin 2007 292

Kalisch LM See Bell JS 2011 316

Kalisch LM Home medicines reviews: extent of uptake by high-risk veterans 2013 182

Kam FSF See Gilbar PJ 1997 214

Kane M Biotechnology: opportunities and skills required 1996 79

Kapoor P See Jindal D 2005 331

Karaksha AA Quality of discharge summaries sent by a regional hospital to general practitioners 2010 208

Karim S See Jindal D 2005 331

Karimpour H See Abdollahi M 2003 12

Karimzad SH See Agarwal J 2014 162

Karmakar GC See Aikman KL 2013 272

Kastango ES Compounded sterila preparations continue to harm or kill patients [editorial] 2008 173

Katelaris CH See Cheong EA 2008 267

Katsogiannis W Nebuliser versus metered dose inhaler use in hospitals 1996 529

Katz B Pharmacological management of pain in older people 2007 63

Kay O Pharmacist prescribing-lessons from abroad [editorial] 2004 259

Kay OC Pharmacist prescribing: review of the literature 2004 300

Kay OC Pharmacist prescribing activities an electronic survey on the opinions of Australian pharmacists 2006 199

Kaye AE See Drummond SH 1994 231

Kaye K Building sustainability 2006 313

Kaye KI Complementary therapies [letter] 2000 23




Kaye KI DUE: a rose by any other name 2000 279

Kaye KI See Kelly M 2004 32

Kaye KI See Maxwell DJ 2006 124

Keefe PA See Targett PL 1997 207



Keefe PA Report on the Ninth World Congress on Pain 2000 286

Keen N CPD-current informed connected [editorial] 2007 89

Keen N Medicines management 2008: education steps out [editorial] 2008 261

Keen N Place for pharmacists in health reform [editorial] 2009 261

Keen N Clinical pharmacy and competency assessment [editorial] 2010 6

Keen N See Jenkins B 2013 8

Keen NJ See Irawati L 2006 286

Kehoe L See Weekes L 2006 91

Keith C See Rando L 2004 95

Keith C Economic evaluation - a tool to support hospital formulary assessments [letter] 2009 165

Keks N Schizophrenia 1996 93

Kelleher PW The pharmacological management of acute myocardial infarction in older people 1995 480

Kelly A-M Are titrated intravenous narcotics an infection risk? [letter] 1995 487

Kelly M Waiting for casemix 1996 130

Kelly M See McFarlane AE 1996 635

Kelly M See McFarlane AE 1997 455

Kelly M Factors influencing adverse drug reaction reporting in New South Wales teaching hospitals 2004 32

Kelly RI See Shen S 2012 150

Kelpie P See Ford D 1996 671

Kemp C The grass isn't always greener … 1999 177

Kemp SM Rurally focused BPharm course: perceptions of graduates 2010 275

Kenneally A See Lubliner M 2005 266

Kenneally AL See Van de Vreede MA 2003 290

Kennedy J See Kunac DL 2010 290

Kennedy JM See Tordoff JM 2004 267

Kennedy JM See Tordoff JM 2005 271

Kent PJ See McConachy KA 1999

Kerr S See Silva MA 2013 37

Kerridge I See Day R 2011 94

Kerridge I See Inam S 2014 195

Kethini T See Kumari R 2003 131

Kethini T Mirtazapine-associated rapid weight gain and decreased physical activity 2004 308

Kettels J ADR case reports [letter] 1997 471

Kevans P See Cocks HJ 2004 109

Khalai S See Abdollahi M 2003 12

Khalessi-Rad See Roberts GW 2012 200

Khalil H Medication reconciliation audit [letter] 2009 166

Khalil H Pharmacy practice in rural Gippsland [letter] 2009 327

Khan GM See Bedi TR 2006 164

Khan M Complementary and alternative medicines use in patients on warfarin and matched controls: a

retrospective cohort study

2011 265

Khan SA Surgical antibiotic prophylaxis in an Indian hospital [letter] 2006 163

Khan SA See Rodrigues GS 2007 78

Khan Z See To NN 1999

Khan ZI Indian hospital pharmacists: patient perspective [letter] 2005 328

Khanal S See Izham MI 2008 331

Khanal S See Maarup N 2011 49

Khar RK See Khan ZI 2005 328

Kheir N See Ibrahim MIM 2014 62

Khera K See Singh A 2014 60

Khoo A Extended roles for pharmacists in warfarin therapy: identifying opportunities for pharmacist

prescribing

2006 190

Khor XY See Shafie AA 2011 163

Khu JV Helicobacter pylori eradication regimens: is there a difference? 2010 194

Khumra S See Chen AW 2010 19

Khumra S See Chen AW 2011 37




Kiani M Dexamethasone use in inpatient palliative care 2011 217

Kiani M See Habak JE 2013 101

Kiatying-Angulee N See Phosri J 2005 115

Killen L See Brett J 2013 97

Kilminister I See MacPherson RD 2006 302

Kilminster IM See Hudson BJ 1995 257

Kilpatrick C Management of Epilepsy in older people 2002 110

King B New pharmacy course at James Cook University [letter] 1998 302

King K See Slater W 1999 216

King MA See Sorensen L 2004 122

King MA See Hattingh HL 2007 174

Kini L See Jose J 2005 333

Kirkpatrick CM See Barras M 2011 183

Kirsa S New PBS reforms-PBS saviour but at what cost to hospitals? [editorial] 2007 93

Kirsa S See Siderov J 2009 117

Kirsa S See Siderov J 2011 181

Kirsa S See Thakerar A 2014 231

Kirsa SW See Dartnell JG 2000 251

Kirsa SW See O'Leary KM 2002 72

Kirsa SW See Rice CA 2007 303

Kirsa SW See Dunning TL 2010 203


Kirsa SW See Coombes I 2012 261

Kirsa SW See Moloney MJ 2013 49


Kirsa SW See Angley M 2014 6

Kishore PV See Paudel R 2006 218

Kivi NJ See Graudins LV 2008 276

Klemz K Daily IV chloride load and the acid-base and biochemical status of ICU patients 2008 296

Klusak A Haemorrhagic stroke due to rivaroxaban and use of prothrombin complex concentrate as a reversal

agent

2014 129

Knight AT See Boyce LE 2013 105

Knott JC See Leow FHP 2006 194

Knott JC See Hassan FA 2006 266

Knott JC See Wong J 2008 92

Knott JC See Chan EW 2011 135

Knott JC See Chan EW 2012 11

Knowler CB See Kumar N 2011 108

Kockler J Stability of paracetamol tablets repackaged in dose administration aids for prn use: implications for

practice

2013 218

Koda-Kimble MA The United States experience 1994 16

Koda-Kimble MA The changing face of pharmacy 1994 83

Koju R See Bedi TR 2006 164

Koller L See To NN 1999

Koller LJ See Thornton PD 1994 387

Koller LJ See Ludington JE 1995 422

Koller LJ See McFarlane AE 1996 635

Koller LJ See Ng K 1997 307

Koller LJ See D'Souza DC 2004 190

Kong D National Medicines Symposium 2002 2002 179

Kong D See Chan EW 2012 11

Kong DC 6th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology [letter] 2000 73

Kong DC See George J 2006 99


Kong DC See Larizza MA 2006 115


Kong DC See Stuchbery P 2007 102

Kong DC See Stuchbery P 2008 126

Kong DC See To TP 2008 219

Kong DC International congress on infectious diseases [letter] 2008 333

Kong DC See Chen AW 2010 19

Kong DC See Chen AW 2011 37




Kong DC See Chan EW 2011 135

Kong DC See Pang RK 2011 192

Kong DC 22nd European Congress of Clinical Microbiology and Infectious Diseases [letter] 2012 333

Kong DCM GlaxoSmithKline Medal of Merit 2013 2013 307

Kong F Haemaccel (polygeline) reactions: anaphylaxis or anaphylactoid? [short communication] 2000 107

Kong F Unanswered questions 2000 289

Kong MS Want to learn more about clinical studies? [letter] 2005 331

Kong MS Medications in pregnancy: impact on time to lactogenesis after parturition 2008 205

Kong RE See Tan ISP 2013 279

Koning SI Antimicrobial prescribing in a rapid assessment medical unit – a multi-phase pilot study 2013 261

Konstantopoulos D Patient perspective on the use of antibiotic containing infusor bottles [letter] 2010 77

Koo J See Tordoff JM 2006 12

Koo MMM Consumer use of consumer medicine information 2005 94

Korajkic A Impact of a pharmacist intervention on ambulatory patients with heart failure: a randomised controlled

study

2011 126

Kowalski SR See Cosh DG 1996 673

Kowalski SR See Nyfort-Hansen K 2001 41

Kowalski SR See Sorich W 2008 111

Kowalski SR Plasma potassium concentration changes associated with trimethoprim used for urinary tract infections 2010 180

Kowalski SR See Widagdo IS 2011 122

Krass I See Boyle CM 1998 413

Krass I See Bajorek BV 2001 93

Krass I See Koo MM 2005 94

Krass I See Van C 2007 182

Krass I See Giam JA 2007 260

Kremer L See Young J 2006 275

Kristensen J Sumatriptan and breastfeeding [inform] 1996 460

Kristoffersen SS Use of alternative medicines on Sydney's North Shore 1997 367

Krum H See Pellizzer AM 1997 406

Krum H See Rayner CR 1998 394

Krum H See Pellizzer AM 1998 432

Krum H See Zimmet H 2006 229

Krumins D See Walton N 2010 130

Kubler P See Avent ML 2010 15

Kubler PA See Mackenzie FD 2006 185

Kulsomboon V See Phosri J 2005 115

Kuluru P See Devabhaktuni R 2013 333

Kumar JK See Parthasarathi G 2003 272

Kumar N Facilitating medication misadventure risk assessment in the emergency medical unit 2011 108

Kumari R Clinical pharmacy in a South Indian government maternity hospital 2003 131

Kunac D See Graudins LV 2009 290

Kunac DL In-line intravenous filtration in neonates: help not hindrance 1999 321

Kunac DL Initial experience with a paediatric pharmacy e-mail network 2001 139

Kunac DL Risk factors for adverse drug events and medication errors in paediatric inpatients: analysis by

admission characteristics

2010 290

Kunhikatta V See Thunga G 2013 163

Kunhikatta V See Awasthi S 2013 248

Kunst AM Northern exposure: renal pharmacy study tour [letter] 2009 246

Kupa A See Eaton VS 2000 58

Kuruvila MT See Sorich W 2008 111

Kyle G See Freeman C 2012 184

Kyriakides P See Rothwell M 2011 290

La Caze AB See Cutts C 2003 70

La Forgia SP Stability and compatibility of morphine midazolam and bupivacaine combinations for intravenous

infusion

2002 65

LaCaze A Adherence and beliefs [editorial] 2012 6

Lakos A See Clifford RM 2011 203

Lakshmi PK Development and use of an independent drug information centre in India 2002 24

Lakshmi PK Doctors' preference for the location of a drug information centre leads to a hospital-based clinical

pharmacy initiative in India

2002 240

Laksmana I See Kairuz TE 2013 117

Lalor D Durg nmae cnofsiuon or drug name confusion? [letter] 2009 246




Lam A Octreotide use in gastric antral vascular ectasia 2013 297

Lam SS See Toh CT 2005 106

Lam SS See Turner SJ 2005 119

Lam SS See deClifford JM 2007 284



Lam SS See Pang RK 2011 192


Lam SSH See Lam A 2013 297

Lam V See Brett J 2013 97

Lamb B Weekend leave for rehabilitation patients and its impact on a hospital pharmacy 1995 149

Lambrianides AL See Seleem M 2011 132

Langford J See Pham L 2003 275

Langford JH See Benrimoj SI 1995 119

Langford JH See Benrimoj SI 1995 230

Larizza M ASCO - the ultimate oncology experience [letter] 2008 163

Larizza MA Factors influencing adherence to molecular therapies in haematology-oncology outpatients 2006 115

Larizza MA Individualised foreign language medication lists for non-english speaking hospital patients 2009 277

Larmour I Cultural change and drug expenditure 1995 220

Larmour I Performance indicators in hospital pharmacy practice 1996 89

Larmour I Spend more on pharmacists to spend less on drugs [letter] 1997 335

Larmour I Hospital pharmacists and the challenge of quality 1998 226

Larmour I See Harding AM 1999

Larmour I See Alvarez S J 2001 13

Larmour I Pharmaceutical reform - a long and winding road 2002 255

Larmour I Introduction of PBS reforms at three Victorian public health services 2003 204

Larmour I See Hodgkinson MR 2009 19

Larmour I Marketing pharmaceuticals: are the benefits real? [editorial] 2011 172

Larmour I See George LJ 2011 212

Latimer SL Non-therapeutic medication omissions: incidence and predictors at an Australian hospital 2011 188

Lau D Chemical stability of voriconazole 1% eye drops 2008 179

Lau ET Compounding practices in Queensland: experiences and perceptions of pharmacists and pharmacy

students

2013 19

Lau NR IV incompatibility - dicloxacillin and magnesium [letter] 2008 162

Lau P Recruitment of oncology patients for an adverse drug reaction study [letter] 2000 175

Lauchlan RL What does the future hold? 1995 41

Lauchlan RL First leg of a journey — the national pharmacy casemix study 1995 342

Lauchlan RL Past — present — future of casemix and pharmacy 1996 125

Lauchlan RL See Howitt KM 1997 302

Lauchlan RL See Stowasser DA 1997 362

Lauchlan RL See Bramley-Moore SR 1998 83

Lauchlan RL Private Health Insurance [career opportunities] 1998 268

Law KK See Hung CW 1997 235

Lawler C Omitted medication doses: frequency and severity 2004 174

Lawrence RI Port Arthur tragedy [letter] 1996 370

Le Blanc L See Frost E 2007 172

Le Blanc T See Westaway KP 2014 44

Le Blanc T See Westaway K 2014 138

Le Couteur DG Evidence ethics and medication management in older people 2010 148

Leach H National Inpatient Medication Chart implementation [editorial] 2006 6

Leach H See Dunning TL 2010 203

Leach HJ Developing the continuum of care in the emergency department [letter] 2004 71

Leach HJ See Maslanka E 2004 131

Leach HJ Optimising the medication management continuum in a private hospital 2004 203

Leach HJ Science and medicine-connecting with society [letter] 2004 330

Leach HJ Herbs and natural supplements: an evidence based guide [book review] 2005 81

Leach MJ Medicine use among older Australians before and after hip fracture 2013 265

Leaver AS Anaesthesia in older people 1999 330

LeBlanc T See Bell JS 2011 316

Lee AH See Wee JS 2007 108

Lee CY Exploring medication risk among older residents in supported residential services: a cross-sectional

study

2011 98




Lee DC See Rollins BM 2013 198

Lee E See Daftary MN 2003 265

Lee E See Hogue VW 2005 112

Lee FTH Advances in diabetes therapy in the elderly 2009 63

Lee K See Bajorek BV 2009 13

Lee NW See Lee SG 2009 95

Lee R See Cook GK 2007 204

Lee SG Assessing flucloxacillin contamination and decontamination - a laboratory study 2009 95

Lee S-G Surface contamination from cytotoxic chemotherapy following preparation and administration 2007 271

Lee S-G See Ambados F 2008 80

Lee S-G Paclitaxel exposure and its effective decontamination 2009 181

Lee S-G See Ambados F 2012 111

Lee T See Sanburg AL 1996 351

Lee YF Restricted antimicrobial use at transitions of care at an Australian hospital 2011 283

Lee YP See Ramadaniati HU 2014 205

Leelvathy DA See Palaian S 2006 77

Lees J International symposium on supportive care in cancer 2001 236

Lees J Amgen international pharmacy preceptorship [letter] 2005 244

Leggett C See Ditty A 2014 220

Lehnbohm EC See Baysari MT 2013 288

Lehnbom EC Impact of a new insulin chart on hospitalised patients with diabetes 2009 45

Lehnbom EC Management of medicines in chronic illness: views of community pharmacists in NSW 2009 207

Lemanski L See Ientile CS 2005 110

Leng CB Medicines spending trends in a Malaysian public hospital [letter] 2011 250

Leong CK See James CR 2008 44

Leong T See Van De Vreede M 2007 197

Leow CC Review of use of newer antidepressants 1994 250

Leow FH Risk and severity of akathisia following administration of metoclopramide in the ED 2006 194

Leow FH See Hassan FA 2006 266

Leslie B See Ryan RE 2011 295

Leung BK See Toh CT 2005 106

Leung BK See Turner SJ 2005 119

Leung BK See deClifford JM 2007 284



Leung BK See Pang RK 2011 192


Leung L See Lau D 2008 179

Leversha A Rural health education 1999 117

Leversha A Rural initiatives 1999 291

Leversha A Empowering our valuable asset: the pharmacy assistant/technician 1999 347

Leversha A Canadian Society of Hospital Pharmacists annual general meeting and educational sessions 2001 56

Leversha A Ward pharmacy technicians assist clinical pharmacists with admissions 2001 130

Leversha A See Simpson MD 2006 119

Leversha A See Khalil H 2009 166

Leversha A Time to increase mentoring in our profession [editorial] 2010 4

Leversha A Rural members meet at the 2009 SHPA federal conference [letter] 2010 164

Leversha A See Dunning TL 2010 203

Levy R See Lee YF 2011 283

Levy R See Costello N 2013 79

Li G Herbs & natural supplements: an evidence-based guide 2010 250

Li RC See Hung CW 1997 235

Lie HK Early experience with the use of celecoxib in a child and adolescent population 2002 27

Lie K Low adherence to vancomycin guidelines at an Australian paediatric hospital 2011 278

Lie-A-Huen L See Boeker EB 2013 41

Liew D See Chan EW 2012 11

Lightfoot TC Drug management in the palliative care of older people [geriatric therapeutics] 1998 45

Lilley B Australian paediatric pharmacy reference group [letter] 1998 289

Lilley BJ See Angalakuditi M 2005 21

Lim AK See Ho L 2005 219

Lim CB Pharmacokinetics of nasal fentanyl 2003 59

Lim CM Stability of insulin aspart in normal saline infusion 2004 11




Lim JW A two-year review of risperidone usage on an acute-care adult psychiatric unit 1997 33

Lim L Treatment and prevention of age-related macular degeneration 2004 53

Lim L See Lockrey G 2011 58

Lim LL See Khu JV 2010 194

Lim SC Pharmacokinetics and bioavailability of hydromorphone nasal spray 2008 191

Lim W See Riley RH 1999

Lim WK Improving medication outcomes in older people 1999 103

Lin FP See Polasek TM 2011 77

Ling JW See Cook GK 2007 204

Linsley RF Performance indicators [letter] 1996 373

Linsley RF Whatever you do don't mention the 'Q' word - perspective on quality in pharmacy and health care 1997 244

Linsley RF Strategies to attract locum pharmacists to hospital practice [practice report] 1998 256

Lipman J See Roberts JA 2009 198

Lipman J See Roberts JA 2009 219

Lipworth W See Day R 2011 94

Lipworth W See Inam S 2014 195

Little PJ See Guidone DM 2014 64

Liu Y See Lim SCB 2008 191

Lloyd A PSA Pharmaceutical Care Project 1996 34

Lo C Electronic medication management systems' influence on hospital pharmacists' work patterns 2010 106

Lo SK See Stuchbery P 2007 102

Lo SK See Stuchbery P 2008 126

Lockrey G Peptic ulcer disease in older people 2011 58

Lockrey GJ Management of peptic ulcer disease in older people 1999 40

Loe EA Inter-regional collaboration for errors and near misses with unfractionated heparin 2008 209

Longworth J 23rd Congress of Collegium Internationale Neuropsychopharmacologicum 2003 48

Longworth JA Child Psychiatry and Drugs 2001 234

Looke DF See Radford JM 1997 140

Looke DF See Radford JM 1998 400

Looke DF See Radford JM 1999

Looke DF See Mackenzie FD 2006 210

Looke DF See Patterson TH 2011 221

Lord JA See Graudins LV 2012 95

Loring S See Patel RP 2013 112

Lourens H See Ho MC 1995 36

Lourens H Introducing ward rounds with visiting medical officers 1999 122

Lovgren S Timeliness and clinical impact of hospital-initiated medication reviews 2009 269

Low J This is your journal calling...[editorial] 1994 7

Low J Standardised documentation of clinical services — the next step? [editorial] 1994 149

Low J Justification of clinical pharmacy services—a new twist? Keep those cards and letters rolling in ...

[editorial]

1994 305

Low J Performance indicators — another challenge? [editorial] 1994 385

Low J If I were a rich man could I buy a pancreas? [editorial] 1995 9

Low J Journal changes [editorial] 1995 10

Low J Pharmacy care [editorial] 1995 117

Low J DUE — dollars or quality? [editorial] 1995 309

Low J Quality use of medicines [editorial] 1995 397

Low J Pharmacy practice — the challenge of new models 1995 501

Low J Conference 1995 [editorial] 1996 5

Low J Pharmaceutical care — an overview 1996 32

Low J Performance indicators— again! [editorial] 1996 209

Low J `...and there's more...' [editorial] 1996 305

Low J Antibiotic resistance: is the horse bolting? [editorial] 1996 521

Low J Technicians and hospital pharmacy [editorial] 1996 621

Low J On a different note [editorial] 1997 5

Low J Electronic publishing [editorial] 1997 107

Low J Drug information - the ongoing challenge [editorial] 1997 286

Low J Adverse drug reactions - where are the case reports? [editorial] 1997 287

Low J Readership survey report 1997 1997 348

Low J Seamless care anyone? [editorial] 1997 356

Low J Research and its sequelae [editorial] 1997 424

Low J Information and privacy [editorial] 1998 2




Low J Whither pharmaceutical care? [editorial] 1998 79

Low J PBS APAC & hospital pharmacy [editorial] 1998 153

Low J Career opportunities and hospital pharmacy [editorial] 1998 224

Low J Pharmacy practice in rural and remote areas [editorial] 1998 301

Low J Competency and mutual recognition [editorial] 1998 392

Low J Performance indicators: Queensland public hospitals' data-set 1998 405

Low J Brave new world or future shock? 1999 2

Low J Practice standards 1999 81

Low J Journal changes 1999 82

Low J Standardisation 1999 135

Low J The DATIS solution—no fallacy 1999 195

Low J Two months in another town 1999 253

Low J Complementary therapies 1999 309

Low J Ethical challenges [editorial] 2000 40

Low J A (not very) brave new world? [editorial] 2000 139

Low J Matters professional and matters industrial 2001 5

Low J A few small steps 2001 90

Low J Hospitals and the PBS revisited 2001 179

Low J Journal of Pharmacy Practice and Research 2001 255

Low J The Journal and other matters 2001 258

Low J Health care - going going? 2002 3

Low J Trans-Tasman regulation of therapeutic products 2002 257

Low J Glimpses of the future 2003 91

Low J Glimpses of the future [editorial] 2003 91

Low J Workforce-the critical issue [editorial] 2003 172

Low J The free trade agreement-an unhealthy prescription? [editorial] 2003 256

Low J Where to now? [editorial] 2004 5

Low J The clinical pharmacy intervention study-what now? [editorial] 2004 89

Low J Pharmacist oversupply - myth or mission? [editorial] 2010 262

Low J Credentialing of advanced pharmacy practice [ed] 2014 11

Lowe A See Kilpatrick C 2002 110

Lowe DB See Ryan RE 2011 295

Lowenthal RM Idarubicin: a new effective drug for treatment of adult acute myeloid leukaemia 1994 159

Loy LM See Patterson TH 2011 221

Lu CY Health outcomes conferences [letter] 2006 76

Lu CY See Day R 2007 4

Lu CY Pharmacogenomics and pharmacovigilance for better patient outcomes [letter] 2009 328

Lu PL See Dooley MJ 2002 141

Lubliner M See Van de Vreede MA 2003 290

Lubliner M Minimising medication mishap: introducing a warfarin safety strategy 2005 266

Lubliner M Preventing potassium problems permanently: eliminating concentrated KCl errors 2006 181

Lucas A See McLachlan GB 2006 81

Lucas C Job exchange between AIDS unit pharmacists 1994 426

Luddington J See Ng C 2013 25

Ludington JE Octreotide associated with raised serum zinc concentrations — a case report 1995 422

Ludington JE See Abdelmessiah D 1997 250

Ludington JE Certification in geriatric pharmacy exam 2002 15

Ludington JE See Lehnbom EC 2009 45

Luetsch K Pharmacists for the future [letter] 2012 249

Luinstra MM Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients 2009 265

Lum E See Barras M 2004 157

Lum E Medication reconciliation - the Queensland Health experience [editorial] 2007 7

Lum E See McLeod SE 2008 196

Lum E See Rothwell M 2011 290

Lum EP Clinical Pharmacy in 2020: an alternative future for clinical pharmacy in a rural setting 2001 46

Lumby J Why has the nurse practitioner been granted prescribing privileges? [editorial] 2010 259

Luu C Management of risperidone-induced galactorrhoea [inform] 1995 548

Lyall H Hospital pharmacy technician training in Australia 1996 71

Lynch M Community pharmacy: strategic change management [book review] 2007 334

Maarup N Possible metformin-induced otorrhoea: a rare case 2011 49

Maarup N See Ibrahim MIM 2014 62

MacAulay K PSA and pharmaceutical care [letter] 1997 412




MacBean CE See Wong J 2008 92

Macdonald JJ See Hambridge JA 2001 121

MacFarlane LM See Korajkic A 2011 126

Macintyre PE See Sorich MJ 2004 22

MacIsaac R See Ho L 2009 34

MacIsaac RJ Treatment of dyslipidaemia in the elderly 2002 188

Mackenzie FD Improving concordance between use of proton pump inhibitors and prescribing guidelines 2002 31

Mackenzie FD Pulmonary and hepatic toxicity due to nitrofurantoin 2004 134

Mackenzie FD Experience with drotrecogin in two Australian hospitals 2006 185

Mackenzie FD Audit of ticarcillan/clavulanate usage in a large teaching hospital 2006 210

Mackey PF See Jackson JK 2005 28

Mackie K International symposium on HIV and emerging infectious diseases [letter] 2008 249

Mackie K International workshop on adverse drug reactions and co-morbidities in HIV [letter] 2010 78

MacKinnon NJ Could 7 million Australians and Canadians be wrong? A status report on medication-use safety in

Australia and Canada [editorial]

2008 6

MacKinnon NJ Achieving hospital pharmacy's dream in Canada [editorial] 2010 174

MacKinnon NJ Pharmacists and rural health: the next frontier? [editorial] 2012 89

Mackson J See Weekes LM 1999

Mackson JM See Tulk RL 1996 392

Maclean H Management of ocular problems in older people 1997 239

MacLellan DG See Fergusson JAE 1997 461

MacLeod D See McD Taylor D 2006 96

MacMillan KB See Tan ISP 2013 279

MacPherson R Extemporaneous dispensing 1999 347

MacPherson R See Pappas A 2002 310

MacPherson R Keto-fusion [letter] 2005 79

MacPherson RD Neonatal epilepsy associated with maternal ingestion of blue cohosh 2006 302

MacPherson RD Strategy to eliminate pethidine use in hospitals [editorial] 2008 88

MacPherson RD See Cao BY 2011 102

Madaki S See Parthasarathi G 2003 272

Maddern D Commercialisation corporatisation privatisation. Setting the scene 1996 45

Maddocks I Evaluation of a spring-driven syringe infusion pump in palliative care 1994 400

Maddocks I See Huppatz C 1998 241

Magarey J Inadvertent administration of ergometrine to newborns [letter] 1996 454

Mahannop P See Thawornchaisit P 2012 189

Mahesh PA See Parthasarathi G 2004 245

Mahler SM Application of emerging technologies in genomics and proteomics to drug development 2003 7

Mak VSL See Hassali MA 2014 125

Malik M Strategic solution to malaria eradication in Pakistan [letter] 2011 73

Malipatil V Management of older people with chronic obstructive pulmonary disease 2009 302

Manallack DT See Northfield SE 2007 98

Manan MM Assessing the pharmaceutical care issues of antiepileptic drug therapy in hospitalised epileptic patients 2014 83

Mangan M See Haywood A 2005 181

Mangan M See Haywood A 2006 25

Mangan M See Bowen L 2007 178

Mangoni AA See To TH 2007 30

Mann T Eutectic mixture of local anaesthetics vs nitrous oxide for cannulation of children in the emergency

department

2007 281

Manning AR See Toh CT 2010 27

Manning R Quality use of medicine in the Northern Territory 1999 347

Mannix L Heart lung transplantation symposium [letter] 2005 248

Manser AJ Computerised physician order entry: strategic issues for Australian hospital pharmacists 1996 664

Manser AJ See Larmour I 1998 226

March G See Yu K 2007 22

March G See Nguyen A 2007 111

March G See Owen SM 2008 121

Marmor GO Medication prescribing surveillance and safety in Australasian emergency departments 2011 113

Marotti SB Pharmacist prescribing in the pre-operative setting [letter] 2009 331

Marotti SB To study or not to study that is the question? [letter] 2010 77

Marriot JL See Weeks GR 2008 271

Marriott J Handbook of pharmacy healthcare [book review] 2003 41

Marriott J See Darzins P 2008 64




Marriott J See Weeks GR 2010 187

Marriott JL See Vuong T 2006 16

Marriott JL See George J 2006 99

Marriott JL See Simpson MD 2006 119

Marriott JL Pharmacist's role in the hospital discharge process 2008 114

Marriott JL Investigating the hospital discharge medication process 2008 117

Marriott JL See Elliott RA 2010 36

Marsden KA See Bereznicki LR 2007 300

Marshall L See Taylor KL KL 2007 287

Martin ED Managing with casemix in South Australia 1996 129

Martin ED See Howitt KM 1997 302

Martin ED Evaluation of an automated drug distribution system in an Australian teaching hospital. Part 1

Implementation

2000 94

Martin ED Evaluation of an automated drug distribution system in an Australian teaching hospital. Part 2

outcomes

2000 141

Martin J See Brien JE 2009 81

Martin J See Ghiculescu RA 2009 140

Martin J See Avent ML 2010 15

Martin RC See James CR 2008 44

Martin S Medication adherence in solid organ transplant recipients and the impact of clinical pharmacy services

[editorial]

2009 257

Martinac G Dopamine-induced gangrene [inform] 1998 250

Marty S Australian national registration and accreditation scheme [editorial] 2010 10

Maslanka E Expanding the role of a pharmacy technician in a private hospital 2004 131

Masood N Pre-emptive discharge prescription processing system 2006 111

Matthews AJ Geranium leaves for cracked nipples 1995 538

Matthews H Pharmacy's role in the St Vincent's Hospital patient care model 1996 28

Matthews JJ Drug use evaluation of ipratropium at two tertiary referral hospitals 2001 279

Matthews ST See Mitchell SJ 2009 122

Matthews ST See Johnston CF 2011 275

Matthews Z Formulation of an oral vitamin K3 powder for prevention of haemorrhagic disease of the newborn 1994 406

Matthews Z See Wykes C 1995 489

Matthews Z Vancomycin continuous infusion: a cohort of 23 intensive care unit patients 2001 108

Maunsell TA See McFarlane AE 1996 635

Maunsell TA See McFarlane AE 1997 455

Maxwell D Improving and learning from practice 2007 38

Maxwell DJ See Boyle CM 1998 413

Maxwell DJ Infliximab in Behcet's disease 2002 209

Maxwell DJ Observations of pharmacy practice in HIV treatment centres in the United Kingdom 2003 282

Maxwell DJ See Sabet P 2004 36

Maxwell DJ International AIDS conference 2004 46

Maxwell DJ See Samios PA 2004 188

Maxwell DJ Community-acquired pneumonia 2004 212

Maxwell DJ Improving quality improvement models 2006 124

Maxwell P Synthetic cannabinomimetics and ‘legal highs’ [brief report] 2014 238

May F Whither 'rational' use of drugs? [editorial] 2008 89

May F W Pharmacy services to meet the needs of future health care 1999 31

May FW See Cosh DG 1996 673

May FW Pharmaceutical care: a bane or a benefit in defining hospital pharmacy practice? 1998 34

May FW See Nyfort-Hansen K 1998 343

May FW Pharmacoepidemiology - a discipline for hospital pharmacists? [editorial] 2010 256

Maycock B See Joyce AW 2007 42

Maylor Z See Choo CS 2006 246

McAllan Z See Gilbar P 1997 470

McAllister J See Costello N 2013 79

McArthur C Prophylaxis for Pneumocystis carinii pneumonia [Inform] 1995 46

McCauley L See Lie K 2011 278

McClure A See Cosh DG 1996 673

McClure AF The Board of Pharmaceutical Specialties Experience 2000 2001 223

McClure AF See Hebbard GS 2001 285

McColl GJ See Osborne RH 2002 276

McColl GJ Treatment of rheumatoid arthritis in the elderly 2005 151




McConachy KA Surgical antibiotic prophylaxis in a private hospital: compliance with guidelines 1999 5

McConachy KA Monitoring thyroxine dosage with serum concentrations of thyroid stimulating hormone 1999 142

McCormack C See Garrett T 2014 29

McCormick CP See Murnane JM 2013 109

McCrory PR Nutritional management in older people 1996 278

McCrudden E See Stewart P 2000 72

McCrudden EA Review of pharmacist-conducted medication histories at three teaching hospitals 1995 261

McCrudden EA Opportunities in coordinated care 1997 458

McD Taylor D Therapeutic errors reported to the Victorian Poisons Information Centre 2006 96

McD Taylor D See Leow FH 2006 194

McD Taylor D See Hassan FA 2006 266

McD Taylor D See Mann T 2007 281

McD Taylor D See Wong J 2008 92

McD Taylor D Effect of nebulised acetylcysteine on sputum quality and diagnostic yield 2009 24

McD Taylor D See Chan EW 2011 135

McD Taylor D See Chan EW 2012 11

McDonald A Pharmacological thromboprophylaxis 1994 285

McDonald C Liquid formulations [letter] 1995 174

McDonald C See Amadio M 1996 371

McDonald C See Smith BA 1996 560

McDonald C Black: James or Joseph? [letter] 1996 673

McDonald CF Management of chronic airflow obstruction in the elderly 1994 344

McDonald CF See Malipatil V 2009 302

McDonald MI See McConachy KA 1999

McDonald PK Evaluation of academic detailing within a coordinated care trial 2003 114

McDougall DAJ Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy 2014 26

McDowell J Formulation in pharmacy practice. 2nd edition. eMixt 2001 319

McEwen J See Boyd IW 2008 23

McFarlane AE Pharmacy technician training program — a review of the first 60 enrolments 1996 635

McFarlane AE Evaluation of a pharmacy technician training program - early trends 1997 455

McGain F See Tan ISP 2013 279

McGavock H The quality of drug use movement: a global perspective [conference presentation] 1998 24

McGovern TL See Behan KP 2010 222

McGovern TL See Walker MP 2012 291

McGrath A See Taylor SE 2007 214

McGrath A See To TP 2014 89

McGregor S Pfizer Pharmacy Grant 2013: American Society of Hematology Annual Meeting and the San Antonio

Breast Cancer Symposium [grant report]

2014 293

McGuiness JV See Dooley MJ 2011 208

McGuire TM Reproducing published practice research in your hospital — it's open wide! 1994 77

McGuire TM A hitchhiker's guide to establishing a drug utilisation evaluation program 1995 315

McGuire TM A pharmaceutical care liaison model 1996 36

McGuire TM See Sanburg AL 1996 351

McGuire TM Conjoint appointments - a Queensland perspective [editorial] 1997 7

McGuire TM See Stowasser DA 1997 362

McGuire TM Medication liaison: an emerging philosophy 1997 403

McGuire TM Highlights from the1998 National Medicines Week phone-in 1999 55

McGuire TM See Coombes JA 2003 194

McKauge L See Stupans I 2011 118

McKauge LM See Owen SM 2010 97

McKellar A See Couch G 2007 210

McKellar AC Does antibiotic choice affect length of stay for community-acquired pneumonia? 2005 25

McKinnon R See Chui SY 2007 124

McKinnon RA Cytochrome P450 1. Multiplicity and function 2000 54

McKinnon RA Cytochrome P450 2. Pharmacogenetics 2000 102

McKinnon RA Cytochrome P450 3. Clinically significant drug interactions 2000 146

McKinnon RA The emergence of pharmacogenomics 2003 133

McKinnon RA See Toy AC 2006 35

McKinnon RA Cytochrome P450 part 1: multiplicity and function 2008 55

McKinnon RA Cytochrome P450 part 2: genetics of inter-individual variability 2008 226

McKinnon RA See Ward MB 2009 55

McKinnon RA See Ibrahim R 2012 283




McKnight DL A multidisciplinary review of the prescription and administration of medications 1994 260

McKnight DL Topical agents used in the repair of minor dermal lacerations in a paediatric ED 1995 356

McKnight DL Preliminary formulation and stability of a spironolactone oral solution for paediatric use 1997 390

McLachlan A J Media and medical research miracles: sorting the spin [ed] 2013 258

McLachlan AJ See Pearce GA 2004 195

McLachlan AJ See Mukhtar S 2004 276

McLachlan AJ See Giam JA 2007 260

McLachlan AJ See Su EY 2008 292

McLachlan AJ See Le Couteur DG 2010 148

McLachlan AJ See Dolton MJ 2012 33

McLachlan G Medication safety is all fun and games [letter] 2008 81

McLachlan GB Experiencing pharmacy practice in rural Tanzania 2005 205

McLachlan GB Bedside medication lockers: help or hindrance? [letter] 2006 81

McLachlan GB Grow clinical pharmacists on supervised pre-registrant wards 2008 47

McLauchlan R See Gilbar P 2007 115

McLauchlan R American society of clinical oncology meeting 2007 134

McLauchlan R See Siderov J 2009 117

McLauchlan R See Siderov J 2011 181

McLennan DN ICD-10-AM activity codes: an opportunity for standardisation 1999 261

McLennan DN National survey of clinical activity documentation practices 2000 6

McLennan DN See Dooley MJ 2000 150

McLeod S See Lum E 2007 7

McLeod SE Value of medication reconciliation in reducing medication errors on admission to hospital 2008 196

McMahon K See Parshuram CM 1998 290

McManus A See Joyce AW 2007 42

McMullan B See Brett J 2013 97

McNally KM Ward stock and unit-supply drug distribution: influence on nursing time pharmacy time and

medication errors

1997 22

McNamara KP Acceptability of videoconference technology for the delivery of CE of rural pharmacists 2006 187

McNeece J The Drug and Therapeutics Information Service 1994 28

McNeece J Flucloxacillin and hepatic injury [inform] 1996 459

McQuillan A See Peng YG 2004 14

McRae A See Van de Vreede M 2008 263

McRobbie D See Coombes JA 2003 194

McWhinney BC See McDougall DAJ 2014 26

Meagher D See Jenney A 1999

Medos Z See Tucci J 2009 223

Mees A See Lie K 2011 278

Meguid SE See Boyle CM 1998 413

Mellor JD Drug interactions between antiepileptics and chemotherapeutic drugs: value of a pre-treatment

pharmaceutical review

2011 42

Mellor JD Complementary and alternative medicines use by cancer patients and the role of the drug information

pharmacist

2012 181

Melocco T See Brien JE 2003 158

Melocco T See Gallego G 2004 100

Melocco T See Gallego G 2005 18

Melocco T See Baysari MT 2012 246

Melocco T See Baysari MT 2013 288

Melvani S See Ho L 2007 190

Merridew CG See Targett PL 1997 207



Merry H See Tsui M 2008 40

Messini AJ See Baker SJ 1995 47

Mewes B Australian pharmacy law and practice [book review] 2010 82

Meyer E See McCrudden EA 1995 261

Meyer M See Rous J 2000 290

Meyer MP Recombinant erythropoietin for anaemia of prematurity-when should treatment start? 2007 217

Michael W See Radford JM 1998 400

Michels AM See Stott SA 1995 417

Mihaila B Chiral stability study of oral liquid clopidogrel formulations for infants 2012 103

Milder T See Brett J 2013 97




Milleer H See Stacey SR 2013 45

Miller J See Slater W 1999 216

Milne DJ Phenytoin infusion revisited: stability and administration 2004 272

Milne R See Mihaila B 2012 103

Milne RW See Milne DJ 2004 272

Milton AG See Ratnaike RN 2000 165



Ming LC See Manan MM 2014 83

Mirkov A Clinical pathway for monthly pulse intravenous cyclophosphamide therapy for lupus nephritis 2012 278

Mirkov SR Design and pilot of a medication review clinic in a dialysis centre 2003 199

Misaghian J See Gudka S 2013 15

Misan GM SHPA Public Hospital Drug Utilisation Data Collection Feasibility Study 1996 59

Misan GM Hospital pharmacy—an end in itself or just a beginning? 1999 342

Mishra P Vomiting due to inhaled ipratropium bromide [letter] 2005 165

Mishra P Drug and therapeutics committee in Nepal 2006 81

Mishra P See Paudel R 2006 218

Mishra P See Izham MI 2008 331

Mitchell B See Van C 2007 182

Mitchell C See McLeod SE 2008 196

Mitchell C See Rothwell M 2011 290

Mitchell CA See Coombes ID 2005 190

Mitchell E See Khan M 2011 265

Mitchell PL See Siderov J 1998 124

Mitchell PL See Siderov J 2000 229

Mitchell SJ Compliance with paracetamol prescribing policies at a Sydney hospital 2009 122

Mitchell SJ See Johnston CF 2011 275

Mitchinson GH Documentation methods for pharmaceutical care activities 1996 215

Mock P Contemporary therapies for depression in older people 2010 58

Mohite SS Outcome of parent education and counselling [letter] 2006 245

Moles R Learning from international pharmacy colleagues: report of two conferences in Lisbon [letter] 2010 331

Moles RJ New South Wales private hospitals and their pharmacy services 2007 119

Moles RJ Young pharmacists as mentors to pharmacy students: partnerships for the future of the profession 2007 265

Moloney M See Thakerar A 2014 231

Moloney MJ Cetuximab extravasation 2013 49

Molyneux M See van Beurden E 2003 51

Monheit B Drug use in Australia 2nd edition [book review] 2004 332

Monk D Response to 'Who can read consumer product information?' [letter] 1997 250

Monk PM The accuracy of a paediatric dosing device 1997 323

Monteiro VE See Roberts GW 2009 50

Moore AM See Pascuet E 2010 92

Moran JA Delirium in the hospitalised elderly 2001 35

Moran JA Pharmacological management of BPH and prostate cancer in older men 2001 115

Morgan SM See Bereznicki LR 2007 300

Morran JL See Borgstedt J 2009 186

Morris B Patient care in not a ‘tick-box’ exercise [ed] 2014 80

Morris C See Thawornchaisit P 2012 189

Morris PL See Hopwood MJ 1994 190

Morris S Clinical pharmacists in primary care - reform and opportunity? [editorial] 2010 261

Morrison JL See Grzeskowiak LE 2010 46

Morrison JL See Grzeskowiak LE 2010 265

Morrissey H See Flavel D 2012 121

Morrissey H See Ball PA 2013 202

Morrow MK Pharmacists in the ED: workforce survey update [letter] 2012 333

Moses G Complementary and alternative medicine use in the elderly 2005 63

Mottram MC Effect of therapeutic guidelines on surgical antibiotic prophylaxis 1997 290

Mouchaileh N See Elliott RA 2014 95

Moulds R Guidelines and essential drug lists: of horses and carts [editorial] 2010 172

Moulds RF See Dartnell JG 1994 333

Moulds RF See Dartnell JG 1994 392

Moulds RF See Brown GJ 1999

Mount P See To TP 2012 118




Moustakos DM See Katsogiannis W 1996 529

Muir PR Burnout among Australian hospital pharmacists 2007 187

Mukhtar S Dissolution of extemporaneous paracetamol capsules 2004 276

Mullan J See Nasser S 2012 129

Mullan J See El-mani SF 2014 113

Mullan JR Community liaison pharmacy: working with the Illawarra division of general practice and the Illawarra

area health service in 1998

1999 217

Mullan JR RAIN SMOG FOG and printed education material 2003 284

Munn CF See Joseph PD 2012 213

Munzner EE Measuring and describing dose omissions using an electronic medication management system 2012 264

Munzner EE See Welch SA 2013 162

Murdoch V See Nasser S 2012 129

Murnane JM Safe prescribing and preparation of continuous subcutaneous infusions in a regional palliative care unit 2013 109

Murnion BP See Mitchell SJ 2009 122

Murphy CE Probable case of ibuprofen-induced neutropenia 2013 135

Murphy CM See Adu A 1995 336

Muscillo N See Lum E 2007 7

Mutavdzic A Hospital pharmacists and behavioural change theory: who why and how? 2010 43

Mutiara R Handbook of pharmacy healthcare [book review] 2003 220

Mutiara R Vancomycin-digging bigger troughs? 2003 293

Myers SP See Drew A 2000 71

Myftiu J See Garg S 2008 28

Myhill KJ In their hour of need – addressing issues of psyche and soma at end of life [ed] 2014 75

Mylrea M Stability of dispersible aspirin tablets repacked into Dosette boxes 2012 204

Naganathan V See Su EY 2008 292

Nagavi BG Drug interactions in prescriptions from selected Indian community pharmacies [letter] 2005 332

Nahata M See Baker S 1998 348

Nair K See Nasser S 2012 129

Nair NM See Palaian S 2006 77

Nair NM See Ghosh S 2006 246

Nair NP A review of the clinical pharmacy services in Kasturba Hospital, India 2003 78

Nair NP See Palaian S 2006 77

Nair S See Thunga G 2013 163

Nashed R See Tucci J 2009 223

Nasser S Documentation of warfarin education provided to hospital patients: a clinical audit 2012 129

Nation R See Baker S 1998 348

Nation R How is the research score card for hospital pharmacy [editorial] 2006 89

Nation RL Pharmacy schools in Australia: when is enough enough? [editorial] 2009 174

Nation RL See Dunning TL 2010 203

Nation RL Accreditation standards for pharmacy courses in Australia: how do we stack up? [editorial] 2011 259

Natoli G See Robinson PJ 1998 160

Naunton M Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital 2003 176

Naunton M See Al Hadithy AF 2005 213

Naunton M See Luinstra MM 2009 265

Naunton M See De Zylva JB 2012 37

NCCTG Standard for the preparation of pharmaceuticals in hospital pharmacy departments 1994 182

Neave G Midazolam for acute agitation in the psychiatric patient [letter] 1994 356

Neave K See Dooley MJ 2011 208

Newby D Australian pharmacoepidemiology course [letter] 1995 52

Newby D Midazolam by mouth [Inform] 1995 192

Newgham C See Adu A 1994 318

Newgreen DB Winning of Australian pharmacy degrees – a retrospect 2009 211

Newman S See O'Leary K 2009 293

Newton JR Presentations of eating disorders later in life 2013 231

Ng C Medication reconciliation challenges at discharge from hospital using an eMMS and electronic

discharge summaries

2013 25

Ng CS Acute renal failure in patients on diuretics and/or NSAID COX-2 inhibitors ACEI ARA 2008 280

Ng D Syndrome of inappropriate antidiuretic hormone secretion associated with SSRIs 1996 358

Ng D Unplanned medication-related admissions to an acute care general teaching hospital 1999 84

Ng K See Lauchlan R 1995 342

Ng K See Abdelmessiah D 1997 250

Ng K Workload measurement practice in Australian hospital pharmacy departments 1997 307




Ng K See Cheong EA 2003 212

Ng K See D'Souza DC 2004 190

Ng KH Australian Medicines Handbook Drug Choice Companion: Aged Care [book review] 2003 332

Ng KH Board of pharmaceutical specialities examination in oncology: do it all alone [letter] 2004 158

Ng KH Tranquilliser use in elderly psychiatric patients 2004 183

Ng SPL New system to administer drugs via the central venous catheter in newborn infants 1998 177

Ng YC See Couch G 2007 210

Ngieng MLL See Zolezzi M 2007 225

Ngo SNT See Ibrahim R 2012 283

Ngo-Thai LL See Dooley MJ 2011 208

Nguyen A See Yu K 2007 22

Nguyen A Classification of findings in the home medicines reviews of post-discharge patients at risk of

medication misadventure

2007 111

Nguyen N-A Pharmacist prescribing in warfarin therapy: exploring clinical utility in the hospital setting 2008 35

Nguyen VT Bisphosphonate-associated atypical femur fracture 2014 35

Nguyen YBN Do health professionals on respiratory wards know how to use inhalers? 2010 211

Nibu P Review of a drug information service in an Indian teaching hospital 2001 144

Nicholls KM See Reginato V 2002 94

Nichols C See Moles RJ 2007 265

Nicklason F Post-stroke emotionalism [letter] 2000 175

Nicolas CM See Marmor GO 2011 113

Nielsen F See To T-P 2013 177

Nieman PE Fred J Boyd Award 1999 1996 148

Nigro O See Ratnaike RN 2000 165



Nigro O See Poh EW 2009 176

Nissen L American Society of Consultant Pharmacists Conference-Geriatrics 06 [letter] 2006 244

Nissen L See Hale A 2009 163

Nissen L See Freeman C 2012 184

Nissen L See Hale A 2013 256

Nissen L See Freeman C 2014 240

Nissen LM Solid medication dosage form modification at the bedside and in the pharmacy of Queensland

hospitals

2009 129

Nissen LM See Lau ET 2013 19

Nissen LM See Thompson W 2013 213

Nita Y Adverse drug reaction reporting: attitudes of Australian hospital pharmacists and doctors 2005 9

Nooney VB See Angley M 2011 27

Norman L Donations to a developing country [letter] 2007 79

Norman TR See Mock P 2010 58

Noroozian M See Ahmadi-Abhari SA 2005 103

Norris DE See Camac KJ 1996 234

Norris PT See Tordoff JM 2004 267

Norris PT New Zealand pharmacists and pharmacist-only medicines 2004 282

Norris PT See Tordoff JM 2005 271

Norris PT See Plant EA 2006 271

Norris RL See Barras M 2011 183

Norris RLG See Anh AV 2006 262

Northfield SE Lipophilicity of beta-adrenoceptor antagonists: a new classification scheme for clinical use 2007 98

Novy M See Welch SA 2000 262

Nutting J Health economics is sexier and management more rewarding [career opportunities] 1998 370

Nyfort-Hansen K Plan or perish 1994 339

Nyfort-Hansen K Clinical Pharmacy a new beginning in India 1998 343

Nyfort-Hansen K See Alderman CP 2000 109

Nyfort-Hansen K Geriatric pharmacy specialisation: the CCGP pathway to Australian accreditation 2001 41

Nyfort-Hansen K See Chu KP 2005 216

Nyfort-Hansen K See Campbell DG 2008 140

Nyfort-Hansen K See Widagdo IS 2011 122

O’Reilly B See Baysari MT 2013 288

O’Reilly BA See Welch SA 2014 161

O’Reilly M See Dunning TL 2010 203

O’Reilly M See Koning SI 2013 261




Oberklaid F In reply: Harle's Herbal Baby's Friend [letter] 1995 353

Oborne C A See Elliott RA 2001 19

Oborne CA See Elliott RA 2003 101

O'Callaghan CJ See Pellizzer AM 1998 432

O'Callaghan CJ See Elliott RA 2011 21

O'Connor K Hospital supply of off-label immunomodulatory drugs 2009 135

Odette S See Wein S 2002 212

Odgers CL Drug budget devolution and internal markets - the future for pharmacy [editorial] 1997 105

Odgers CL The Pharmaceutical Benefits Scheme and public hospitals [editorial snapshot] 2000 45

O'Doherty R See Duguid M 2002 94

O'Donnell D See Chase D 2008 312

Ogle SJ See Bajorek BV 2001 93

Olagundoye A See Daftary MN 2003 265

Oldfield B See Zolezzi M 2007 225

Oldman R A guide to pharmacy technicians on safe handling of cytotoxics [practice report] 1998 356

O'Leary K Evidence-based core clinical pharmacy services [editorial] 2004 173

O'Leary K See Duguid MJ 2005 201

O'Leary K Hospital pharmacy technician qualifications [editorial] 2005 259

O'Leary K Link between clinical pharmacy services pharmacy staffing and hospital mortality rates [editorial] 2007 256

O'Leary K Coordinated strategies to attract pharmacists to the public hospital sector in Victoria 2009 293

O'Leary K SHPA continuing professional development program [letter] 2009 327

O'Leary K See Elliott RA 2012 125

O'Leary KM Snapshot of hospital pharmacy workforce in Australia 2002 72

O'Leary KM Survey of implementation levels and pharmacy requirements for the continuum of quality use of

medicines between hospital and community

2003 93

O'Leary KM Snapshot of the Australian public hospital pharmacy workforce in 2003 2004 104

O'Leary KM Pharmacy clinical and distribution service delivery models in Australian public hospitals 2004 114

O'Leary KM See Stowasser DA 2004 293

O'Leary KM Victorian hospital pharmacy technician workforce survey 2006 32

O'Leary KM Snapshot of the Australian public hospital pharmacy workforce in 2005 2006 103

O'Leary KM Pharmaceutical review: resource implications for the pharmacy component in Australian public

hospitals

2006 291

O'Leary KM See Gilbar P 2007 115

O'Leary KM Snapshot of the Australian Public Hospital Pharmacy Workforce in 2007 2009 28

O'Leary KM Clinical pharmacist staffing levels needed to deliver clinical services in Australian hospitals 2010 217

O'Leary KM Two national surveys of hospital pharmacy technician activities to support the review of national

qualifications

2012 43

O'Leary KM A professional development framework for pharmacists [editorial] 2012 259

O'Leary KM Access to pharmacist medication review services [editorial] 2013 88

Olsen WA See Mukhtar S 2004 276

Olver JS See Mock P 2010 58

Omar SH See Jindal D 2005 331

O'Neill MS See Jepsen DM 2013 29

Onishko C See Chui SY 2007 124

Onishko CR Childhood pain - in sickness and in health 2007 45

Ooi S-C See Tong EY 2012 140

O'Reilly B Causes of warfarin resistance [inform] 1995 488

O'Reilly BA See Drew AK 1995 433

O'Reilly M See Jenney A 1999

Osborne GA See Sorich MJ 2004 22

Osborne RH Management of osteoarthritis in older people 2002 276

O'Shea TJ Outcome of restricting antibiotic prescribing 1995 139

O'Shea TJ Accuracy of aseptic dilutions 1996 254

O'Shea TJ Checking prescriptions before dispensing 1997 321

O'Shea TJ Impact of nurse education on the incidence of omitted medication doses in hospital inpatients 2009 114

Osti B See Shankar PR 2009 162

O'Sullivan C Herbal products for babies [inform] 1995 191

O'Sullivan C In reply: Harle's Herbal Baby's Friend [letter] 1995 353

O'Sullivan G See Welch S 2010 333

Ouaida D See Boyle CM 1998 413

Overland V The use of ACE-inhibitors after myocardial infarction 2002 232

Owen S See Stupans I 2011 118




Owen SM Experiential placements: nurturing interactive pharmacists by planning and scaffolding for improved

communication

2008 121

Owen SM Support needed by pharmacy students in experiential placements: stakeholders' expectations 2010 97

Padhye V See Angley M 2011 27

Padhye V Alternatives to post-discharge home medication reviews for high-risk patients: doctors' and

pharmacists' views

2012 273

Padma GR See Palaian S 2006 77

Paech MJ See Lim CB 2003 59

Paech MJ See Lim CM 2004 11

Paech MJ See Lim SCB 2008 191

Page MA See McNally KM 1997 22

Page MA Prescribing in teaching hospitals: a qualitative study of social and cultural dynamics 2008 286

Pajkos A See Whiteley RK 2002 153

Palaian S See Mishra P 2005 165

Palaian S Impact of counselling hospitalised diabetic patients [letter] 2006 77

Palaian S See Bedi TRS 2006 164

Palaian S See Paudel R 2006 218

Palaian S See Ghosh S 2006 246

Palaian S See Maarup N 2011 49

Palaian S See Hassali MA 2011 80

Palaian S See Sanburg A 2011 165

Palain S See Hassali MA 2009 245

Palian S Pharmacovigilance sessions for undergraduate pharmacy students in Malaysia [letter] 2009 329

Paloumis S See McCrudden EA 1995 261

Pan M See To TP 2012 118

Pandii W See Thawornchaisit P 2012 189

Pang RK Smart infusion pumps reduce intravenous medication administration errors at an Australian teaching

hospital

2011 192

Pappas A Pharmaceutical calculations student evaluation of computer-assisted learning 1998 312

Pappas A Computer-assisted exam revision by pharmacy students 1999 10

Pappas A Extemporaneous dispensing: opinions of Victorian community pharmacists 1999 196

Pappas A Extemporaneous prescribing: whatever happened to it? A survey of Australian GPs 2002 310

Pappas A The art, science, and technology of pharmaceutical compounding [book review] 2003 42

Pappas A Allen's compounded formulations-the complete U. S. pharmacist collection [book review] 2003 245

Parikh S Cardiovascular risk reduction in the extreme elderly 2013 62

Pariti B See Priyadarshini M 2014 61

Parke J Influencing psychotropic prescribing and auditing the results 1998 13

Parke J Olanzapine for treatment-resistant schizophrenia 1999 54

Parke J Developing a form to enhance the continuum of medication care following hospital discharge 2003 268

Parke J Risk analysis of errors in prescribing dispensing and administering medications within a district

hospital

2006 21

Parker D See Maddocks I 1994 400

Parker D See Huppatz C 1998 241

Parker FC See Pescod DC 1995 280

Parker JM Leading the way in renal medicine [letter] 2004 158

Parker S See Tasker J 1997 251

Parker SM See Bolton PG 2004 8

Parkes SC See Dartnell JG 1994 392

Parkins P See Bogovic A 2000 222

Parkins P A study tour of paediatric total parenteral nutrition services in North American hospitals 2001 307

Parkinson AM Time utilisation study of pharmacy support staff [short communication] 1998 436

Parks TE See Peterson GM 1996 545

Parshuram CM Acceptability of flavoured and unflavoured oral prednisolone solution in children with acute asthma

[letter]

1998 290

Parsons B Tightropes clowns trapeze and performance — casemix in Victoria 1995 1996 128

Parsons B See Magarey J 1996 454

Parsons B AuSPEN conference [letter] 2000 176

Parsotam N See Zolezzi M 2007 225

Parsotam N See Loe EA 2008 209

Parthasarathi G See Nibu P 2001 144

Parthasarathi G Assessment of drug-related problems and clinical pharmacists' interventions in an Indian teaching

hospital

2003 272




Parthasarathi G See Ramesh M 2004 218

Parthasarathi G Choosing an inhaled corticosteroid for asthma: making an informed decision [letter] 2004 245

Parthasarathi G See Joseph J 2010 279

Pascuet E Visual thematic analysis of children's illustrations to improve receptiveness to pictorial asthma action

plans

2010 92

Passlow CA See Murnane JM 2013 109

Patel B Pharmaceutical review-a lost opportunity? [editorial] 2006 259

Patel B GlaxoSmithKline Medal of Merit 2011 2011 304

Patel B Providing culturally appropriate palliative care [ed] 2014 78

Patel H See Thunga G 2013 163

Patel RP Stability of diluted iron polymaltose in PVC infusion bags 2013 112

Patterson TH Revisiting guidelines and inappropriate use of ticarcillin/clavulanate at an Australian teaching hospital 2011 221

Patullo C See Avent ML 2010 15

Paudel R Urticarial skin reaction induced by oral clonidine 2006 218

Pearce B British oncology pharmacy association symposium [letter] 2008 78

Pearce G See Day R 2007 4

Pearce GA Bioequivalence: How why and what does it really mean? 2004 195

Pearce MJ Regular paracetamol dosing reduces narcotic requirements in treating post-operative orthopaedic pain 1995 13

Pearson GJ See Barry AR 2009 256

Peck R See Sorensen L 2004 122

Peisah C Pharmacological management of challenging behaviours in people with dementia 1997 49

Peisah C Correction 2 [letter] 1997 159

Pellizzer AM Clinical utility of digoxin in elderly patients in sinus rhythm with chronic heart failure 1997 406

Pellizzer AM Polypharmacy in a major Australian teaching hospital [short communication] 1998 432

Peng L See Lim CM 2004 11

Peng YG Renal function peak anti-Xa levels and enoxaparin dosing 2004 14

Penm J Professional transgressions by Australian pharmacists 2009 192

Perera D See Elliott RA 2012 125

Perera D See Elliott RA 2014 95

Perez AG See Aldama PC 2003 330

Perlman M See Blackah J 1994 281

Pescod DC Postoperative pain management in older people 1995 280

Peterson G See Bereznicki L 2005 173

Peterson GM See Drummond SH 1994 231

Peterson GM See Leow CC 1994 250

Peterson GM TDM: Clinical pharmacy activity with a shortening half-life? [editorial] 1996 305

Peterson GM Pilot study of nebulised morphine for dyspnoea in palliative care patients 1996 545

Peterson GM Pharmaceutical care specialisation and certification [letter] 1997 336

Peterson GM Bring on the all-rounders 1999 48

Peterson GM See Naunton M 2003 176

Peterson GM See Bereznicki LR 2006 162

Peterson GM Bring clinical pharmacy to the community-expand hospital outpatient clinics! [editorial] 2009 88

Peterson GM See Luinstra MM 2009 265

Peterson GM Drug interaction dilemmas [editorial] 2011 7

Petrie AF See Low J 1998 405

Petrie G A quality opportunity 2004 297

Petrie GM See McGuire TM 1995 315

Petrie GM Casemix in Queensland — doing it differently 1996 131

Petrie GM See Stowasser DA 1997 362

Pham L 5-HT3 antagonists in the treatment of postoperative nausea and vomiting 2003 275

Phillips AJ See Grzeskowiak LE 2008 9

Phillips CJ See Dionysopoulos D 2011 75

Phillips CJ Research translation and clinical pharmacy [letter] 2014 63

Phillips PA Pharmacological aspects of electrolyte disturbances in older people 1996 363

Phillips S The importance of independent guidelines [ed] 2013 172

Phosri J Impact of COX-2 inhibitors in Thai orthopaedic outpatients 2005 115

Phulwani K See Tsui M 2008 40

Pilbeam M See Barras M 2011 183

Pillai KK See Jindal D 2005 331

Pillans p See Ghiculescu RA 2008 32

Pillans PI See Radford JM 1999

Pillans PI See Coombes ID 2001 102




Pillans PI See Mackenzie FD 2002 31



Pillans PI See Ng CS 2008 280

Pillans PI See Patterson TH 2011 221

Pilotto LSJ See Ball PA 2013 202

Pink JA See Bollella G 2008 107

Piryani R See Shankar PR 2009 245

Piryani RM See Shankar PR 2009 162

Plant EA Workforce and service delivery analysis across NZ hospital pharmacy departments 2006 271

Plianbangchang P Survey of job satisfaction among pharmacists in Thailand 2003 117

Plummer D See Robertson K 2012 193

Plumridge RJ Contracting pharmacy services [editorial] 1996 523

Plumridge RJ Will fallacies in pharmacy determine our future? 1999 193

Plumridge RJ International networking: what is in it for you? [editorial] 2000 4

Plumridge RJ See Clifford RM 2003 208

Plumridge RJ Pharmacoeconomics: challenges in developing the fourth dimension of drug evaluation 2003 287

Plumridge RJ International pharmacy: what role does it play in promoting professional practice? 2004 43

Plumridge RJ See Nita Y 2005 9

Plumridge RJ See James CR 2008 44

Poh EW Pharmaceutical reforms: clinical pharmacy ward service versus a medical team model 2009 176

Poland KE See Inderjeeth CA 2010 229

Polasek TM Beyond CYP2C19 - a new chapter in clopidogrel pharmacogenics [editorial] 2011 14

Polasek TM Clinically relevant information on pharmacokinetic drug-drug interactions [letter] 2011 77

Polasek TM Rapid progress on the clopidogrel PON1 story [editorial] 2011 258

Ponniah AP See Lovgren S 2009 269

Ponniah AP See Angley M 2011 27

Ponniah AP See Padhye V 2012 273

Pont L See Dolton MJ 2012 33

Poole S See Dooley MJ 2011 208

Poole S See Chieng R 2014 105

Poole SG Bleomycin sulphate dosing nomenclature [letter] 1998 211

Poole SG Drugs in ambulatory infusion devices: the appropriate temperature for stability testing 1999 328

Poole SG See Dooley MJ 2008 188

Poole SG See Korajkic A 2011 126

Poudel A See Izham MI 2008 331

Poudel A See Palian S 2009 329

Poulier MV See Rofail S 1999

Poulier MV See Matthews JJ 2001 279

Poulson LK Acute adrenal insufficiency-withholding of medicines in the peri-operative period 2005 311

Power DA Biological drugs and the coming of biosimilars 2008 137

Power DA See Hsieh M 2009 230

Prabhu M See Mishra P 2005 165

Prabhu V See Awasthi S 2013 248

Prabhu V See Singh A 2014 60

Pragnell M Administration support 1996 70

Prankerd RJ Practical aspects of the stability testing of formulated drug products 1995 405

Prankerd RJ In reply: Stability trials — how much degradation is enough? [letter] 1996 291

Prankerd RJ Extemporaneous compounding [editorial] 1997 201

Prankerd RJ See Benson HA 1997 222




Prankerd RJ Optimisation of drug delivery - 7. Bioreversible chemical modifications of drugs 1998 165

Prankerd RJ See Benson HA 1998 13,17,

36,84,

182

Prankerd RJ Optimisation of Drug Delivery: 11. Delivery of therapeutic peptides and proteins 1999 20

Prankerd RJ Optimisation of Drug Delivery: 12. Delivery of gene therapy 1999 149

Prankerd RJ Pharmaceutical preformulation 1999 180

Prankerd RJ Complementary medicines [editorial snapshot] 2000 93

Prankerd RJ Extemporaneous compounding [editorial] 2005 173




Prankerd RJ Compounded products - stability studies in hospital pharmacy departments [editorial] 2009 5

Prankerd RJ A new ultimate standard of mass [editorial] 2011 256

Pratt NL See Bell JS 2011 316

Pratt NL See Leach MJ 2013 265

Preisz P See Welch SA 2000 262

Primrose JG See Roughead EE 1998 7

Print SA See Shaw JP 2013 122

Priyadarshini M See Bhagvandas NS 2013 247

Priyadarshini M Occupational hazards of pesticides: plight of farmers [letter] 2014 61

Proietto J See Haywood CC 2013 145

Pson G A new millennium and clinical pharmacy: reasons for optimism [editorial] 2000 2

Pson G Challenges facing academic pharmacy: the provision of quality practical teaching 2000 45

Pson G COX-2 specific inhibitors in cancer [letter] 2000 120

Pson G Assuring quality in pharmacy practice: high time for action 2001 87

Pulver L See McCrudden EA 1995 261

Pulver LK See Matthews Z 1994 406

Pulver LK An Australian PharmD: Doctor of clinical pharmacy The University of Queensland 1999 284

Pym HC National Prescribing Service and educational visits 1999 290

Quah SM See Couch G 2007 210

Quek B See Ng SPL 1998 177

Quinn DI See Welch SA 2000 262

Quinn S See Roberts GW 2013 276

Qumari S See Crosara SLR 2013 221

Rabih N See Tordoff JM 2006 12

Radford JM Vancomycin usage review in the era of vancomycin-resistant enterococci (VRE) 1997 140

Radford JM Reducing inappropriate prescribing of vancomycin 1998 400

Radford JM Drug usage evaluation of antimicrobial therapy for community-acquired pneumonia 1999 317

Radford JM Siestas sangria and selection pressure: antimicrobial resistance and the implications for hospital

practice

2001 60

Radford JM See Coombes ID 2001 102

Radford JM See Mackenzie FD 2002 31

Radoui A See Ibrahim MIM 2014 62

Raehl CL Game changer for US hospitals: medical staff membership for pharmacists [editorial] 2012 89

Raines M Treatment of Fasciola hepatica infection [inform] 1996 273

Ram PL See Clifford RM 2011 203

Ramadaniati HU Snapshot versus continuous documentation of pharmacists’ interventions: are snapshots worthwhile? 2014 205

Ramesh M See Nibu P 2001 144

Ramesh M See Parthasarathi G 2003 272

Ramesh M Aspirin-induced sneezing 2004 218

Ramesh M See Joseph J 2010 279

Ramrattan MA See Boeker EB 2013 41

Ramsay EN See Bell JS 2011 316

Ramsay EN See Kalisch LM 2013 182

Ramzan I See Pearce GA 2004 195

Rando L Diabetes ward management-room for improvement 2004 95

Rao BH See Khan SA 2006 163

Rao DA See Lakshmi PK 2002 240

Rao PG Evaluation of a drug information service in a South Indian teaching hospital 2005 40

Rao PG Prescribing pattern of fluoroquinolones in India [letter] 2005 166

Rao PG See Jose J 2005 333

Rao PG See Khan SA 2006 163

Rao PG See Ghosh S 2006 246

Rashford M Protecting the unborn child from isotretinoin [letter] 1995 539

Ratnaike RN Drug-associated diarrhoea and constipation in older people. Diarrhoea 2000 165

Ratnaike RN Drug-associated diarrhoea and constipation in older people. Constipation 2000 210

Ratnaike RN Chemotherapy-induced diarrhoea. In reply [letter] 2000 230

Ratnapala DN See Seleem M 2011 132

Ravenscroft PJ See Schneider JJ 1997 29

Raymond K See Hung CW 1997 235

Raymond PM Adverse drug reaction reporting in Melbourne teaching hospitals 1994 237

Rayner CR Drug use evaluation of vancomycin 1998 394

Rayner CR PharmD or not PharmD that is the question! 1999 121




Rayner CR See Yin C 2002 320

Rayner CR See Taylor MJ 2003 18

Razman I Bioavailability, bioequivalence, generics and switching or substitution: science, emotion and vested

interests [editorial]

2010 90

Read T See Yin C 2002 320

Reed BL See Roller L 2008 79

Reeve J See Brien JE 2009 81

Reeves D See Garrett T 2009 99

Reeves D See Garrett T 2010 269

Reeves M See Seaton SM 2009 104

Reginato V Alteplase: a safe and cost-effective alternative to urokinase 2002 94

Reid CM See Coombes ID 2005 190

Reinhold J See Mackenzie FD 2006 210

Reith DM See Tordoff JM 2004 267

Reith DM See Tordoff JM 2005 271

Reith DM See Kunac DL 2010 290

Renwick J Clinical pharmacists: from bedside to clinical research [career opportunities] 1998 439

Rhodes J See Koning SI 2013 261

Rice CA American Society of Clinical Oncology Conference 2004 207

Rice CA Measuring pharmacy workload associated with clinical trials 2007 303

Rice CA See Hynes KI 2010 300

Richards CV A quality assurance audit for an aseptic dispensing facility [short communication] 1998 329

Richardson K See Baysari MT 2012 246

Richardson K See Baysari MT 2013 288

Richardson KL See Munzner EE 2012 264

Richardson KL See Ng C 2013 25

Richardson KL See Welch SA 2013 162

Richardson KL See Welch SA 2014 161

Richardson V Adapting to change 1994 48

Rigby D See Gilbert A 2013 4

Rigby D See Angley M 2014 6

Rigby D See Freeman C 2014 240

Riley RH See Stott SA 1995 417

Riley RH Premedication for surgery: a survey of Australian practice 1999 206

Riley RH Herbal medicines 1999 346

Riminton S See O'Connor K 2009 135

Robert N See Thunga G 2013 163

Roberts AS See Moles RJ 2007 265

Roberts G See Cosh D 1996 673

Roberts G Australian Clinical Pharmacy Award 2011 2011 307

Roberts G See Grzeskowiak LE 2012 5

Roberts G Personalised e-warfarin initiation charts to improve patient outcomes [letter] 2013 161

Roberts GW BPS-time for an Australian equivalent? 2001 226

Roberts GW Dosing of key renally cleared drugs in the elderly-time to be wary of the eGFR 2006 204

Roberts GW Pattern of high-dose prednisolone-induced hyperglycaemia in COPD exacerbations 2009 50

Roberts GW Immediate post-administration safety of bolus gentamicin 2012 200

Roberts GW Post-operative warfarin re-initiation – modelling a loading dose strategy 2013 276

Roberts J Australian Clinical Pharmacy Award 2012 2012 308

Roberts JA Pharmacists investigating adverse penicillin responses-pilot study 2007 200

Roberts JA Expanding horizons - needs you to travel over them [letter] 2007 333

Roberts JA Midazolam metabolism: implications for individualised dosing? 2009 198

Roberts JA Tissue distribution of beta-lactam antibiotics: continuous versus bolus dosing 2009 219

Roberts L See Robertson K 2012 193

Roberts M The SHPA grants and awards program 1997 351

Roberts M See Lilley B 1998 289

Roberts M Effective pharmacist involvement in the healthcare team improves patient outcomes 2002 171

Roberts M See Kiani M 2011 217

Roberts M See Lie K 2011 278

Roberts M See Blogg LC 2012 287

Roberts MJ See Lim CB 2003 59

Roberts MJ Managing pharmacy beyond the hospital walls: present and future services for home health care 2003 128

Roberts MJ See Lim CM 2004 11




Roberts MJ See Angalakuditi M 2005 21

Roberts MS See Sorensen L 2004 122

Roberts MS Home medicines review [letter] 2004 159

Roberts MS See Ientile CS 2005 110

Robertson A See Schwantzer M 1994 439

Robertson JM See McKnight DL 1994 260

Robertson K Complexity and workload of cytotoxic manufacturing at a regional hospital: a comparative study 2012 193

Robertson MB See Raymond PM 1994 237

Robertson MB See Rando L 2004 95

Robertson S See Mylrea M 2012 204

Robertson S See Kockler J 2013 218

Robins M See Lumby J 2010 259

Robinson G See Wheeler AJ 2007 33

Robinson J See McD Taylor D 2006 96

Robinson M See Clark LM 2001 134

Robinson MK Erythropoietin: use in a critically ill patient refusing a blood transfusion 1997 38

Robinson MK Communicating the message - Pharmacists as educators [practice report] 1998 121

Robinson MK Inpatients' satisfaction with clinical pharmacists' counselling 1999 162

Robinson PJ Comparison of high-dose and standard-dose pancreatic enzyme capsules in children with cystic

fibrosis

1998 160

Rocca A See O'Leary KM 2006 32

Rodrigues GS Clinical pharmacy: an Indian surgeon's perspective [letter] 2007 78

Rofail S The quality use of nimodipine: assessing the impact of consensus guidelines 1999 137

Rofail S Are patients on long-term corticosteroids receiving bone loss therapy? 2006 29

Rofe OC See Koning SI 2013 261

Rogerson JW See Moran JA 2001 115

Rokahr C See Dunning TL 2010 203

Roller L See Pappas A 1998 312

Roller L Pre-registrant pharmacists' views on the length of post-Bpharm training in Victoria [letter] 2008 79

Rollins BM Insulin dosage preparation and administration: prefilled pens versus syringes 2013 198

Roman C Acute trauma and resuscitation preceptorship [grant report] 2014 165

Rose ML See Bogovic A 2000 222

Rossi S See Westaway K 2014 138

Rothwell M Retrospective analysis of emergency readmissions to rural and regional hospitals 2011 290

Roufogalis BD See Brown JA 2009 281

Roughead E Building a safer system for Australian health care: essential role of clinical pharmacy services

[editorial]

2004 88

Roughead EE Coding drug-related admissions in medical records: is it adequate for monitoring the quality of

medication use?

1998 7

Roughead EE See Tett S 2000 191

Roughead EE See Kalisch LM 2007 292

Roughead EE Medication use by Australian war veterans in residential aged-care facilities 2008 14

Roughead EE See Bell JS 2011 316

Roughead EE See Kalisch LM 2013 182

Roughead EE See Leach MJ 2013 265

Rous JR Comparison of gentamicin and netilmicin dosing schedules in newborn infants [letter] 2000 290

Rowe L Development of a manual of indicators for drug use in Australian hospitals 1998 38

Rowett D See Westaway KP 2014 44

Rowett D See Westaway K 2014 138

Rowett D Tomorrow’s Pharmacist. Registration Exam Questions III. [book review] 2014 304

Rowett DS See Alderman CP 1995 511

Rowett DS See Cosh D 1996 673

Rowett DS Formation of an SHPA academic detailing/educational outreach COSP 2002 87

Rowett DS Clinical pharmacy: Influencing healthcare decision-making 2002 269

Rozek T See Mihaila B 2012 103

Rucklidge MW See Lim CB 2003 59

Ruff TA See Giles ML 1999

Ruffin RE See Vial RJ 2002 57

Rumsey S Ciprofloxacin-induced seizures — the need for increased vigilance 1995 145

Rusli RA See Manan MM 2014 83

Russell LM See Lehnbom EC 2009 207

Ryan AN See Kunst AM 2009 246




Ryan DM Introducing a daily patient report for clinical pharmacists 2005 37

Ryan G See Owen SM 2010 97

Ryan M Hospitals and pharmacy-the next five years [editorial] 2005 6

Ryan M Time for a single system for funding medicines [editorial] 2011 12

Ryan MJ Organisational restructuring in Australian hospitals — implications for pharmacy services 1996 22

Ryan MJ Restructuring healthcare systems — considerations for pharmacists [editorial] 1996 522

Ryan MJ A two-day national consumer medicines information phone-in 1998 304

Ryan MJ Realising the potential [editorial snapshot] 2000 46

Ryan MJ See Jackson JK 2001 262

Ryan MJ Many have a part to play [editorial] 2003 4

Ryan MJ Australian electronic management policy and systems 2007 49

Ryan MJ Don't think don't hope do! [editorial] 2009 91

Ryan RE Evidence on optimal prescribing and medicines use for decision makers: scope and application of the

Rx for Change database

2011 295

Saab YB Attitudes of physicians to professional roles of community pharmacists in Lebanon 2004 18

Sabet P Evaluation of mycophenolate for unregistered indications 2004 36

Sadeghi M See Ahmadi-Abhari SA 2005 103

Saleem F Education and health-related quality of life: are interventions always beneficial? [letter] 2011 333

Samios PA Role of therapeutic drug monitoring in HIV therapy 2004 188

Samios PA Capturing pharmacy activities using barcode technology 2013 207

Sampanthar R Technician's perspective of casemix 1996 68

Sanbrook A See Katsogiannis W 1996 529

Sanburg A Just another boring seminar? [letter] 2008 163

Sanburg A Where there are no pharmacists: a guide to managing medicines for all health workers [book review] 2011 165

Sanburg A Chronic Diseases Workshop, Vanuatu 2011 2012 82

Sanburg AL Stepping out of constipation — an educational campaign 1996 351

Sanburg AL Pharmacy training in the Solomon Islands - a personal account 1997 473

Sanburg AL An opportunity to compare our services 1999 281

Sanburg AL Taking pharmacy on tour in Vanuatu 2006 212

Sanders DC See Coombes ID 2002 17

Sanders DJ See Stott SA 1995 417

Sanders J See Mellor JD 2012 181

Sanders J See Thakerar A 2014 231

Sandhu G Czech-ing out ISOPP [letter] 2011 73

Sankham RD See Kaleemuddin M 2001 26

Sansgiry SS Consumer perceptions of generic drug substitution practices in the USA 2004 262

Sansom L The PBS-its future 2001 257

Sansom L Future healthcare delivery-where is pharmacy? [editorial] 2007 6

Sansom L Pharmacists, pharmacovigilance, unapproved indications and the TGA [editorial] 2010 88

Sansom LN See Roughead EE 1998 7

Sansom LN Hospital pharmacy practice: its place in the future 1998 426

Sansom LN Fred J Boyd Award 2014 2014 297

Santamaria NM See George J 2006 107

Santamaria NM See George J 2006 278

Santoro VA Management of controlled drug (schedule 8) liquid discrepancies to achieve best practice 2013 194

Sardjono DA See Rando L 2004 95

Sattar DA See Sonallah H 2014 159

Saulnier JL See Schlatter J 1997 395

Saunders A Drugs in breast milk — timing of mother's dose and baby's feed [inform] 1995 295

Saunders A In reply: Drugs in breast milk — timing of mother's dose and baby's feed [letter] 1995 486

Saunders A In reply: Dosage of drugs in breast milk [letter] 1996 289

Saunders A Drug information services in Victoria [editorial] 1998 391

Saunders A It is time to abandon 'alternative medicines' and 'complementary medicines' [editorial] 2005 263

Scahill S Applying organisation theory to hospital pharmacy research: the case of 'culture' Down Under

[editorial]

2012 175

Schapel GJ See Dollman WB 1996 229

Schelleman A See To TP 2005 33

Schlatter J Stability of enalapril solutions prepared from tablets in sterile water 1997 395

Schneemann K The Free Trade Agreement is a win-win opportunity [letter] 2004 69

Schneider CR See Clifford RM 2011 203

Schneider H See Dooley MJ 2008 188

Schneider J Report on the Congress of the European Association of Palliative Care 2001 232




Schneider JJ A study of the osmolality and pH of subcutaneous drug infusion solution 1997 29

Scholes S Conference on supportive care in cancer [letter] 2005 79

Schubert AL See Dartnell JGA 1994 333

Schwantzer M Folic acid supplementation in the peri-conceptional period [letter] 1994 439

Scollay DA Psoriasis 1994 350

Scott DA Post-operative pain relief 1996 121

Scott IA See Coombes ID 2002 17

Scott S Quality of clinical pharmacy services [editorial] 2004 258

Scott SD Central and peripheral neurotoxicity from metronidazole [case report] 1994 325

Scott SD See Rumsey S 1995 145

Scott SD Pharmaceutical care specialisation and certification [editorial] 1997 201

Scott SD In reply [letter] 1997 337

Scott SD Time to take stock and evaluate [editorial] 2004 90

Scott-Walker TM A review of the prophylaxis and treatment of postoperative nausea and vomiting 2000 157

Scoular D See Pascuet E 2010 92

Seale R See Ryan MJ 1998 304

Seale RE See Jackson JK 2001 262

Searle J See Hattingh HL 2007 174

Seaton SM Oxycodone as a component of multimodal analgesia post-caesarean section in Australia and NZ 2009 104

Seaton SM Impact of a hospital pharmacy technician facilitated medication delivery system 2010 199

See OG See Hassali MA 2014 125

Sekhar-M S The story of metformin continues… [letter] 2014 289

Selby PR See Cheh RM 2010 184

Seleem M Managing patients on antiplatelet drugs requiring emergency non-cardiac surgery 2011 132

Sellars N See Maddocks I 1994 400

Semple S See Roughead L 2004 88

Seng WT Information technology and the pharmacist [editorial] 2005 257

Seng WT See Tan CH 2014 17

Senturk-Raif R See George LJ 2011 212

Seubert LJ See Clifford RM 2011 203

Shadnia S See Abdolkarim P 2002 297

Shafie AA See Hassali MA 2009 245


Shafie AA See Elkalmi RM 2010 245

Shafie AA See Malik M 2011 73


Shafie AA Separation of the dispensing role - an indispensable health reform [letter] 2011 163

Shafie AA See Leng CB 2011 250

Shafie AA See Chin KL 2011 332

Shafie AA See Saleem F 2011 333

Shah K Angioedema possibly associated with ezetimibe 2006 301

Shah SS Should pharmacists in Australia have access to a structured general level training program? 2013 129

Shahin D See Garg S 2008 28

Shakib S See Armenores P 2006 40

Shakib S See Yu K 2007 22

Shakib S See Nguyen A 2007 111

Shakib S See Borgstedt J 2009 186

Shakib S See Lovgren S 2009 269

Shakib S See Angley M 2011 27

Shakib S See Padhye V 2012 273

Shankar PR See Das R 2005 310

Shankar PR See Palaian S 2006 77

Shankar PR See Hassali MA 2009 79

Shankar PR Impact of a medicine and therapeutics committee at a new medical college in Nepal [letter] 2009 162

Shankar PR Pharmacovigilance awareness in a medical school in Nepal [letter] 2009 245

Shankar PR Clinical pharmacy and pharmacology in Nepal [letter] 2012 247

Shankar R See Sanburg A 2011 165

Sharkey K See Parikh S 2013 62

Sharley N See Tran MD 2012 218

Sharley NA See La Forgia SP 2002 65

Sharley NA Stability and compatibility of alfentanil HCl and morphine SO4 in polypropylene syringes 2003 279

Sharley NA See Milne DJ 2004 272




Sharley NA Stability of mixtures formulated from warfarin tablets or powder 2007 95

Sharley NA See De Rosa NF 2008 212

Sharley NA See Hopkins AM 2012 115

Sharma H See Jindal D 2005 331

Sharratt G See Baysari MT 2012 246

Shastri M See Patel RP 2013 112

Shaw DR See Chu KP 2010 119

Shaw JP The four-year course in New Zealand [editorial] 1996 406

Shaw JP Development of a postgraduate educational program for pharmacist prescribers in New Zealand 2013 122

Shaw JP See Zolezzi M 2014 188

Sheehan M See Feeney GFX 1997 42

Shen S Pharmacotherapy for skin disorders in older people 2012 150

Shenfield GM See Kristoffersen SS 1997 367

Shenfield GM See Bajorek BV 2001 93

Shenfield GM See Kelly M 2004 32

Sheridan J Reporting purchasers of pseudoephedrine products to police: NZ community pharmacists' experiences 2007 19

Sheridan J See Wheeler AJ 2007 33

Sheridan L See Angley M 2011 27

Shilson AD See To TP 2008 219

Shore EG See Shore MF 2011 175

Shore MF Rethinking healthcare leadership [editorial] 2011 175

SHPA Position paper consumer product information [CPI] May 1994 1994 266

SHPA Strategic Plan 1998-2000 1999 244

SHPA Research and Development Grants Program 1999 249

SHPA Strategic Plan 1998-2000 Part 2 1999 305

SHPA Strategic Plan 1998-2000 Part 3 1999 359

SHPA Pharmaceutical funding reforms: proposed introduction of the PBS into public hospitals 2000 254

SHPA Direct to consumer advertising of prescription medicines [position statement] 2000 295

Shrestha R See Hassali MA 2009 245

Shute R See Westaway K 2014 138

Siderov J Cancer chemotherapy in the elderly [geriatric therapeutics] 1998 124

Siderov J See Ang T-S 1998 430

Siderov J See Bayles M 1999

Siderov J BCOP: a new regimen for the oncology pharmacist 1999 338

Siderov J Chemotherapy-induced diarrhoea [letter] 2000 229

Siderov J Non-sedating antihistamines for premedication in ambulatory oncology patients 2002 108

Siderov J Receiving cytotoxic drugs - standard practice or Russian Roulette? 2002 178

Siderov J Workload statistics in cytotoxic preparation - is a one-for-one approach enough? 2003 68

Siderov J Occupational exposure to cytotoxic drugs and health monitoring [letter] 2003 159

Siderov J What the-informing consumers of the cost of cytotoxic admixtures [letter] 2003 244

Siderov J PBS ANS SOS! [letter] 2005 165

Siderov J Safe handling hysteria [letter] 2005 166

Siderov J What's in a name? Lack of pronunciation in Consumer Medicine Information 2005 293

Siderov J Is the death knell for cytotoxic manufacturing in hospitals ringing? [letter] 2006 78

Siderov J See Carrington C 2007 81

Siderov J Tallman lettering - sounds good but where is the evidence? [reply letter] 2009 80

Siderov J Surface contamination of cytotoxic chemotherapy preparation areas in Australian hospital pharmacy

departments

2009 117

Siderov J External surface contamination of cytotoxic admixtures: caveat emptor 2011 181

Silva MA 2009 H1N1 pandemic influenza: let’s get involved! [editorial] 2009 259

Silva MA Stability of two long-acting insulin formalations after 28 days 2013 37

Silva MA See Rollins BM 2013 198

Sim L Patients' understanding of drug allergy and documentation-is there a link? 2005 276

Simioni D Implementation of pharmaceutical care plans in a hospital ward 1996 221

Simpson JM See Adu A 1999

Simpson JM See Smith MA 2002 227

Simpson MD The first graduate cohort at CSU: what impact on the rural pharmacist shortage? 2002 69

Simpson MD See Biddle RA 2003 55

Simpson MD Pharmaceutical care: impact on asthma medication use 2004 26

Simpson MD Developing a mentoring module to enhance an online national pharmacy preceptor training program 2006 119

Sims SA See Cutts C 2001 207

Singh A How safe is high-alert dispensing in the developing world? [letter] 2014 60




Singh D Future directions for hospital pharmacy technicians [letter] 2006 164

Singh S See Dooley MJ 2003 111

Singhal R See Ramesh M 2004 218

Singhal R See Nagavi BG 2005 332

Sinnollareddy MG See Nguyen VT 2014 35

Sirianni L See McLachlan GB 2006 81

Sission CM See Cheong EA 2008 267

Sitaram BR See Corallo C 1995 129

Skinner MJ See Tong EY 2012 140

Slader CA Audit of celecoxib and rofecoxib use: St Vincent's Public Hospital Darlinghurst 2003 74

Slader CA The Graduates' Forum [letter] 2003 157

Slader CA See Bennett A 2003 183

Slader SAA Evaluation of a weight-based heparin dosing protocol 2005 15

Slaimankhel J See Tordoff JM 2006 12

Slater W Outstanding prescriptions—the challenge 1999 216

Sless D Response to 'Who can read consumer product information?' [letter] 1997 252

Smart S Treatment of haemophilia A [letter] 1996 291

Smith AJ The efficacy of complementary medicines: where is the evidence? [editorial] 2012 174

Smith BA The stability of foscarnet in the presence of potassium [letter] 1996 560

Smith CD See Blennerhassett JD 2006 175

Smith CL Management of the older patient with multiple myeloma 2004 142

Smith K See Baker S 1998 348

Smith MA General practitioner acceptance of medication review in Sydney nursing homes 2002 227

Smith NA See Hattingh HL 2007 174

Smith T Recent PHARM meeting [letter] 1997 338

Smith W See Garg A 2013 332

Smithson J See Neave G 1994 356

Smyth JP See Yeung MY 1999

Smyth JP See Yeung MY 2000 98




Snell B See Jackson JK 2004 290

Snell B Guidelines and essential drug lists: of horses and carts [letter] 2010 331

Snellgrove CA See Hecker JR 2003 24

Snowdon GM Using genetic algorithms on a PC to compile staff rosters 1998 232

Somasundaram R Low-dose nebulised epoprostenol in the management of acute respiratory distress syndrome 2011 45

Sonallah H Medication reconciliation service conducted by clinical pharmacists in Qatar [letter] 2014 159

Sorensen L In-home medication reviews for war veterans: early experience in Australia 2004 122

Sorensen L See Ientile CS 2005 110

Sorgetti L See Pappas A 1998 312

Sorgetti L See Pappas A 1999

Sorich MJ Comparison of dextropropoxyphene and paracetamol with paracetamol after third molar dental

extractions

2004 22

Sorich MJ See Sorich W 2008 111

Sorich MJ See McKinnon RA 2008 226

Sorich MJ See Ward MB 2009 55

Sorich MJ See Gordon J 2011 271

Sorich W Vitamin B12 deficiency in the elderly using metformin long term: prevalence and relationship to

putative risk factors

2008 111

Soricj MJ See McKinnon RA 2008 55

Spalding AR See O'Shea TJ 2009 114

Spark MJ See Kemp SM 2010 275

Spark MJ See Brown KE 2012 196

Spelman D See Rayner CR 1998 394

Spelman D See Coutsouvelis J 2011 225

Spicer WJ See Rayner CR 1998 394

Spiers M BMS withdraws from New Zealand [letter] 1998 211

Spinks JM See Jackson JK 2004 290

Spooner LM See Silva MA 2009 259

Sprigg J See Sorich MJ 2004 22

Spurling L Pharmacy services to improve continuity of care-is it time for a national approach? 2006 259




Spurling LK See To TH 2007 30

Spurling LK See Angley M 2011 27

Spurling LK See Padhye V 2012 273

Srikanth VK Management of stroke in older people: a pharmacological perspective 2000 60

Srikanth VK Post-stroke emotionalism: in reply [letter] 2000 176

Staatz CE See Stowasser DA 2000 47

Stacey SR Paediatric pharmacy in Australia: where have we come from and where do we need to go? 2013 45

Stafford L Comparison of paediatric steroid mixtures [short communication] 1998 246

Stafford L Antiplatelet and proton pump inhibitor prescribing in patients with ACS [letter] 2006 79

Steadman KJ See Nissen LM 2009 129

Steadman KJ See Lau ET 2013 19

Steadman KJ See Kairuz TE 2013 117

Stehlik P See Elliott RA 2013 312

Stell R Successful integration of a clinical pharmacist into a disease management unit 2008 132

Stevens G See Dolton MJ 2012 33

Stevens M The Australian Illicit Drug Guide 2001 320

Stevenson B ISOPP symposium-a gem for oncology [letter] 2003 244

Stevenson B Highlights from the Third ISOPP Australasian regional symposium [letter] 2003 329

Stevenson B Annual MD Anderson Symposium on cancer chemotherapy 2004 41

Stevenson B Taking the midnight train to Georgia [letter] 2006 248

Stevenson B See Carrington C 2007 81

Stewart C See Pascuet E 2010 92

Stewart D Pharmacist prescribing: a view from the UK [ed] 2009 7

Stewart JM See White S 2007 321

Stewart K A practical guide to pharmaceutical care 1999 180

Stewart K Survey methodology [ed] 2000 90

Stewart K See Lau P 2000 175

Stewart K See Pappas A 2002 310

Stewart K Handbook of nonprescription drugs: an interactive approach to self-care [book review] 2003

Stewart K See George J 2006 99


Stewart K See Larizza MA 2006 115


Stewart K See Lee CY 2011 98

Stewart P Possible myocarditis with clozapine [letter] 2000 72

Stewart P Where should we be going with professional development? 2001 3

Stewart P CPMPlus an innovative web-based patient monitoring system for Clozaril centres 2001 56

Stewart P Academic capacity - missing element from the pharmacy workforce study [ed] 2010 177

Stewart PJ Hospital pharmacy research [editorial] 1997 6

Stewart PJ Where should we be going in pharmacy education? [ed] 2008 176

Stockigt JR Flawed PI and CMI for thyroid and adrenal medications: where to from here? [ed] 2007 88

Stokes J See Hale A 2009 163

Stokes J See Coombes I 2010 111

Storie WJ See Coombes ID 2001 102

Storie WJ See Mackenzie FD 2004 134

Story DA See To T-P 2013 177

Stott SA The cardiovascular effects of nasal Cophenylcaine Forte spray 1995 417

Stowasser D Ninety-seven per cent 2004 315

Stowasser DA Info quality: a major consideration in the development of medication liaison services 1997 362

Stowasser DA See McGuire TM 1997 403

Stowasser DA Can yesterday's events tell you what's going to happen tomorrow? 1999 279

Stowasser DA Identifying drug-related readmissions is there a better way of assessing the contribution of adverse

medication events?

2000 47

Stowasser DA See Coombes ID 2002 15


Stowasser DA A randomised controlled trial of medication liaison services-patient outcomes 2002 133

Stowasser DA A randomised controlled trial of medication liaison services - acceptance and use by health

professionals

2002 221

Stowasser DA See O'Leary KM 2003 93

Stowasser DA Understanding the medicines management pathway 2004 293


Stowasser DA See Hale A 2009 163




Stowasser M See Stowasser DA 2000 47



Stranks SN See Sorich W 2008 111

Streater J See Dooley MJ 2001 125

Street A See Lubliner M 2005 266

Street A See Dooley MJ 2011 208

Street AM See McDonald A 1994 285

Street PR See Moran JA 2001 115

Stride PJ See Seleem M 2011 132

Strumpman D See Kumar N 2011 108

Stuchbery P Measuring the time required to provide components of clinical pharmacy services 2007 102

Stuchbery P Determining clinical pharmacy workload by patient disease classification in medical and surgical

patients

2008 126

Stuchbery P See O'Leary KM 2010 217

Stupans I See Owen SM 2010 97

Stupans I Indicators of a quality clinical placement in pharmacy: stakeholder perspectives 2011 118

Stupans I Lifelong learning: views of Australian pharmacy interns 2012 30

Sturtevant JM See Mackenzie FD 2006 210

Sturtevant JM See Ng CS 2008 280

Su EY Anticoagulation control in hospitalised patients on warfarin 2008 292

Subish P See Mishra P 2006 81

Sucic Kim A See Armour CL 1998 410

Suen WS See Foran SM 1996 429

Suen WS Ethnic community group presentations 1999 56

Suen WS Introducing the pharmacy management program 2002 91

Suhaj A See Sekhar-M S 2014 289

Sullivan JA Prednisolone disodium phosphate stability in a prednisolone oral solution 1994 397

Summers R Pharmaceutical care — a planned approach 1996 37

Sumpter M See Masood N 2006 111

Sundararajan V See Koning SI 2013 261

Sunderland VB Four-year Bachelor of Pharmacy course in Australia [ed] 1996 405

Sunderland VB See Berbatis CG 1996 671

Sunderland VB See McNally KM 1997 22

Sunderland VB See McKnight DL 1997 390



Sunderland VB See Lim CB 2003 59

Sunderland VB See Angalakuditi M 2005 21

Sunderland VB Registration of pharmacy technicians in the UK [ed] 2005 89

Sunderland VB See Angalakuditi MV 2005 183

Sunderland VB See Joyce AW 2007 42

Sunderland VB Over-the-counter status of medicines [ed] 2009 91

Sunderland VB See Hoti K 2010 175

Sunderland VB See Wibowo Y 2012 26

Sussman G See Weller C 2006 318

Sutherland DM See Riley RH 1999

Suzuki N See Blogg LC 2012 287

Svirskis D See Garg S 2008 28

Swan BJ See Bortoletto DA 2004 288

Swan G Interferon — it should not be all Greek to pharmacists [letter] 1996 560

Swan GT Highly Specialised Drugs Program — time to reflect? [letter] 1994 175

Swan GT See Benzie JL 1997 430

Sweidan M See Jackson JK 2004 290

Sweidan M See Brien JE 2009 81

Swetenham K See Tait P 2014 120

Swift I See Brown KE 2012 196

Szabo F See De Zylva JB 2012 37

Sze RYH See Hung CW 1997 235

Szoeke C See Campbell S 2009 147

Tait P Future directions for pharmacy education 2002 263

Tait P Competency frameworks for hospital pharmacists [letter] 2009 248




Tait P Forging an advanced practice role for pharmacists in palliative care 2014 120

Tait PA Assessment drives learning 2005 211

Tait PA See Dubrava S 2007 16

Talegaonkar S See Khan ZI 2005 328

Tan A See Ng SPL 1998 177

Tan AC Medication information transfer: an exploratory study in a rural Queensland community 2012 48

Tan CH Drug cross-contamination of barcode unit dose repackager in a tertiary academic medical centre 2014 17

Tan E Quality use of medicines in children [letter] 2004 330

Tan E See Dooley MJ 2008 216

Tan EL Improving decision outcomes of drug and therapeutics committees 2003 65

Tan EL Stakeholder opinions on the implementation of drug and therapeutics committee decisions 2004 178

Tan ISP Audit of the use of a smart infusion pump’s drug libraries 2013 279

Tan MF See Kowalski SR 2010 180

Tang CD See Hopkins AM 2012 115

Tang T See Baysari MT 2012 178

Tanner F See Ho L 2005 219

Tanner FE See McLachlan GB 2008 47

Tao MM See McCrudden EA 1995 261

Tappley N See Alvarez SJ 2001 13

Targett PL Compatibility and stability of drug adjuvants and morphine tartrate in polypropylene syringes 1997 207

Targett PL Determining stability of haloperidol in 10 mL polypropylene syringes [letter] 1997 338

Targett PL Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes 1997 452

Tasker J Response to 'Who can read consumer product information?' [letter] 1997 251

Tatoulis J Statins play a crucial role in the fight against coronary heart disease [letter] 2013 332

Tattam BN See Graudins LV 2008 276

Taylor D McD See Khan M 2011 265

Taylor DR Sustained success of collaboratively developed ondansetron guidelines 1995 522

Taylor G Continuing professional development program [ed] 1996 623

Taylor G SHPA Postgraduate Studies Board of Review: final report to Federal Council 2000 121

Taylor G See O'Leary KM 2010 217

Taylor G See O'Leary KM 2013 88

Taylor G Clinical pharmacy COSP - Standards of Practice for Clinical Pharmacy Services [ed] 2013 91

Taylor KL Acceptance of a Chlamydia screening program in community pharmacies 2007 287

Taylor MJ Vancomycin: continuously used intermittently debated [letter] 2003 18

Taylor S Making of mentors and role models 2005 323

Taylor S See Simpson MD 2006 119

Taylor S See McD Taylor D 2009 24

Taylor S See Elliott RA 2009 216

Taylor SE Advanced clinical training programs [letter] 1997 412

Taylor SE Pharmacotherapy casebook: a patient-focused approach, 2nd edition [book review] 2000 231

Taylor SE Pharmacotherapy: a pathophysiologic approach, 4th edition [book review] 2000 231

Taylor SE Pharmacokinetics made easy [book review] 2003 245

Taylor SE See Valoppi G 2006 136

Taylor SE See Shah K 2006 301

Taylor SE Intervention to reduce the use of error-prone prescribing abbreviations in the emergency department 2007 214

Taylor SE See Khan M 2011 265

Taylor SE See Tran T 2012 100

Taylor SE See Booth JC 2012 296

Taylor SJ See Gallego G 2004 100

Taylor SJ See Gallego G 2005 18

Tenni P See Peng YG 2004 14

Tenni P See Angley M 2014 6

Tenni PC National survey of clinical pharmacy services 1996 416

Tenni PC See Roberts M 1997 351

Tenni PC See Bright JM 2000 10

Teo CK Understanding compliance to an antibiotic prescribing policy: perspectives of policymakers and

prescribers

2013 32

Tett S Across the dividing range-bridging the divides [ed] 2003 172

Tett SE Hospital TDM with community liaison. a pharmacokinetic study in the real world 1997 435

Tett SE Pharmacy - working together 1997 449

Tett SE See Pulver LK 1999

Tett SE Therapeutic drug monitoring and clinical toxicology-opportunities not to be missed 1999 82




Tett SE Quality use of medicines-onwards up the pyramid [ed] 2000 191

Tett SE See Duffull SB 2001 200

Tett SE See Matthews JJ 2001 279

Tett SE See Overland V 2002 232

Tett SE See Cutts C 2003 70

Thakerar A See Mellor JD 2012 181

Thakerar A See Moloney MJ 2013 49

Thakerar A Pharmacist advice on the safety of Complementary and Alternative Medicines during conventional

anticancer treatment

2014 231

Thawornchaisit P Combined neem oil 6% and eucalyptus oil 16% w/w lotion for treating head lice: in vitro and in vivo

efficacy studies

2012 189

Thiele JM See Coombes ID 2002 17

Thien H See Mirkov A 2012 278

Thom J See Peng YG 2004 14

Thomas AE See Grzeskowiak LE 2014 22

Thomas B Warfarin information on discharge summaries [letter] 2005 245

Thomas MG See Aikman KL 2013 272

Thomas S See Parthasarathi G 2004 245

Thompson B See Accordino A 1994 312

Thompson BC See Accordino A 1996 629

Thompson D See Thawornchaisit P 2012 189

Thompson W Australian pharmacists' understanding of their continuing professional development obligations 2013 213

Thomson B Fred J Boyd Award 2011 2011 302

Thomson WA See Lamour I 1997 335

Thomson WA See Pellizzer A-M 1998 432

Thomson WA See Elliott RA 1999

Thomson WA New SHPA constitution [ed] 2000 89

Thomson WA See Larmour I 2003 204

Thornton P Accountable clinical pharmacy practice [ed] 2004 258

Thornton P Health care and notions of risk [book review] 2004 333

Thornton P Reporting the real value of a hospital pharmacy service 2007 138

Thornton PD Assessment of medication errors in a seven-day issue individualised patient drug distribution system 1994 387

Thornton PD See Benrimoj SI 1995 119

Thornton PD See Benrimoj SI 1995 230

Thornton PD Information technology and hospital pharmacy practice 1996 143

Thornton PD Medication errors - a systems approach [editorial] 1997 106

Thornton PD Verification of medication orders [letter] 1997 158

Thornton PD Medication errors 1999 300

Thornton PD A responsible brave new world [editorial] 2000 190

Thornton PD Medication safety - The current state of safety in Australian hospitals 2002 11

Thornton PD Safety briefs 2002 100

Thornton PD GlaxoSmithKline Medal of Merit 2001 2002 265

Thornton PD See D'Souza DC 2004 190

Thornton PD Who is responsible for medication safety? [ed] 2009 258

Thrimawithane T See Garg S 2008 28

Thunga G Successful management of mixed amlodipine and atenolol overdose [letter] 2013 163

Thunga G See Bhagvandas NS 2013 247

Thunga G See Awasthi S 2013 248

Thunga G See Devabhaktuni R 2013 333

Thunga G See Singh A 2014 60

Thunga G See Priyadarshini M 2014 61

Thunga G See Agarwal J 2014 162

Thunga G See Sekhar-M S 2014 289

Thurlow PJ Anticoagulation in older people 1997 328

Tibballs J Eucalyptus oil — medicinal therapy or folk remedy? 1995 516

Ticehurst R See Aikman KL 2013 272

Tierney JM See McFarlane AE 1997 455

Tierney JM See Armour CL 1998 410

Tierney JT See To T-P 2000 202

Titchen T See Kainey S 2004 70

Titchen T See Juliana GS 2005 187

Tkaczuk M See Lee S-G 2007 271




Tkaczuk M See Ambados F 2008 80

Tkaczuk M See Lee S-G 2009 181

To NNL Low levels of adherence to antibiotic prescribing guidelines within emergency departments 1999 155

To TH Using personal digital assistants for a pharmacist intervention monitoring database: cost analysis 2007 30

To TP Stability of flucloxacillin in a hospital in the home program [letter] 1998 289

To TP Serotonergic and dopaminergic agents facilitate rehabilitation following hypoxic brain injury 2000 202

To TP Contrast media-implications for pharmacists 2005 33

To TP See Taylor SE 2007 214

To TP Stability of a formulated N-acetylcysteine capsule for prevention of contrast-induced nephropathy 2008 219

To TP See Ho L 2009 34

To TP Stability of intravenous flucloxacillin solutions used for hospital-in-the-home 2010 10

To TP Urinary alkalinisation with oral sodium bicarbonate for patients at risk of contrast-induced

nephropathy

2012 118

To TP See Phillips CJ 2014 63

To TP Feasibility and stability of metaraminol in pre-filled syringes 2014 89

To T-P Oral medication administration in patients with restrictions on oral intake - a snapshot survey 2013 177

Toh CT Impact of increased clinical pharmacy activities 2005 106

Toh CT See Turner SJ 2005 119

Toh CT Barriers to medication adherence in chronic heart failure patients during home visits 2010 27

Tomlin AC See Dionysopoulos D 2011 75

Tong E See Dooley MJ 2011 208

Tong N See Rayner CR 1998 394

Tonkin AL See Armenores P 2006 40

Tonti-Filippini N Ethical issues in casemix funding 1996 136

Tordoff JM Processes for the assessment and introduction of new medicines in New Zealand hospitals 2004 267

Tordoff JM Influence of the national hospital pharmaceutical strategy on the assessment of new medicines in New

Zealand public hospitals

2005 271

Tordoff JM Pharmacoeconomics: a reliable tool for decisions on new medicines? 2006 12

Tordoff JM See Plant EA 2006 271

Touma S See Nasser S 2012 129

Towers KA TSANZ annual scientic meeting [letter] 2008 77

Toy AC Possible role for clinical pharmacists in identifying pharmacogenomic interventions 2006 35

Trajceska L See Booth JC 2012 296

Tran MD Stability of amoxycillin clindamycin and meropenem in peritoneal dialysis solution 2012 218

Tran T See Elliott RA 2009 216

Tran T Development and evaluation of an hospital pharmacy generated interim residential care medication

administration card

2012 100

Tran T See Elliott RA 2014 95

Tran W Over-anticoagulation in elderly warfarinised patients 2013 283

Traverso ML Activities of an Argentinian regional centre of pharmacovigilance [letter] 2004 246

Tremewen DR See Jeffreys AJ 1994 430

Trenerry H Lithium and tardive dyskinesia [inform] 1995 192

Treseder RJ See Graudins LV 2012 95

Tribe KL See Blennerhassett JD 2006 175

Tribe RW TGA's international involvement with GMP [ed] 1997 426

Trinh D See Tucci J 2009 223

Trissel LA See Xu QA 1998 156

Truong J Australian and New Zealand Intensive Care Society meeting [letter] 2009 78

Tsingos C Learning styles: should they be considered? [letter] 2013 334

Tsui M Implementing a hospital vendor-managed inventory system 2008 40

Tsui MK See Larmour I 2003 204

Tsuyuki RT See Zolezzi M 2014 188

Tuan S Clinical pharmacy services to a nursing home — a unique situation 1994 22

Tucci J Paracetamol and ibuprofen for paediatric pain and fever 2009 223

Tuck EJ See Toh CT 2010 27

Tucker IG See Boulton DW 1994 151

Tucker IG Stability trials — how much degradation is enough? [letter] 1996 289

Tuddenham HM Public hospital application of the PBS — PBS or prescription for bureaucratic shambles? 1996 65

Tuffin PH Palliative care in Europe 1995 272

Tuffin PH See Burgess CL 2007 306

Tuffin PH See Kiani M 2011 217

Tulk RL Developing hospital pharmacy practice in Fiji 1996 392




Tulk RL Quality improvement conference: what's in it for pharmacists? 2003 218

Turner S Do we need a neonatal and paediatric pharmacists group in Australia? [letter] 1998 68

Turner S Unregistered and off-label drug use in paediatric inpatients 1999 265

Turner S Small patients big problems! 2001 64

Turner S See Kunac DL 2001 139

Turner S See Lie HKH 2002 27

Turner S Medicines for children 2nd edition [book review] 2004 161

Turner S See Angalakuditi M 2005 21

Turner S See Chui SY 2007 124

Turner S Improving safety, reducing risk 2007 136

Turner S See Graudins LV 2009 290

Turner S See Ditty A 2014 220

Turner SC Pain in childhood: the big questions 2004 48

Turner SC See Stacey SR 2013 45

Turner SJ Establishing the role of a clinical pharmacy technician 2005 119

Turnidge J Principles of appropriate prescribing of antimicrobials. Part II — practical examples 1995 202

Twaddle A See Habak JE 2013 101

Udayasiri R See Leow FHP 2006 194

Ullyot N See Pascuet E 2010 92

Unwin S See Patterson TH 2011 221

Upadhyay DK See Mishra P 2005 165

Vaillancourt R See Pascuet E 2010 92

Valiya SN Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation 2005 279

Valoppi G Analagesic selection in patients on abstinence therapies 2006 136

van Beurden E Preventing falls among older people - current practice and attitudes among community pharmacists 2003 51

Van C General practitioner perceptions of extended pharmacy services and modes of collaboration with

pharmacists

2007 182

Van De Vreede M See Lubliner M 2005 266

Van De Vreede M See Lubliner M 2006 181

Van De Vreede M Using the medical emergency team to supplement an existing adverse drug event reporting framework 2007 197

Van De Vreede M Intravenous potassium chloride use in hospitals: current practice 2008 19

Van De Vreede M Options for an ISMP affiliate in Australia 2008 51

Van De Vreede M See Dooley MJ 2008 216

Van De Vreede M Successful introduction of tallman letters to reduce medication selection errors in a hospital network 2008 263

Van De Vreede M See Dunning TL 2010 203

Van De Vreede MA Introducing a multidisciplinary medication safety program in a major hospital 2003 290

Van De Vreede MA European forum on quality improvement in health care 2005 199

Van Dyk DD See Mahler SM 2003 7

van Lent-Evers N See Boeker EB 2013 41

Vandenbroucke J Surface contamination from cytotoxic chemotherapy [letter] 2008 79

Varma M See Bhagvandas NS 2013 247

Varma S See Habak JE 2013 101

Vassarotti R See Angley M 2014 6

Vaughan F Australian medicines handbook drug choice companion: emergency and primary care 2001 237

Vaughan GN NCCTG standard for the preparation of pharmaceuticals in Australian hospital pharmacy departments

[letter]

1994 174

Vaughan GN Non-approved indications for drugs [letter] 1994 356

Vaughan K See Weekes L 2006 91

Verduci L A practical guide to pharmaceutical care [book review] 2003 331

Verma A Folic acid for methotrexate-induced neutropenia [letter] 2005 245

Vernon G Access to drugs and information [ed] 2005 258

Vernon GM Survey of drugs imported by Australian hospital pharmacy departments 1995 32

Vernon GM Development of an international network of drug information centres [on a different note] 1998 115

Vernon GM GlaxoSmithKline Medal of Merit 2000 2001 276

Vernon GM Pharmabridge - colleagues across continents [letter] 2007 80

Vernon GM Australian pharmacists and counterfeit drugs [ed] 2007 256

Vernon GM Pharmacovigilance for new drugs [ed] 2011 262

Verrinder A See Wood PJ 2004 285

Vial JH See Bereznicki LR 2007 300

Vial RJ Smoking cessation program using nicotine patches linking hospital to the community 2002 57

Vickery K See Whiteley RK 2002 153

Vidovic R Supportive care in cancer [letter] 2005 329




Viénet M Appointment of a research coordinator 1994 59

Vieyra AC See Aldama PC 2003 330

Vizgoft J See Nasser S 2012 129

Vracar D Australian General Practitioners' views on pharmacist prescribing 2008 96

Vujovic O See Rayner CR 1998 394

Vuong T Unnecessary medicines stored in homes of patients at risk of medicinal misadventure 2006 16

Vuong T See George J 2006 99

Wagner TJ Beyond metropolitan: renal pharmacy study tour [letter] 2010 165

Wainwright C See Nguyen YBN 2010 211

Walker GJ See Dollman WB 1996 229

Walker MP Medication management of adult patients admitted to hospital with epilepsy seizure or convulsion 2012 291

Wall D See Burnett D 2003 296

Wall GC See Crosara SLR 2013 221

Wallace AT See Yeung MY 1996 556

Walsh M Casemix as a management tool — the pros and cons 1996 132

Walsh MK See Lubliner M 2005 266

Walsh RL See Boyd IW 2008 23

Walter MD See Hudson BJ 1995 257

Walton N Rapid desensitisation of an immunocompetent patient with cotrimoxazole hypersensitivity 2010 130

Wan V Meeting of pharmacy students from the Asia-Pacific region [letter] 2005 329

Wan V MPH: a post-graduate study opportunity for pharmacists [letter] 2012 248

Wanandy T See Patel RP 2013 112

Wang L Antiplatelet therapy for acute coronary syndromes 2000 270

Ward M Gene profiles in drug design [book review] 2008 334

Ward M See Tran MD 2012 218

Ward MB See McKinnon RA 2003 133



Ward MB Cytochrome P450 part 3: impact of drug-drug interactions 2009 55

Ware GJ Unit-of-issue medicine administration: time and cost-benefits in a geriatric unit 1994 329

Wark JD See Choo CS 2006 246

Warne GL The treatment of growth disorders 1994 444

Warren J See Calabretto JP 2005 99

Warrior N Hospira Young Pharmacist Award in 2013: Optimising your dosing: optimising your practice [grant

report]

2014 291

Wee JS Prolonged antibiotic therapy for recurrent urinary tract infections in aged-care residents: time to

change the dogma?

2007 108

Weekes L Medicines information for consumers [ed] 2006 91

Weekes L Quality use of medicines and the life journey [ed] 2009 172

Weekes LM The impact of the Special Access Scheme on a hospital pharmacy department 1994 307

Weekes LM See Bicknell ME 1995 527

Weekes LM Performance quality and outcomes [ed] 1996 308

Weekes LM See Day R 1996 622

Weekes LM See Rowe L 1998 38

Weekes LM National Prescribing Service and educational visits 1999 290

Weekes LM Understanding influencing and evaluating drug use 2002 161

Weeks G Prescribing for success [letter] 2010 80

Weeks GR Public hospital pharmacists competing in the private sector 1996 49

Weeks GR A journey through quality in health care, medication safety and electronic prescribing 2003 124

Weeks GR See Larmour I 2003 204

Weeks GR Pharmacist prescribing: let's have the debate [ed] 2004 4

Weeks GR See Bortoletto DA 2004 288

Weeks GR See Birdsey GH 2005 287

Weeks GR Collaborative prescribing: views of SHPA pharmacist members 2008 271

Weeks GR Australian hospital pharmacists' experiences of a UK non-medical prescribing course 2010 187

Weeks GR Hospital pharmacist-led lipid clinic for surgical patients with peripheral vascular disease at a regional

Australian hospital

2012 17

Wein S Ketamine as a possible cause of delirium 2002 212

Weir M See Ryan RE 2011 295

Welch S See Weekes LM 1994 307

Welch S Emergency medicine pharmacy [ed] 2006 88

Welch S See Betteridge F 2007 78




Welch S Australian Clinical Pharmacy Award 2009 2009 313

Welch S Decanting chlorhexidine antiseptic solution into sterile dishes [letter] 2010 333

Welch S See Baysari MT 2012 246

Welch SA The evolving area of emergency medicine pharmacy 1997 325

Welch SA Promoting rational prescribing by emergency department junior medical officers 2000 262

Welch SA The use of complementary medicines by inpatients at St Vincent's Hospital Sydney 2001 110

Welch SA Role of the pharmacy technician in Emergency 2003 16

Welch SA See Slader CA 2003 74

Welch SA See Lawler C 2004 174

Welch SA See Slader SA 2005 15

Welch SA Pharmaceutical review-emergency medicine pharmacist perspective [ed] 2006 261

Welch SA Scope of pharmacy services to the emergency department 2007 27

Welch SA See Lehnbom EC 2009 45

Welch SA See Munzner EE 2012 264

Welch SA See Morrow MK 2012 333

Welch SA See Ng C 2013 25

Welch SA Fasting and medication omissions [letter] 2013 162

Welch SA Mobile-device-accessible information for emergency department doctors [letter] 2014 161

Welch SA See Heath EK 2014 201

Weller C Wound dressings update 2006 318

Wendel N See Siderov J 2002 108

Went D See Garrett T 2010 269

West KM See Welch SA 2003 16

Westaway K Safe use of statins in elderly people 2014 138

Westaway KP Optimising therapy for patients with neuropathic pain 2014 44

Westbrook JI See Lo C 2010 10

Wheeler AJ Developing clinical practice guidelines for the medication management of acute behavioural

disturbance

2007 33

Whennan LD Impact of pharmaceutical reforms on non-prescription medication management in post-natal women

following discharge from hospital

2012 22

Whicker SD See Welch SA 2000 262

Whitby RM See Radford JM 1997 140

White S See McKnight DL 1997 390

White S Role of adjuvant therapy in older people with breast cancer 2007 321

Whitehead C See Ng D 1999 84

Whiteley RK Biofilms that impact on human health 2002 153

Whitfield K See Coombes I 2010 111

Whitfield K ASHP midyear clinical meeting 2010 [letter] 2011 76

Whitfield K Innovation – an essential leadership skill, limited only be one’s own imagination [grant report] 2014 167

Whitlock A See Dooley MJ 2008 188

Whitty JA To determine the importance of ward pharmacists reviewing discharge prescriptions 2001 300

Whyte IM See Drew A 2000 71

Wibowo Y Comparative analysis of rural community pharmacy practice in Western Australia in 2002 and 2006 2012 26

Widagdo IS Prevalence of potentially inappropriate medication use in elderly hospitalised patients 2011 122

Wiedmann RJ See Andrews HP 2001 183

Wiese MD Raised INR with concurrent warfarin and azithromycin 1999 159

Wiese MD Unexpected orthostatic hypotension with venlafaxine 1999 215

Wilcox C The medication chart as an integral tool in the pharmaceutical care plan 2001 268

Wilkes J Board of Pharmaceutical Specialties Oncology [on a different note] 2000 118

Wilkes J Not just Gatorade and gridiron-bone marrow transplant too 2004 129

Wilkinson JM See Simpson MD 2002 69

Wilkinson JM See Biddle RA 2003 55

Wilkinson TJ See Scott SD 1994 325

Wilkinson TJ See Rumsey S 1995 145

Wilks JJ See Dooley MJ 2001 125

Williams AF See Dunning TL 2010 203

Williams Db See Sharley NA 2007 95

Williams ID See Freeman C 2012 184

Williams ID See Freeman C 2014 240

Williams K See Pham L 2003 275

Williams KA See Gu P 2011 196

Williams L See To TP 2010 101




Williams R Changes in society affecting medicine and pharmacy 1994 83

Williams TJ See Hirth KE 2002 185

Williamson M See Brown JA 2009 281

Willis J See Roberts JA 2007 200

Willis M See Nguyen YBN 2010 211

Wilmot V See Carrington C 2007 81

Wilmott V Variety in Vancouver - International Symposium on Oncology Pharmacy Practice 2002 305

Wilmott V International symposium on oncology pharmacy practice 2004 210

Wilmott V International symposium on oncology pharmacy practice 2007 47

Wilsher ML See Aikman KL 2013 272

Wilson DI See Tsui M 2008 40

Wilson KM See Schneider JJ 1997 29

Wilson R See Larizza MA 2009 277

Wilson RK Severe infusion-related reaction to liposomal amphotericin B 2013 51

Wilson SG See Van De Vreede M 2008 19

Wilson SG See O'Leary KM 2013 88

Wiltshire SL See Armenores P 2006 40

Winearls JR See Ballantine DL 2014 108

Winkle CM See McDonald PK 2003 114

Winspear C See Slater W 1999 216

Winter SJ Evaluation of consumer medicine information provision from an outpatient dispensary 2013 11

Wiseman M See Van De Vreede M 2008 263

Witney KA See Coutsouvelis J 2011 225

Wodak AD See Bramley-Moore SR 1998 83

Wong EM See Larmour I 1998 226

Wong J Prevalence and validity of self-reported antibiotic allergy in emergency department patients 2008 92

Wong VK Stability of Konakion repacked in dropper bottles for oral administration 1996 641

Wood MJ See Larmour I 1998 226

Wood P See Seleem M 2011 132

Wood PJ Community pharmacists and men's health in rural Victoria 2004 285

Woodford HJ Managing behavioural symptoms of dementia [letter] 2005 327

Woodhouse D Correction 1 [letter] 1997 159

Woods DJ See Boulton DW 1994 151

Woods DJ See Fawcett JP 1995 19

Woods DJ Use of tablets to formulate oral liquid preparations [letter] 1995 52

Woods DJ The academic-practitioner — a vital role in pharmacy education [ed] 1996 407

Woods DJ See Fawcett JP 1996 552

Woods DJ See Vernon GM 1998 115

Woods M See Lumby J 2010 259

Woodward M Hypnosedatives and the elderly-are we doing enough to reduce risk and improve outcomes? [ed] 2006 5

Woodward M Immunisation of older people 2012 316

Woodward M See Elliott RA 2014 95

Woodward MC See Fong CM 1995 372

Woodward MC Tacrine — for and against. The case for 1995 566

Woodward MC The management of insomnia in older people 1996 462

Woodward MC See Lim WK 1999

Woodward MC See Elliott RA 2001 19

Woodward MC See Harvey PA 2001 212

Woodward MC Constipation in older people pharmacological management issues 2002 37


Woodward MC Prevention of Alzheimer's disease and other dementias 2003 138

Woodward MC Deprescribing: achieving better health outcomes for older people through reducing medications 2003 323

Woodward MC Pharmacological treatment of challenging neuropsychiatric symptoms of dementia 2005 228

Woodward MC Managing insomnia in older people 2007 236

Woodward MC See Roughead EE 2008 14


Woodward MC Drug treatments in development for Alzheimer's disease 2012 58

Workman B See Parikh S 2013 62

Workman BS Management of chronic pain in older people 1998 361

Worswick J See Ryan RE 2011 295

Woulfe J See Owen SM 2010 97

Wright C Advances at AIDS 2014. What does the future look like and how can we better use the tools we have 2014 183




now?

Wright F Oncology pharmacy practice in the pharmacogenomic age [letter] 2010 246

Wright M The lion the witch and the wardrobe [letter] 2003 16

Wright S See O'Leary K 2009 293

Wu TS Providing quality patient care that is safe and efficient - is it available? [ed] 2009 11

Wu TS Can pharmacists afford not to champion medication safety? [ed] 2010 176

Wu TS Patient safety must be a priority [ed] 2012 258

Wyer S National Medicines Week activities 1999 57

Wyer SL Documentation of penicillin allergy in a veterans' hospital 1997 296

Wyer SL A review of pharmacy services in Australian collocated hospitals 2000 256

Wykes C Hib vaccine in splenectomised patients [inform] 1995 489

Xu QA Compatibility of paclitaxel in 5% glucose and 0.9% NS injections with EVA minibags 1998 156

Xue Z See Daftary MN 2003 265

Yao M See Lim SCB 2008 191

Yates M Urinary tract infection in the elderly 1999 166

Yau L See Bajorek BV 2009 13

Yeatman HR See Mullan JR 2003 284

Yee J See Young J 2006 275

Yee KC See Bushell MA 2013 292

Yee KC See El-den S 2014 224

Yeung MY Flexible film isolator: an inexpensive option for small volume aseptic dispensing 1996 556

Yeung MY Concurrent frusemide-theophylline dosing reduces serum vancomycin concentrations in preterm

infants

1999 269

Yeung MY Targeting gentamicin concentration in babies: the younger the baby the larger the loading dose and the

longer the dose interval

2000 98

Yeung MY Transient profound thrombocytopenia in a premature infant: is this a ranitidine-induced immune

reaction? [clinical communication]

2000 172

Yeung MY Hypertension and bradycardia associated with high-dose dexamethasone in a premature infant with

borderline hyponatraemia [clinical communication]

2000 205

Yeung MY Targeting gentamicin therapeutic ranges during the first week of life in infants in neonatal intensive

care

2001 291

Yeung S See O'Leary K 2009 293

Yin C Prevalence of complementary and alternative medicine use by adults with cystic fibrosis 2002 320

Yip A Identifying temporal changes to the prescribing of anti-arrhythmics for atrial fibrillation 2010 285

Yip AY See Kiani M 2011 217

Young CE See McFarlane AE 1997 455

Young J Feasibility of monitoring biochemical and haemodynamic effects of ACE inhibitors 2006 275

Young R See Feeney GF 1997 42

Young RS See Peterson GM 1996 545

Youngman J Medicines managers-the next generation [ed] 2005 261

Yu AM See Sharley NA 2007 95

Yu K Enhancing continuity of care in therapeutics: development of a post-discharge home medicines review

model

2007 22

Yu K See Nguyen A 2007 111

Zeglinski P See To TP 2014 89

Zeimer H Medications and falls in older people 2008 148

Zhang G See Lim SC 2008 191

Zhang JY See Boyd IW 2008 23

Zimmet H Beta-blockers for treatment of heart failure in the elderly 2006 229

Zolezzi M Drug use evaluation of ondansetron in postoperative nausea and vomiting 2007 11

Zolezzi M Investigation of trigger tools for detecting adverse drug reactions 2007 225

Zolezzi M Provision of health/disease screening and medication monitoring/management in New Zealand

community pharmacies

2014 188

Zulkifly HH See Abd Wahab MS 2013 162

Zulueta W See Bajorek BV 2009 13

the journal of pharmacy practice and research · ahmed d see sonallah h 2014 159 ... journal of...

Documents